Protein	Len	3	4	8	11	12	16	LogFoldChange	absolute value logfoldchange	Zstatistic	absolute value z statistic	fdr	FDRup	FDRdown																												
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	GO:0004674			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0005089			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0005524			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0005576			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0005829			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0005863			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0005886			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0007275			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0014704			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0016604			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0030018			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0030154			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0030506			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0031430			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0031432			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0035023			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0042383			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0046777			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_HMCN1.23.44|m.42684	6167	129	6	172	198	226	213	0.765	0.765	10.9093	10.9093	0	0	0.541437	CHOYP_HMCN1.23.44|m.42684	A2AAJ9	OBSCN_MOUSE	21.8	1697	1028	71	4110	5740	3547	5010	1.00E-49	202	1	A2AAJ9	OBSCN_MOUSE	reviewed	Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK)	Obscn Gm878	Mus musculus (Mouse)	8891	cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]	 GO:0046872			cd00063;	PF00041;PF07679;PF00612;PF00069;PF00621;	cytosol [GO:0005829]; extracellular region [GO:0005576]; intercalated disc [GO:0014704]; M band [GO:0031430]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; striated muscle myosin thick filament [GO:0005863]; Z disc [GO:0030018]; ankyrin binding [GO:0030506]; ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine/threonine kinase activity [GO:0004674]; Rho guanyl-nucleotide exchange factor activity [GO:0005089]; titin binding [GO:0031432]; cell differentiation [GO:0030154]; multicellular organism development [GO:0007275]; protein autophosphorylation [GO:0046777]; regulation of Rho protein signal transduction [GO:0035023]
CHOYP_BRAFLDRAFT_80496.6.10|m.29014	5311	35	43	43	99	108	79	0.907	0.907	9.5591	9.5591	0	0	0.541501	CHOYP_BRAFLDRAFT_80496.6.10|m.29014	Q6DFV8	VWDE_MOUSE	29.2	250	153	9	4630	4867	394	631	2.00E-20	103	1	Q6DFV8	VWDE_MOUSE	reviewed	von Willebrand factor D and EGF domain-containing protein	Vwde Gm467	Mus musculus (Mouse)	926		GO:0005576				PF00094;	extracellular region [GO:0005576]
CHOYP_LOC101173335.2.4|m.33982	2976	64	16	91	115	106	128	0.757	0.757	8.4281	8.4281	0	0	0.541566	CHOYP_LOC101173335.2.4|m.33982	P15989	CO6A3_CHICK	23.35	1884	1260	64	1	1826	53	1810	1.00E-117	424	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	GO:0004867			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC101173335.2.4|m.33982	2976	64	16	91	115	106	128	0.757	0.757	8.4281	8.4281	0	0	0.541566	CHOYP_LOC101173335.2.4|m.33982	P15989	CO6A3_CHICK	23.35	1884	1260	64	1	1826	53	1810	1.00E-117	424	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0005578			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC101173335.2.4|m.33982	2976	64	16	91	115	106	128	0.757	0.757	8.4281	8.4281	0	0	0.541566	CHOYP_LOC101173335.2.4|m.33982	P15989	CO6A3_CHICK	23.35	1884	1260	64	1	1826	53	1810	1.00E-117	424	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0005581			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC101173335.2.4|m.33982	2976	64	16	91	115	106	128	0.757	0.757	8.4281	8.4281	0	0	0.541566	CHOYP_LOC101173335.2.4|m.33982	P15989	CO6A3_CHICK	23.35	1884	1260	64	1	1826	53	1810	1.00E-117	424	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0007155			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_contig_045550|m.53021	249	22	7	19	60	57	64	1.369	1.369	7.9869	7.9869	0	0	0.541649																												
CHOYP_LOC100538313.1.1|m.64152	3294	46	10	78	90	87	113	0.805	0.805	7.8923	7.8923	0	0	0.541677	CHOYP_LOC100538313.1.1|m.64152	P15989	CO6A3_CHICK	23.36	1952	1284	67	40	1935	38	1833	7.00E-104	379	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	GO:0004867			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC100538313.1.1|m.64152	3294	46	10	78	90	87	113	0.805	0.805	7.8923	7.8923	0	0	0.541677	CHOYP_LOC100538313.1.1|m.64152	P15989	CO6A3_CHICK	23.36	1952	1284	67	40	1935	38	1833	7.00E-104	379	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0005578			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC100538313.1.1|m.64152	3294	46	10	78	90	87	113	0.805	0.805	7.8923	7.8923	0	0	0.541677	CHOYP_LOC100538313.1.1|m.64152	P15989	CO6A3_CHICK	23.36	1952	1284	67	40	1935	38	1833	7.00E-104	379	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0005581			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC100538313.1.1|m.64152	3294	46	10	78	90	87	113	0.805	0.805	7.8923	7.8923	0	0	0.541677	CHOYP_LOC100538313.1.1|m.64152	P15989	CO6A3_CHICK	23.36	1952	1284	67	40	1935	38	1833	7.00E-104	379	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0007155			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	GO:0001725			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0004687			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0005524			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0005737			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0005911			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0006939			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0014820			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0019899			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0030027			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0030335			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0032060			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0032154			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0035690			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0035865			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0046872			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0051928			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0060414			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0070062			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0071277			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0071476			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_HMCN1.19.44|m.39500	3182	59	4	80	100	104	98	0.785	0.785	7.5846	7.5846	0	0	0.541757	CHOYP_HMCN1.19.44|m.39500	Q6PDN3	MYLK_MOUSE	23.24	766	470	30	2262	2933	39	780	6.00E-23	112	1	Q6PDN3	MYLK_MOUSE	reviewed	"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]"	Mylk	Mus musculus (Mouse)	1941	aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]	 GO:0090303			cd00063;	PF00041;PF07679;PF00069;	cell-cell junction [GO:0005911]; cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; stress fiber [GO:0001725]; ATP binding [GO:0005524]; enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687]; aorta smooth muscle tissue morphogenesis [GO:0060414]; bleb assembly [GO:0032060]; cellular hypotonic response [GO:0071476]; cellular response to calcium ion [GO:0071277]; cellular response to drug [GO:0035690]; cellular response to potassium ion [GO:0035865]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell migration [GO:0030335]; positive regulation of wound healing [GO:0090303]; smooth muscle contraction [GO:0006939]; tonic smooth muscle contraction [GO:0014820]
CHOYP_CO6A3.3.5|m.39796	2929	38	9	65	79	75	92	0.821	0.821	7.2658	7.2658	0	0	0.54184	CHOYP_CO6A3.3.5|m.39796	P15989	CO6A3_CHICK	23.36	1948	1262	72	345	2225	32	1815	2.00E-104	380	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	GO:0004867			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_CO6A3.3.5|m.39796	2929	38	9	65	79	75	92	0.821	0.821	7.2658	7.2658	0	0	0.54184	CHOYP_CO6A3.3.5|m.39796	P15989	CO6A3_CHICK	23.36	1948	1262	72	345	2225	32	1815	2.00E-104	380	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0005578			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_CO6A3.3.5|m.39796	2929	38	9	65	79	75	92	0.821	0.821	7.2658	7.2658	0	0	0.54184	CHOYP_CO6A3.3.5|m.39796	P15989	CO6A3_CHICK	23.36	1948	1262	72	345	2225	32	1815	2.00E-104	380	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0005581			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_CO6A3.3.5|m.39796	2929	38	9	65	79	75	92	0.821	0.821	7.2658	7.2658	0	0	0.54184	CHOYP_CO6A3.3.5|m.39796	P15989	CO6A3_CHICK	23.36	1948	1262	72	345	2225	32	1815	2.00E-104	380	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0007155			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC100369657.2.2|m.45309	552	7	1	13	33	39	29	1.622	1.622	7.1629	7.1629	0	0	0.541876	CHOYP_LOC100369657.2.2|m.45309	P19891	ASNS_CRIGR	57.96	559	224	4	1	550	1	557	0	694	1	P19891	ASNS_CRIGR	reviewed	Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Glutamine-dependent asparagine synthetase)	ASNS AS	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	561	glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]	GO:0004066	PATHWAY: Amino-acid biosynthesis; L-asparagine biosynthesis; L-asparagine from L-aspartate (L-Gln route): step 1/1.		cd01991;cd00712;	PF00733;PF13537;	asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]
CHOYP_LOC100369657.2.2|m.45309	552	7	1	13	33	39	29	1.622	1.622	7.1629	7.1629	0	0	0.541876	CHOYP_LOC100369657.2.2|m.45309	P19891	ASNS_CRIGR	57.96	559	224	4	1	550	1	557	0	694	1	P19891	ASNS_CRIGR	reviewed	Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Glutamine-dependent asparagine synthetase)	ASNS AS	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	561	glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]	 GO:0005524	PATHWAY: Amino-acid biosynthesis; L-asparagine biosynthesis; L-asparagine from L-aspartate (L-Gln route): step 1/1.		cd01991;cd00712;	PF00733;PF13537;	asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]
CHOYP_LOC100369657.2.2|m.45309	552	7	1	13	33	39	29	1.622	1.622	7.1629	7.1629	0	0	0.541876	CHOYP_LOC100369657.2.2|m.45309	P19891	ASNS_CRIGR	57.96	559	224	4	1	550	1	557	0	694	1	P19891	ASNS_CRIGR	reviewed	Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Glutamine-dependent asparagine synthetase)	ASNS AS	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	561	glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]	 GO:0006541	PATHWAY: Amino-acid biosynthesis; L-asparagine biosynthesis; L-asparagine from L-aspartate (L-Gln route): step 1/1.		cd01991;cd00712;	PF00733;PF13537;	asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]
CHOYP_LOC100369657.2.2|m.45309	552	7	1	13	33	39	29	1.622	1.622	7.1629	7.1629	0	0	0.541876	CHOYP_LOC100369657.2.2|m.45309	P19891	ASNS_CRIGR	57.96	559	224	4	1	550	1	557	0	694	1	P19891	ASNS_CRIGR	reviewed	Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Glutamine-dependent asparagine synthetase)	ASNS AS	Cricetulus griseus (Chinese hamster) (Cricetulus barabensis griseus)	561	glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]	 GO:0070981	PATHWAY: Amino-acid biosynthesis; L-asparagine biosynthesis; L-asparagine from L-aspartate (L-Gln route): step 1/1.		cd01991;cd00712;	PF00733;PF13537;	asparagine synthase (glutamine-hydrolyzing) activity [GO:0004066]; ATP binding [GO:0005524]; glutamine metabolic process [GO:0006541]; L-asparagine biosynthetic process [GO:0070981]
CHOYP_LOC101169658.2.3|m.20752	325	11	5	21	24	35	76	1.339	1.339	6.9635	6.9635	0	0	0.54194																												
CHOYP_PPUTW619_2764.1.1|m.44946	1034	32	2	44	51	57	55	0.771	0.771	6.1333	6.1333	0	0	0.542239																												
CHOYP_contig_041958|m.48141	140	33	33	43	53	75	76	0.659	0.659	5.6106	5.6106	0	0	0.542392																												
CHOYP_CATA.3.3|m.21642	517	41	24	51	65	63	81	0.626	0.626	5.3915	5.3915	0	0	0.542568	CHOYP_CATA.3.3|m.21642	Q9XZD5	CATA_TOXGO	59.96	472	184	4	24	491	16	486	0	584	1	Q9XZD5	CATA_TOXGO	reviewed	Peroxisomal catalase (EC 1.11.1.6)		Toxoplasma gondii	502	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	GO:0004096				PF00199;PF06628;	peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]
CHOYP_CATA.3.3|m.21642	517	41	24	51	65	63	81	0.626	0.626	5.3915	5.3915	0	0	0.542568	CHOYP_CATA.3.3|m.21642	Q9XZD5	CATA_TOXGO	59.96	472	184	4	24	491	16	486	0	584	1	Q9XZD5	CATA_TOXGO	reviewed	Peroxisomal catalase (EC 1.11.1.6)		Toxoplasma gondii	502	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	 GO:0005777				PF00199;PF06628;	peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]
CHOYP_CATA.3.3|m.21642	517	41	24	51	65	63	81	0.626	0.626	5.3915	5.3915	0	0	0.542568	CHOYP_CATA.3.3|m.21642	Q9XZD5	CATA_TOXGO	59.96	472	184	4	24	491	16	486	0	584	1	Q9XZD5	CATA_TOXGO	reviewed	Peroxisomal catalase (EC 1.11.1.6)		Toxoplasma gondii	502	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	 GO:0006979				PF00199;PF06628;	peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]
CHOYP_CATA.3.3|m.21642	517	41	24	51	65	63	81	0.626	0.626	5.3915	5.3915	0	0	0.542568	CHOYP_CATA.3.3|m.21642	Q9XZD5	CATA_TOXGO	59.96	472	184	4	24	491	16	486	0	584	1	Q9XZD5	CATA_TOXGO	reviewed	Peroxisomal catalase (EC 1.11.1.6)		Toxoplasma gondii	502	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	 GO:0020037				PF00199;PF06628;	peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]
CHOYP_CATA.3.3|m.21642	517	41	24	51	65	63	81	0.626	0.626	5.3915	5.3915	0	0	0.542568	CHOYP_CATA.3.3|m.21642	Q9XZD5	CATA_TOXGO	59.96	472	184	4	24	491	16	486	0	584	1	Q9XZD5	CATA_TOXGO	reviewed	Peroxisomal catalase (EC 1.11.1.6)		Toxoplasma gondii	502	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	 GO:0042744				PF00199;PF06628;	peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]
CHOYP_CATA.3.3|m.21642	517	41	24	51	65	63	81	0.626	0.626	5.3915	5.3915	0	0	0.542568	CHOYP_CATA.3.3|m.21642	Q9XZD5	CATA_TOXGO	59.96	472	184	4	24	491	16	486	0	584	1	Q9XZD5	CATA_TOXGO	reviewed	Peroxisomal catalase (EC 1.11.1.6)		Toxoplasma gondii	502	hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]	 GO:0046872				PF00199;PF06628;	peroxisome [GO:0005777]; catalase activity [GO:0004096]; heme binding [GO:0020037]; metal ion binding [GO:0046872]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]
CHOYP_LOC100486063.5.9|m.39538	1913	45	15	61	64	71	75	0.607	0.607	5.3557	5.3557	0	0	0.542605	CHOYP_LOC100486063.5.9|m.39538	Q8C6K9	CO6A6_MOUSE	23.6	1140	734	33	796	1912	26	1051	7.00E-66	252	1	Q8C6K9	CO6A6_MOUSE	reviewed	Collagen alpha-6(VI) chain	Col6a6	Mus musculus (Mouse)	2265	cell adhesion [GO:0007155]	GO:0005576				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_LOC100486063.5.9|m.39538	1913	45	15	61	64	71	75	0.607	0.607	5.3557	5.3557	0	0	0.542605	CHOYP_LOC100486063.5.9|m.39538	Q8C6K9	CO6A6_MOUSE	23.6	1140	734	33	796	1912	26	1051	7.00E-66	252	1	Q8C6K9	CO6A6_MOUSE	reviewed	Collagen alpha-6(VI) chain	Col6a6	Mus musculus (Mouse)	2265	cell adhesion [GO:0007155]	 GO:0005578				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_LOC100486063.5.9|m.39538	1913	45	15	61	64	71	75	0.607	0.607	5.3557	5.3557	0	0	0.542605	CHOYP_LOC100486063.5.9|m.39538	Q8C6K9	CO6A6_MOUSE	23.6	1140	734	33	796	1912	26	1051	7.00E-66	252	1	Q8C6K9	CO6A6_MOUSE	reviewed	Collagen alpha-6(VI) chain	Col6a6	Mus musculus (Mouse)	2265	cell adhesion [GO:0007155]	 GO:0005581				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_LOC100486063.5.9|m.39538	1913	45	15	61	64	71	75	0.607	0.607	5.3557	5.3557	0	0	0.542605	CHOYP_LOC100486063.5.9|m.39538	Q8C6K9	CO6A6_MOUSE	23.6	1140	734	33	796	1912	26	1051	7.00E-66	252	1	Q8C6K9	CO6A6_MOUSE	reviewed	Collagen alpha-6(VI) chain	Col6a6	Mus musculus (Mouse)	2265	cell adhesion [GO:0007155]	 GO:0007155				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_LOC587610.3.3|m.27175	706	10	7	26	31	41	33	0.943	0.943	5.2757	5.2757	0	0	0.542693	CHOYP_LOC587610.3.3|m.27175	P00687	AMY1_MOUSE	52.49	503	202	14	15	482	5	505	9.00E-160	478	1	P00687	AMY1_MOUSE	reviewed	"Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary and hepatic alpha-amylase)"	Amy1 Amy-1-a Amy1a	Mus musculus (Mouse)	511	carbohydrate catabolic process [GO:0016052]	GO:0004556				PF00128;PF02806;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]
CHOYP_LOC587610.3.3|m.27175	706	10	7	26	31	41	33	0.943	0.943	5.2757	5.2757	0	0	0.542693	CHOYP_LOC587610.3.3|m.27175	P00687	AMY1_MOUSE	52.49	503	202	14	15	482	5	505	9.00E-160	478	1	P00687	AMY1_MOUSE	reviewed	"Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary and hepatic alpha-amylase)"	Amy1 Amy-1-a Amy1a	Mus musculus (Mouse)	511	carbohydrate catabolic process [GO:0016052]	 GO:0005509				PF00128;PF02806;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]
CHOYP_LOC587610.3.3|m.27175	706	10	7	26	31	41	33	0.943	0.943	5.2757	5.2757	0	0	0.542693	CHOYP_LOC587610.3.3|m.27175	P00687	AMY1_MOUSE	52.49	503	202	14	15	482	5	505	9.00E-160	478	1	P00687	AMY1_MOUSE	reviewed	"Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary and hepatic alpha-amylase)"	Amy1 Amy-1-a Amy1a	Mus musculus (Mouse)	511	carbohydrate catabolic process [GO:0016052]	 GO:0005615				PF00128;PF02806;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]
CHOYP_LOC587610.3.3|m.27175	706	10	7	26	31	41	33	0.943	0.943	5.2757	5.2757	0	0	0.542693	CHOYP_LOC587610.3.3|m.27175	P00687	AMY1_MOUSE	52.49	503	202	14	15	482	5	505	9.00E-160	478	1	P00687	AMY1_MOUSE	reviewed	"Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary and hepatic alpha-amylase)"	Amy1 Amy-1-a Amy1a	Mus musculus (Mouse)	511	carbohydrate catabolic process [GO:0016052]	 GO:0016052				PF00128;PF02806;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]
CHOYP_LOC587610.3.3|m.27175	706	10	7	26	31	41	33	0.943	0.943	5.2757	5.2757	0	0	0.542693	CHOYP_LOC587610.3.3|m.27175	P00687	AMY1_MOUSE	52.49	503	202	14	15	482	5	505	9.00E-160	478	1	P00687	AMY1_MOUSE	reviewed	"Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary and hepatic alpha-amylase)"	Amy1 Amy-1-a Amy1a	Mus musculus (Mouse)	511	carbohydrate catabolic process [GO:0016052]	 GO:0016160				PF00128;PF02806;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]
CHOYP_LOC587610.3.3|m.27175	706	10	7	26	31	41	33	0.943	0.943	5.2757	5.2757	0	0	0.542693	CHOYP_LOC587610.3.3|m.27175	P00687	AMY1_MOUSE	52.49	503	202	14	15	482	5	505	9.00E-160	478	1	P00687	AMY1_MOUSE	reviewed	"Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary and hepatic alpha-amylase)"	Amy1 Amy-1-a Amy1a	Mus musculus (Mouse)	511	carbohydrate catabolic process [GO:0016052]	 GO:0031404				PF00128;PF02806;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]
CHOYP_LOC587610.3.3|m.27175	706	10	7	26	31	41	33	0.943	0.943	5.2757	5.2757	0	0	0.542693	CHOYP_LOC587610.3.3|m.27175	P00687	AMY1_MOUSE	52.49	503	202	14	15	482	5	505	9.00E-160	478	1	P00687	AMY1_MOUSE	reviewed	"Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary and hepatic alpha-amylase)"	Amy1 Amy-1-a Amy1a	Mus musculus (Mouse)	511	carbohydrate catabolic process [GO:0016052]	 GO:0070062				PF00128;PF02806;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; amylase activity [GO:0016160]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]
CHOYP_BRAFLDRAFT_118790.1.1|m.29970	507	6	8	8	26	21	25	1.224	1.224	5.0471	5.0471	0	0	0.542948	CHOYP_BRAFLDRAFT_118790.1.1|m.29970	Q9C6B9	PEAM3_ARATH	51.81	496	228	4	10	503	3	489	8.00E-177	513	1	Q9C6B9	PEAM3_ARATH	reviewed	Phosphoethanolamine N-methyltransferase 3 (EC 2.1.1.103)	NMT3 At1g73600 F25P22.1 F6D5.1	Arabidopsis thaliana (Mouse-ear cress)	490	methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]	GO:0000234	PATHWAY: Phospholipid metabolism; phosphatidylcholine biosynthesis; phosphocholine from phosphoethanolamine: step 1/1.			PF08241;	cytoplasm [GO:0005737]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]
CHOYP_BRAFLDRAFT_118790.1.1|m.29970	507	6	8	8	26	21	25	1.224	1.224	5.0471	5.0471	0	0	0.542948	CHOYP_BRAFLDRAFT_118790.1.1|m.29970	Q9C6B9	PEAM3_ARATH	51.81	496	228	4	10	503	3	489	8.00E-177	513	1	Q9C6B9	PEAM3_ARATH	reviewed	Phosphoethanolamine N-methyltransferase 3 (EC 2.1.1.103)	NMT3 At1g73600 F25P22.1 F6D5.1	Arabidopsis thaliana (Mouse-ear cress)	490	methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]	 GO:0005737	PATHWAY: Phospholipid metabolism; phosphatidylcholine biosynthesis; phosphocholine from phosphoethanolamine: step 1/1.			PF08241;	cytoplasm [GO:0005737]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]
CHOYP_BRAFLDRAFT_118790.1.1|m.29970	507	6	8	8	26	21	25	1.224	1.224	5.0471	5.0471	0	0	0.542948	CHOYP_BRAFLDRAFT_118790.1.1|m.29970	Q9C6B9	PEAM3_ARATH	51.81	496	228	4	10	503	3	489	8.00E-177	513	1	Q9C6B9	PEAM3_ARATH	reviewed	Phosphoethanolamine N-methyltransferase 3 (EC 2.1.1.103)	NMT3 At1g73600 F25P22.1 F6D5.1	Arabidopsis thaliana (Mouse-ear cress)	490	methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]	 GO:0006656	PATHWAY: Phospholipid metabolism; phosphatidylcholine biosynthesis; phosphocholine from phosphoethanolamine: step 1/1.			PF08241;	cytoplasm [GO:0005737]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]
CHOYP_BRAFLDRAFT_118790.1.1|m.29970	507	6	8	8	26	21	25	1.224	1.224	5.0471	5.0471	0	0	0.542948	CHOYP_BRAFLDRAFT_118790.1.1|m.29970	Q9C6B9	PEAM3_ARATH	51.81	496	228	4	10	503	3	489	8.00E-177	513	1	Q9C6B9	PEAM3_ARATH	reviewed	Phosphoethanolamine N-methyltransferase 3 (EC 2.1.1.103)	NMT3 At1g73600 F25P22.1 F6D5.1	Arabidopsis thaliana (Mouse-ear cress)	490	methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]	 GO:0008757	PATHWAY: Phospholipid metabolism; phosphatidylcholine biosynthesis; phosphocholine from phosphoethanolamine: step 1/1.			PF08241;	cytoplasm [GO:0005737]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]
CHOYP_BRAFLDRAFT_118790.1.1|m.29970	507	6	8	8	26	21	25	1.224	1.224	5.0471	5.0471	0	0	0.542948	CHOYP_BRAFLDRAFT_118790.1.1|m.29970	Q9C6B9	PEAM3_ARATH	51.81	496	228	4	10	503	3	489	8.00E-177	513	1	Q9C6B9	PEAM3_ARATH	reviewed	Phosphoethanolamine N-methyltransferase 3 (EC 2.1.1.103)	NMT3 At1g73600 F25P22.1 F6D5.1	Arabidopsis thaliana (Mouse-ear cress)	490	methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]	 GO:0032259	PATHWAY: Phospholipid metabolism; phosphatidylcholine biosynthesis; phosphocholine from phosphoethanolamine: step 1/1.			PF08241;	cytoplasm [GO:0005737]; phosphoethanolamine N-methyltransferase activity [GO:0000234]; S-adenosylmethionine-dependent methyltransferase activity [GO:0008757]; methylation [GO:0032259]; phosphatidylcholine biosynthetic process [GO:0006656]
CHOYP_BRAFLDRAFT_90332.3.4|m.18933	627	9	6	20	32	36	22	0.965	0.965	4.9015	4.9015	0	0	0.543093	CHOYP_BRAFLDRAFT_90332.3.4|m.18933	Q8C6K9	CO6A6_MOUSE	26.6	609	395	14	24	625	615	1178	1.00E-55	210	1	Q8C6K9	CO6A6_MOUSE	reviewed	Collagen alpha-6(VI) chain	Col6a6	Mus musculus (Mouse)	2265	cell adhesion [GO:0007155]	GO:0005576				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_BRAFLDRAFT_90332.3.4|m.18933	627	9	6	20	32	36	22	0.965	0.965	4.9015	4.9015	0	0	0.543093	CHOYP_BRAFLDRAFT_90332.3.4|m.18933	Q8C6K9	CO6A6_MOUSE	26.6	609	395	14	24	625	615	1178	1.00E-55	210	1	Q8C6K9	CO6A6_MOUSE	reviewed	Collagen alpha-6(VI) chain	Col6a6	Mus musculus (Mouse)	2265	cell adhesion [GO:0007155]	 GO:0005578				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_BRAFLDRAFT_90332.3.4|m.18933	627	9	6	20	32	36	22	0.965	0.965	4.9015	4.9015	0	0	0.543093	CHOYP_BRAFLDRAFT_90332.3.4|m.18933	Q8C6K9	CO6A6_MOUSE	26.6	609	395	14	24	625	615	1178	1.00E-55	210	1	Q8C6K9	CO6A6_MOUSE	reviewed	Collagen alpha-6(VI) chain	Col6a6	Mus musculus (Mouse)	2265	cell adhesion [GO:0007155]	 GO:0005581				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_BRAFLDRAFT_90332.3.4|m.18933	627	9	6	20	32	36	22	0.965	0.965	4.9015	4.9015	0	0	0.543093	CHOYP_BRAFLDRAFT_90332.3.4|m.18933	Q8C6K9	CO6A6_MOUSE	26.6	609	395	14	24	625	615	1178	1.00E-55	210	1	Q8C6K9	CO6A6_MOUSE	reviewed	Collagen alpha-6(VI) chain	Col6a6	Mus musculus (Mouse)	2265	cell adhesion [GO:0007155]	 GO:0007155				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_LOC100486063.6.9|m.44250	2179	30	7	43	44	50	54	0.646	0.646	4.8768	4.8768	0	0	0.543117	CHOYP_LOC100486063.6.9|m.44250	A2AX52	CO6A4_MOUSE	24.98	1245	803	38	921	2135	34	1177	3.00E-90	332	1	A2AX52	CO6A4_MOUSE	reviewed	Collagen alpha-4(VI) chain	Col6a4 Dvwa	Mus musculus (Mouse)	2309	cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]	GO:0005576				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; protein complex [GO:0043234]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]
CHOYP_LOC100486063.6.9|m.44250	2179	30	7	43	44	50	54	0.646	0.646	4.8768	4.8768	0	0	0.543117	CHOYP_LOC100486063.6.9|m.44250	A2AX52	CO6A4_MOUSE	24.98	1245	803	38	921	2135	34	1177	3.00E-90	332	1	A2AX52	CO6A4_MOUSE	reviewed	Collagen alpha-4(VI) chain	Col6a4 Dvwa	Mus musculus (Mouse)	2309	cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]	 GO:0005578				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; protein complex [GO:0043234]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]
CHOYP_LOC100486063.6.9|m.44250	2179	30	7	43	44	50	54	0.646	0.646	4.8768	4.8768	0	0	0.543117	CHOYP_LOC100486063.6.9|m.44250	A2AX52	CO6A4_MOUSE	24.98	1245	803	38	921	2135	34	1177	3.00E-90	332	1	A2AX52	CO6A4_MOUSE	reviewed	Collagen alpha-4(VI) chain	Col6a4 Dvwa	Mus musculus (Mouse)	2309	cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]	 GO:0005581				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; protein complex [GO:0043234]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]
CHOYP_LOC100486063.6.9|m.44250	2179	30	7	43	44	50	54	0.646	0.646	4.8768	4.8768	0	0	0.543117	CHOYP_LOC100486063.6.9|m.44250	A2AX52	CO6A4_MOUSE	24.98	1245	803	38	921	2135	34	1177	3.00E-90	332	1	A2AX52	CO6A4_MOUSE	reviewed	Collagen alpha-4(VI) chain	Col6a4 Dvwa	Mus musculus (Mouse)	2309	cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]	 GO:0007155				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; protein complex [GO:0043234]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]
CHOYP_LOC100486063.6.9|m.44250	2179	30	7	43	44	50	54	0.646	0.646	4.8768	4.8768	0	0	0.543117	CHOYP_LOC100486063.6.9|m.44250	A2AX52	CO6A4_MOUSE	24.98	1245	803	38	921	2135	34	1177	3.00E-90	332	1	A2AX52	CO6A4_MOUSE	reviewed	Collagen alpha-4(VI) chain	Col6a4 Dvwa	Mus musculus (Mouse)	2309	cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]	 GO:0043234				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; protein complex [GO:0043234]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]
CHOYP_LOC100486063.6.9|m.44250	2179	30	7	43	44	50	54	0.646	0.646	4.8768	4.8768	0	0	0.543117	CHOYP_LOC100486063.6.9|m.44250	A2AX52	CO6A4_MOUSE	24.98	1245	803	38	921	2135	34	1177	3.00E-90	332	1	A2AX52	CO6A4_MOUSE	reviewed	Collagen alpha-4(VI) chain	Col6a4 Dvwa	Mus musculus (Mouse)	2309	cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]	 GO:0070208				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; protein complex [GO:0043234]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]; protein heterotrimerization [GO:0070208]
CHOYP_FND2.3.4|m.40482	685	28	8	38	42	41	51	0.632	0.632	4.6443	4.6443	0	0	0.543339	CHOYP_FND2.3.4|m.40482	Q8AV58	SDK1_CHICK	24.09	465	312	15	132	572	1158	1605	3.00E-19	96.7	1	Q8AV58	SDK1_CHICK	reviewed	Protein sidekick-1	SDK1	Gallus gallus (Chicken)	2169	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	GO:0005886			cd00063;	PF00041;PF07679;	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]
CHOYP_FND2.3.4|m.40482	685	28	8	38	42	41	51	0.632	0.632	4.6443	4.6443	0	0	0.543339	CHOYP_FND2.3.4|m.40482	Q8AV58	SDK1_CHICK	24.09	465	312	15	132	572	1158	1605	3.00E-19	96.7	1	Q8AV58	SDK1_CHICK	reviewed	Protein sidekick-1	SDK1	Gallus gallus (Chicken)	2169	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	 GO:0007156			cd00063;	PF00041;PF07679;	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]
CHOYP_FND2.3.4|m.40482	685	28	8	38	42	41	51	0.632	0.632	4.6443	4.6443	0	0	0.543339	CHOYP_FND2.3.4|m.40482	Q8AV58	SDK1_CHICK	24.09	465	312	15	132	572	1158	1605	3.00E-19	96.7	1	Q8AV58	SDK1_CHICK	reviewed	Protein sidekick-1	SDK1	Gallus gallus (Chicken)	2169	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	 GO:0007416			cd00063;	PF00041;PF07679;	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]
CHOYP_FND2.3.4|m.40482	685	28	8	38	42	41	51	0.632	0.632	4.6443	4.6443	0	0	0.543339	CHOYP_FND2.3.4|m.40482	Q8AV58	SDK1_CHICK	24.09	465	312	15	132	572	1158	1605	3.00E-19	96.7	1	Q8AV58	SDK1_CHICK	reviewed	Protein sidekick-1	SDK1	Gallus gallus (Chicken)	2169	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	 GO:0010842			cd00063;	PF00041;PF07679;	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]
CHOYP_FND2.3.4|m.40482	685	28	8	38	42	41	51	0.632	0.632	4.6443	4.6443	0	0	0.543339	CHOYP_FND2.3.4|m.40482	Q8AV58	SDK1_CHICK	24.09	465	312	15	132	572	1158	1605	3.00E-19	96.7	1	Q8AV58	SDK1_CHICK	reviewed	Protein sidekick-1	SDK1	Gallus gallus (Chicken)	2169	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	 GO:0016021			cd00063;	PF00041;PF07679;	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]
CHOYP_FND2.3.4|m.40482	685	28	8	38	42	41	51	0.632	0.632	4.6443	4.6443	0	0	0.543339	CHOYP_FND2.3.4|m.40482	Q8AV58	SDK1_CHICK	24.09	465	312	15	132	572	1158	1605	3.00E-19	96.7	1	Q8AV58	SDK1_CHICK	reviewed	Protein sidekick-1	SDK1	Gallus gallus (Chicken)	2169	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	 GO:0030054			cd00063;	PF00041;PF07679;	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]
CHOYP_FND2.3.4|m.40482	685	28	8	38	42	41	51	0.632	0.632	4.6443	4.6443	0	0	0.543339	CHOYP_FND2.3.4|m.40482	Q8AV58	SDK1_CHICK	24.09	465	312	15	132	572	1158	1605	3.00E-19	96.7	1	Q8AV58	SDK1_CHICK	reviewed	Protein sidekick-1	SDK1	Gallus gallus (Chicken)	2169	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	 GO:0042802			cd00063;	PF00041;PF07679;	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]
CHOYP_FND2.3.4|m.40482	685	28	8	38	42	41	51	0.632	0.632	4.6443	4.6443	0	0	0.543339	CHOYP_FND2.3.4|m.40482	Q8AV58	SDK1_CHICK	24.09	465	312	15	132	572	1158	1605	3.00E-19	96.7	1	Q8AV58	SDK1_CHICK	reviewed	Protein sidekick-1	SDK1	Gallus gallus (Chicken)	2169	homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]	 GO:0045202			cd00063;	PF00041;PF07679;	cell junction [GO:0030054]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; synapse [GO:0045202]; identical protein binding [GO:0042802]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416]
CHOYP_GIGA6.1.1|m.38687	547	53	11	59	63	63	69	0.516	0.516	4.4602	4.4602	0	0	0.543549	CHOYP_GIGA6.1.1|m.38687	P86789	GIGA6_CRAGI	92.76	290	20	1	1	289	12	301	0	542	1	P86789	GIGA6_CRAGI	reviewed	Gigasin-6		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	302		GO:0016021				PF00144;	integral component of membrane [GO:0016021]
CHOYP_CO6A3.2.5|m.39533	1769	38	11	49	51	61	55	0.576	0.576	4.3961	4.3961	0	0	0.543645	CHOYP_CO6A3.2.5|m.39533	O42401	MATN3_CHICK	35.45	189	116	2	1158	1343	53	238	3.00E-26	118	1	O42401	MATN3_CHICK	reviewed	Matrilin-3	MATN3	Gallus gallus (Chicken)	452		GO:0005509				PF07645;PF10393;PF00092;	proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]
CHOYP_CO6A3.2.5|m.39533	1769	38	11	49	51	61	55	0.576	0.576	4.3961	4.3961	0	0	0.543645	CHOYP_CO6A3.2.5|m.39533	O42401	MATN3_CHICK	35.45	189	116	2	1158	1343	53	238	3.00E-26	118	1	O42401	MATN3_CHICK	reviewed	Matrilin-3	MATN3	Gallus gallus (Chicken)	452		 GO:0005578				PF07645;PF10393;PF00092;	proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]
CHOYP_BRAFLDRAFT_103544.1.1|m.38439	2603	21	0	25	35	25	37	0.741	0.741	4.3209	4.3209	0	0	0.54378	CHOYP_BRAFLDRAFT_103544.1.1|m.38439	P0C6B8	SVEP1_RAT	26.55	1857	1220	55	206	1964	1684	3494	6.00E-150	528	1	P0C6B8	SVEP1_RAT	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	Svep1	Rattus norvegicus (Rat)	3564	cell adhesion [GO:0007155]	GO:0005509			cd00033;cd00152;	PF00008;PF07645;PF07699;PF02494;PF00354;PF00084;PF00092;	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]
CHOYP_BRAFLDRAFT_103544.1.1|m.38439	2603	21	0	25	35	25	37	0.741	0.741	4.3209	4.3209	0	0	0.54378	CHOYP_BRAFLDRAFT_103544.1.1|m.38439	P0C6B8	SVEP1_RAT	26.55	1857	1220	55	206	1964	1684	3494	6.00E-150	528	1	P0C6B8	SVEP1_RAT	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	Svep1	Rattus norvegicus (Rat)	3564	cell adhesion [GO:0007155]	 GO:0005576			cd00033;cd00152;	PF00008;PF07645;PF07699;PF02494;PF00354;PF00084;PF00092;	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]
CHOYP_BRAFLDRAFT_103544.1.1|m.38439	2603	21	0	25	35	25	37	0.741	0.741	4.3209	4.3209	0	0	0.54378	CHOYP_BRAFLDRAFT_103544.1.1|m.38439	P0C6B8	SVEP1_RAT	26.55	1857	1220	55	206	1964	1684	3494	6.00E-150	528	1	P0C6B8	SVEP1_RAT	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	Svep1	Rattus norvegicus (Rat)	3564	cell adhesion [GO:0007155]	 GO:0005737			cd00033;cd00152;	PF00008;PF07645;PF07699;PF02494;PF00354;PF00084;PF00092;	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]
CHOYP_BRAFLDRAFT_103544.1.1|m.38439	2603	21	0	25	35	25	37	0.741	0.741	4.3209	4.3209	0	0	0.54378	CHOYP_BRAFLDRAFT_103544.1.1|m.38439	P0C6B8	SVEP1_RAT	26.55	1857	1220	55	206	1964	1684	3494	6.00E-150	528	1	P0C6B8	SVEP1_RAT	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	Svep1	Rattus norvegicus (Rat)	3564	cell adhesion [GO:0007155]	 GO:0007155			cd00033;cd00152;	PF00008;PF07645;PF07699;PF02494;PF00354;PF00084;PF00092;	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]
CHOYP_BRAFLDRAFT_103544.1.1|m.38439	2603	21	0	25	35	25	37	0.741	0.741	4.3209	4.3209	0	0	0.54378	CHOYP_BRAFLDRAFT_103544.1.1|m.38439	P0C6B8	SVEP1_RAT	26.55	1857	1220	55	206	1964	1684	3494	6.00E-150	528	1	P0C6B8	SVEP1_RAT	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	Svep1	Rattus norvegicus (Rat)	3564	cell adhesion [GO:0007155]	 GO:0016020			cd00033;cd00152;	PF00008;PF07645;PF07699;PF02494;PF00354;PF00084;PF00092;	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]
CHOYP_LOC100030437.1.3|m.5994	681	39	14	48	50	60	58	0.552	0.552	4.3186	4.3186	0	0	0.543784	CHOYP_LOC100030437.1.3|m.5994	P15989	CO6A3_CHICK	23.41	645	438	20	56	680	38	646	1.00E-41	167	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	GO:0004867			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC100030437.1.3|m.5994	681	39	14	48	50	60	58	0.552	0.552	4.3186	4.3186	0	0	0.543784	CHOYP_LOC100030437.1.3|m.5994	P15989	CO6A3_CHICK	23.41	645	438	20	56	680	38	646	1.00E-41	167	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0005578			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC100030437.1.3|m.5994	681	39	14	48	50	60	58	0.552	0.552	4.3186	4.3186	0	0	0.543784	CHOYP_LOC100030437.1.3|m.5994	P15989	CO6A3_CHICK	23.41	645	438	20	56	680	38	646	1.00E-41	167	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0005581			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC100030437.1.3|m.5994	681	39	14	48	50	60	58	0.552	0.552	4.3186	4.3186	0	0	0.543784	CHOYP_LOC100030437.1.3|m.5994	P15989	CO6A3_CHICK	23.41	645	438	20	56	680	38	646	1.00E-41	167	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0007155			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_PIF.3.6|m.18904	434	19	1	26	31	29	32	0.758	0.758	4.2893	4.2893	0	0	0.543844																												
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	GO:0000226			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0005737			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0005794			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0005813			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0005859			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0006941			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0007010			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0007015			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0007030			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0007088			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0008093			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0008307			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0014704			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0030018			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0031430			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0034067			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0045214			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0048471			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0050775			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0051015			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0051371			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0055003			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0071688			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:0097493			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_HMCN2.9.12|m.44986	1026	28	3	36	40	46	42	0.677	0.677	4.1815	4.1815	0	0	0.5441	CHOYP_HMCN2.9.12|m.44986	O75147	OBSL1_HUMAN	21.88	617	358	27	333	901	982	1522	0.000001	56.6	1	O75147	OBSL1_HUMAN	reviewed	Obscurin-like protein 1	OBSL1 KIAA0657	Homo sapiens (Human)	1896	actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]	 GO:1990393			cd00063;	PF07679;	3M complex [GO:1990393]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; intercalated disc [GO:0014704]; M band [GO:0031430]; muscle myosin complex [GO:0005859]; perinuclear region of cytoplasm [GO:0048471]; Z disc [GO:0030018]; actin filament binding [GO:0051015]; cytoskeletal adaptor activity [GO:0008093]; muscle alpha-actinin binding [GO:0051371]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; actin filament organization [GO:0007015]; cardiac myofibril assembly [GO:0055003]; cytoskeleton organization [GO:0007010]; Golgi organization [GO:0007030]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of dendrite morphogenesis [GO:0050775]; protein localization to Golgi apparatus [GO:0034067]; regulation of mitotic nuclear division [GO:0007088]; sarcomere organization [GO:0045214]; striated muscle contraction [GO:0006941]; striated muscle myosin thick filament assembly [GO:0071688]
CHOYP_CATA.1.3|m.11120	326	31	16	34	43	42	54	0.581	0.581	4.1777	4.1777	0	0	0.54411																												
CHOYP_contig_050645|m.60289	206	4	2	8	9	14	28	1.353	1.353	4.1742	4.1742	0	0	0.544119	CHOYP_contig_050645|m.60289	Q08420	SODE_RAT	26.67	150	103	6	31	179	48	191	0.000000002	58.9	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_contig_050645|m.60289	206	4	2	8	9	14	28	1.353	1.353	4.1742	4.1742	0	0	0.544119	CHOYP_contig_050645|m.60289	Q08420	SODE_RAT	26.67	150	103	6	31	179	48	191	0.000000002	58.9	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0001666			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_contig_050645|m.60289	206	4	2	8	9	14	28	1.353	1.353	4.1742	4.1742	0	0	0.544119	CHOYP_contig_050645|m.60289	Q08420	SODE_RAT	26.67	150	103	6	31	179	48	191	0.000000002	58.9	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0004784			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_contig_050645|m.60289	206	4	2	8	9	14	28	1.353	1.353	4.1742	4.1742	0	0	0.544119	CHOYP_contig_050645|m.60289	Q08420	SODE_RAT	26.67	150	103	6	31	179	48	191	0.000000002	58.9	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0005507			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_contig_050645|m.60289	206	4	2	8	9	14	28	1.353	1.353	4.1742	4.1742	0	0	0.544119	CHOYP_contig_050645|m.60289	Q08420	SODE_RAT	26.67	150	103	6	31	179	48	191	0.000000002	58.9	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0005615			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_contig_050645|m.60289	206	4	2	8	9	14	28	1.353	1.353	4.1742	4.1742	0	0	0.544119	CHOYP_contig_050645|m.60289	Q08420	SODE_RAT	26.67	150	103	6	31	179	48	191	0.000000002	58.9	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0005634			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_contig_050645|m.60289	206	4	2	8	9	14	28	1.353	1.353	4.1742	4.1742	0	0	0.544119	CHOYP_contig_050645|m.60289	Q08420	SODE_RAT	26.67	150	103	6	31	179	48	191	0.000000002	58.9	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0005737			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_contig_050645|m.60289	206	4	2	8	9	14	28	1.353	1.353	4.1742	4.1742	0	0	0.544119	CHOYP_contig_050645|m.60289	Q08420	SODE_RAT	26.67	150	103	6	31	179	48	191	0.000000002	58.9	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0006979			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_contig_050645|m.60289	206	4	2	8	9	14	28	1.353	1.353	4.1742	4.1742	0	0	0.544119	CHOYP_contig_050645|m.60289	Q08420	SODE_RAT	26.67	150	103	6	31	179	48	191	0.000000002	58.9	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0008270			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_contig_050645|m.60289	206	4	2	8	9	14	28	1.353	1.353	4.1742	4.1742	0	0	0.544119	CHOYP_contig_050645|m.60289	Q08420	SODE_RAT	26.67	150	103	6	31	179	48	191	0.000000002	58.9	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0031012			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_contig_050645|m.60289	206	4	2	8	9	14	28	1.353	1.353	4.1742	4.1742	0	0	0.544119	CHOYP_contig_050645|m.60289	Q08420	SODE_RAT	26.67	150	103	6	31	179	48	191	0.000000002	58.9	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0046688			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_contig_050645|m.60289	206	4	2	8	9	14	28	1.353	1.353	4.1742	4.1742	0	0	0.544119	CHOYP_contig_050645|m.60289	Q08420	SODE_RAT	26.67	150	103	6	31	179	48	191	0.000000002	58.9	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0070062			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_LOC100708991.5.5|m.59991	450	6	5	9	21	17	20	1.125	1.125	4.1597	4.1597	0	0	0.544158	CHOYP_LOC100708991.5.5|m.59991	A6H584	CO6A5_MOUSE	30.08	399	244	10	52	449	471	835	4.00E-36	147	1	A6H584	CO6A5_MOUSE	reviewed	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)	Col6a5 Col29a1 Gm7455	Mus musculus (Mouse)	2640	cell adhesion [GO:0007155]	GO:0005576				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_LOC100708991.5.5|m.59991	450	6	5	9	21	17	20	1.125	1.125	4.1597	4.1597	0	0	0.544158	CHOYP_LOC100708991.5.5|m.59991	A6H584	CO6A5_MOUSE	30.08	399	244	10	52	449	471	835	4.00E-36	147	1	A6H584	CO6A5_MOUSE	reviewed	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)	Col6a5 Col29a1 Gm7455	Mus musculus (Mouse)	2640	cell adhesion [GO:0007155]	 GO:0005578				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_LOC100708991.5.5|m.59991	450	6	5	9	21	17	20	1.125	1.125	4.1597	4.1597	0	0	0.544158	CHOYP_LOC100708991.5.5|m.59991	A6H584	CO6A5_MOUSE	30.08	399	244	10	52	449	471	835	4.00E-36	147	1	A6H584	CO6A5_MOUSE	reviewed	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)	Col6a5 Col29a1 Gm7455	Mus musculus (Mouse)	2640	cell adhesion [GO:0007155]	 GO:0005581				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_LOC100708991.5.5|m.59991	450	6	5	9	21	17	20	1.125	1.125	4.1597	4.1597	0	0	0.544158	CHOYP_LOC100708991.5.5|m.59991	A6H584	CO6A5_MOUSE	30.08	399	244	10	52	449	471	835	4.00E-36	147	1	A6H584	CO6A5_MOUSE	reviewed	Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain)	Col6a5 Col29a1 Gm7455	Mus musculus (Mouse)	2640	cell adhesion [GO:0007155]	 GO:0007155				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_LOC587610.1.3|m.16984	716	6	3	14	20	22	19	1.025	1.025	4.0931	4.0931	0	0	0.544345	CHOYP_LOC587610.1.3|m.16984	P00690	AMYP_PIG	49.7	505	217	14	10	479	3	505	2.00E-152	459	1	P00690	AMYP_PIG	reviewed	"Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)"	AMY2	Sus scrofa (Pig)	511	carbohydrate catabolic process [GO:0016052]	GO:0004556				PF00128;PF02806;	extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]
CHOYP_LOC587610.1.3|m.16984	716	6	3	14	20	22	19	1.025	1.025	4.0931	4.0931	0	0	0.544345	CHOYP_LOC587610.1.3|m.16984	P00690	AMYP_PIG	49.7	505	217	14	10	479	3	505	2.00E-152	459	1	P00690	AMYP_PIG	reviewed	"Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)"	AMY2	Sus scrofa (Pig)	511	carbohydrate catabolic process [GO:0016052]	 GO:0005509				PF00128;PF02806;	extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]
CHOYP_LOC587610.1.3|m.16984	716	6	3	14	20	22	19	1.025	1.025	4.0931	4.0931	0	0	0.544345	CHOYP_LOC587610.1.3|m.16984	P00690	AMYP_PIG	49.7	505	217	14	10	479	3	505	2.00E-152	459	1	P00690	AMYP_PIG	reviewed	"Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)"	AMY2	Sus scrofa (Pig)	511	carbohydrate catabolic process [GO:0016052]	 GO:0005615				PF00128;PF02806;	extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]
CHOYP_LOC587610.1.3|m.16984	716	6	3	14	20	22	19	1.025	1.025	4.0931	4.0931	0	0	0.544345	CHOYP_LOC587610.1.3|m.16984	P00690	AMYP_PIG	49.7	505	217	14	10	479	3	505	2.00E-152	459	1	P00690	AMYP_PIG	reviewed	"Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)"	AMY2	Sus scrofa (Pig)	511	carbohydrate catabolic process [GO:0016052]	 GO:0016052				PF00128;PF02806;	extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]
CHOYP_LOC587610.1.3|m.16984	716	6	3	14	20	22	19	1.025	1.025	4.0931	4.0931	0	0	0.544345	CHOYP_LOC587610.1.3|m.16984	P00690	AMYP_PIG	49.7	505	217	14	10	479	3	505	2.00E-152	459	1	P00690	AMYP_PIG	reviewed	"Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)"	AMY2	Sus scrofa (Pig)	511	carbohydrate catabolic process [GO:0016052]	 GO:0031404				PF00128;PF02806;	extracellular space [GO:0005615]; alpha-amylase activity [GO:0004556]; calcium ion binding [GO:0005509]; chloride ion binding [GO:0031404]; carbohydrate catabolic process [GO:0016052]
CHOYP_MTHR.1.1|m.54596	650	7	7	9	17	21	18	0.938	0.938	4.0655	4.0655	0	0	0.544426	CHOYP_MTHR.1.1|m.54596	Q5I598	MTHR_BOVIN	64	600	212	3	35	633	44	640	0	818	1	Q5I598	MTHR_BOVIN	reviewed	Methylenetetrahydrofolate reductase (EC 1.5.1.20)	MTHFR	Bos taurus (Bovine)	655	methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	GO:0004489	PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion.		cd00537;	PF02219;	cytosol [GO:0005829]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]
CHOYP_MTHR.1.1|m.54596	650	7	7	9	17	21	18	0.938	0.938	4.0655	4.0655	0	0	0.544426	CHOYP_MTHR.1.1|m.54596	Q5I598	MTHR_BOVIN	64	600	212	3	35	633	44	640	0	818	1	Q5I598	MTHR_BOVIN	reviewed	Methylenetetrahydrofolate reductase (EC 1.5.1.20)	MTHFR	Bos taurus (Bovine)	655	methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	 GO:0005829	PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion.		cd00537;	PF02219;	cytosol [GO:0005829]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]
CHOYP_MTHR.1.1|m.54596	650	7	7	9	17	21	18	0.938	0.938	4.0655	4.0655	0	0	0.544426	CHOYP_MTHR.1.1|m.54596	Q5I598	MTHR_BOVIN	64	600	212	3	35	633	44	640	0	818	1	Q5I598	MTHR_BOVIN	reviewed	Methylenetetrahydrofolate reductase (EC 1.5.1.20)	MTHFR	Bos taurus (Bovine)	655	methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	 GO:0006555	PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion.		cd00537;	PF02219;	cytosol [GO:0005829]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]
CHOYP_MTHR.1.1|m.54596	650	7	7	9	17	21	18	0.938	0.938	4.0655	4.0655	0	0	0.544426	CHOYP_MTHR.1.1|m.54596	Q5I598	MTHR_BOVIN	64	600	212	3	35	633	44	640	0	818	1	Q5I598	MTHR_BOVIN	reviewed	Methylenetetrahydrofolate reductase (EC 1.5.1.20)	MTHFR	Bos taurus (Bovine)	655	methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	 GO:0006730	PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion.		cd00537;	PF02219;	cytosol [GO:0005829]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]
CHOYP_MTHR.1.1|m.54596	650	7	7	9	17	21	18	0.938	0.938	4.0655	4.0655	0	0	0.544426	CHOYP_MTHR.1.1|m.54596	Q5I598	MTHR_BOVIN	64	600	212	3	35	633	44	640	0	818	1	Q5I598	MTHR_BOVIN	reviewed	Methylenetetrahydrofolate reductase (EC 1.5.1.20)	MTHFR	Bos taurus (Bovine)	655	methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]	 GO:0035999	PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion.		cd00537;	PF02219;	cytosol [GO:0005829]; methylenetetrahydrofolate reductase (NAD(P)H) activity [GO:0004489]; methionine metabolic process [GO:0006555]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate interconversion [GO:0035999]
CHOYP_LOC101068378.3.3|m.29759	1028	14	7	29	33	30	37	0.724	0.724	4.0477	4.0477	0	0	0.544478	CHOYP_LOC101068378.3.3|m.29759	Q8N2E2	VWDE_HUMAN	28.79	646	397	27	3	611	7	626	4.00E-58	222	1	Q8N2E2	VWDE_HUMAN	reviewed	von Willebrand factor D and EGF domain-containing protein	VWDE	Homo sapiens (Human)	1590		GO:0005576				PF00094;	extracellular region [GO:0005576]
CHOYP_LOC101169658.1.3|m.18820	469	1	0	2	9	11	26	2.614	2.614	4.0453	4.0453	0	0	0.544486	CHOYP_LOC101169658.1.3|m.18820	Q08420	SODE_RAT	29.27	164	96	7	318	467	65	222	0.00000001	59.3	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	GO:0000303			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_LOC101169658.1.3|m.18820	469	1	0	2	9	11	26	2.614	2.614	4.0453	4.0453	0	0	0.544486	CHOYP_LOC101169658.1.3|m.18820	Q08420	SODE_RAT	29.27	164	96	7	318	467	65	222	0.00000001	59.3	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0001666			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_LOC101169658.1.3|m.18820	469	1	0	2	9	11	26	2.614	2.614	4.0453	4.0453	0	0	0.544486	CHOYP_LOC101169658.1.3|m.18820	Q08420	SODE_RAT	29.27	164	96	7	318	467	65	222	0.00000001	59.3	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0004784			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_LOC101169658.1.3|m.18820	469	1	0	2	9	11	26	2.614	2.614	4.0453	4.0453	0	0	0.544486	CHOYP_LOC101169658.1.3|m.18820	Q08420	SODE_RAT	29.27	164	96	7	318	467	65	222	0.00000001	59.3	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0005507			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_LOC101169658.1.3|m.18820	469	1	0	2	9	11	26	2.614	2.614	4.0453	4.0453	0	0	0.544486	CHOYP_LOC101169658.1.3|m.18820	Q08420	SODE_RAT	29.27	164	96	7	318	467	65	222	0.00000001	59.3	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0005615			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_LOC101169658.1.3|m.18820	469	1	0	2	9	11	26	2.614	2.614	4.0453	4.0453	0	0	0.544486	CHOYP_LOC101169658.1.3|m.18820	Q08420	SODE_RAT	29.27	164	96	7	318	467	65	222	0.00000001	59.3	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0005634			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_LOC101169658.1.3|m.18820	469	1	0	2	9	11	26	2.614	2.614	4.0453	4.0453	0	0	0.544486	CHOYP_LOC101169658.1.3|m.18820	Q08420	SODE_RAT	29.27	164	96	7	318	467	65	222	0.00000001	59.3	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0005737			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_LOC101169658.1.3|m.18820	469	1	0	2	9	11	26	2.614	2.614	4.0453	4.0453	0	0	0.544486	CHOYP_LOC101169658.1.3|m.18820	Q08420	SODE_RAT	29.27	164	96	7	318	467	65	222	0.00000001	59.3	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0006979			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_LOC101169658.1.3|m.18820	469	1	0	2	9	11	26	2.614	2.614	4.0453	4.0453	0	0	0.544486	CHOYP_LOC101169658.1.3|m.18820	Q08420	SODE_RAT	29.27	164	96	7	318	467	65	222	0.00000001	59.3	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0008270			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_LOC101169658.1.3|m.18820	469	1	0	2	9	11	26	2.614	2.614	4.0453	4.0453	0	0	0.544486	CHOYP_LOC101169658.1.3|m.18820	Q08420	SODE_RAT	29.27	164	96	7	318	467	65	222	0.00000001	59.3	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0031012			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_LOC101169658.1.3|m.18820	469	1	0	2	9	11	26	2.614	2.614	4.0453	4.0453	0	0	0.544486	CHOYP_LOC101169658.1.3|m.18820	Q08420	SODE_RAT	29.27	164	96	7	318	467	65	222	0.00000001	59.3	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0046688			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_LOC101169658.1.3|m.18820	469	1	0	2	9	11	26	2.614	2.614	4.0453	4.0453	0	0	0.544486	CHOYP_LOC101169658.1.3|m.18820	Q08420	SODE_RAT	29.27	164	96	7	318	467	65	222	0.00000001	59.3	1	Q08420	SODE_RAT	reviewed	Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1) (Superoxide dismutase B)	Sod3 Sod-3	Rattus norvegicus (Rat)	244	response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]	 GO:0070062			cd00305;	PF00080;	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]; copper ion binding [GO:0005507]; superoxide dismutase activity [GO:0004784]; zinc ion binding [GO:0008270]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to superoxide [GO:0000303]
CHOYP_LOC100709262.1.2|m.17960	1317	36	14	41	44	49	53	0.502	0.502	4.0129	4.0129	0	0	0.544583	CHOYP_LOC100709262.1.2|m.17960	P15989	CO6A3_CHICK	24.88	824	562	22	291	1098	35	817	3.00E-62	239	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	GO:0004867			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC100709262.1.2|m.17960	1317	36	14	41	44	49	53	0.502	0.502	4.0129	4.0129	0	0	0.544583	CHOYP_LOC100709262.1.2|m.17960	P15989	CO6A3_CHICK	24.88	824	562	22	291	1098	35	817	3.00E-62	239	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0005578			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC100709262.1.2|m.17960	1317	36	14	41	44	49	53	0.502	0.502	4.0129	4.0129	0	0	0.544583	CHOYP_LOC100709262.1.2|m.17960	P15989	CO6A3_CHICK	24.88	824	562	22	291	1098	35	817	3.00E-62	239	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0005581			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC100709262.1.2|m.17960	1317	36	14	41	44	49	53	0.502	0.502	4.0129	4.0129	0	0	0.544583	CHOYP_LOC100709262.1.2|m.17960	P15989	CO6A3_CHICK	24.88	824	562	22	291	1098	35	817	3.00E-62	239	1	P15989	CO6A3_CHICK	reviewed	Collagen alpha-3(VI) chain	COL6A3	Gallus gallus (Chicken)	3137	cell adhesion [GO:0007155]	 GO:0007155			cd00063;	PF01391;PF00014;PF00092;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_BRAFLDRAFT_130131.1.1|m.11020	220	0	0	0	13	10	7	2.521	2.521	4.0109	4.0109	0	0	0.544589	CHOYP_BRAFLDRAFT_130131.1.1|m.11020	Q8N6F8	WBS27_HUMAN	35.84	173	107	4	39	211	32	200	1.00E-26	107	1	Q8N6F8	WBS27_HUMAN	reviewed	Williams-Beuren syndrome chromosomal region 27 protein	WBSCR27	Homo sapiens (Human)	245							
CHOYP_FND2.4.4|m.44570	706	17	6	22	26	33	28	0.724	0.724	3.9329	3.9329	0	0	0.544825	CHOYP_FND2.4.4|m.44570	H2A0L8	FND2_PINMG	47.24	580	279	7	26	582	39	614	6.00E-157	475	1	H2A0L8	FND2_PINMG	reviewed	Fibronectin type III domain-containing protein 2		Pinctada margaritifera (Black-lipped pearl oyster)	624		GO:0005576			cd00063;	PF00041;	extracellular region [GO:0005576]
CHOYP_LRRX1.6.11|m.41895	724	0	0	2	7	10	11	2.113	2.113	3.9117	3.9117	0	0	0.544889	CHOYP_LRRX1.6.11|m.41895	Q7Z5L3	C1QL2_HUMAN	36.6	153	76	5	578	723	149	287	3.00E-14	77.4	1	Q7Z5L3	C1QL2_HUMAN	reviewed	Complement C1q-like protein 2 (C1q and tumor necrosis factor-related protein 10) (C1q/TNF-related protein 10)	C1QL2 CTRP10	Homo sapiens (Human)	287	protein oligomerization [GO:0051259]	GO:0005576				PF00386;PF01391;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; protein oligomerization [GO:0051259]
CHOYP_LRRX1.6.11|m.41895	724	0	0	2	7	10	11	2.113	2.113	3.9117	3.9117	0	0	0.544889	CHOYP_LRRX1.6.11|m.41895	Q7Z5L3	C1QL2_HUMAN	36.6	153	76	5	578	723	149	287	3.00E-14	77.4	1	Q7Z5L3	C1QL2_HUMAN	reviewed	Complement C1q-like protein 2 (C1q and tumor necrosis factor-related protein 10) (C1q/TNF-related protein 10)	C1QL2 CTRP10	Homo sapiens (Human)	287	protein oligomerization [GO:0051259]	 GO:0005581				PF00386;PF01391;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; protein oligomerization [GO:0051259]
CHOYP_LRRX1.6.11|m.41895	724	0	0	2	7	10	11	2.113	2.113	3.9117	3.9117	0	0	0.544889	CHOYP_LRRX1.6.11|m.41895	Q7Z5L3	C1QL2_HUMAN	36.6	153	76	5	578	723	149	287	3.00E-14	77.4	1	Q7Z5L3	C1QL2_HUMAN	reviewed	Complement C1q-like protein 2 (C1q and tumor necrosis factor-related protein 10) (C1q/TNF-related protein 10)	C1QL2 CTRP10	Homo sapiens (Human)	287	protein oligomerization [GO:0051259]	 GO:0051259				PF00386;PF01391;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; protein oligomerization [GO:0051259]
CHOYP_LOC100708991.3.5|m.40072	447	6	5	6	18	15	18	1.142	1.142	3.9002	3.9002	0	0	0.544923	CHOYP_LOC100708991.3.5|m.40072	Q6DCQ6	VWA2_XENLA	25.06	411	264	13	43	445	333	707	2.00E-20	97.8	1	Q6DCQ6	VWA2_XENLA	reviewed	von Willebrand factor A domain-containing protein 2 (A domain-containing protein similar to matrilin and collagen) (AMACO)	vwa2	Xenopus laevis (African clawed frog)	790		GO:0005509				PF00008;PF00092;	basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]
CHOYP_LOC100708991.3.5|m.40072	447	6	5	6	18	15	18	1.142	1.142	3.9002	3.9002	0	0	0.544923	CHOYP_LOC100708991.3.5|m.40072	Q6DCQ6	VWA2_XENLA	25.06	411	264	13	43	445	333	707	2.00E-20	97.8	1	Q6DCQ6	VWA2_XENLA	reviewed	von Willebrand factor A domain-containing protein 2 (A domain-containing protein similar to matrilin and collagen) (AMACO)	vwa2	Xenopus laevis (African clawed frog)	790		 GO:0005604				PF00008;PF00092;	basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]
CHOYP_LOC100708991.3.5|m.40072	447	6	5	6	18	15	18	1.142	1.142	3.9002	3.9002	0	0	0.544923	CHOYP_LOC100708991.3.5|m.40072	Q6DCQ6	VWA2_XENLA	25.06	411	264	13	43	445	333	707	2.00E-20	97.8	1	Q6DCQ6	VWA2_XENLA	reviewed	von Willebrand factor A domain-containing protein 2 (A domain-containing protein similar to matrilin and collagen) (AMACO)	vwa2	Xenopus laevis (African clawed frog)	790		 GO:0005615				PF00008;PF00092;	basement membrane [GO:0005604]; extracellular space [GO:0005615]; calcium ion binding [GO:0005509]
CHOYP_PGBM.2.3|m.44777	733	17	0	19	22	32	23	0.764	0.764	3.8446	3.8446	0	0	0.545089	CHOYP_PGBM.2.3|m.44777	O95428	PPN_HUMAN	23.4	329	202	14	356	653	915	1224	3.00E-12	74.3	1	O95428	PPN_HUMAN	reviewed	Papilin	PAPLN UNQ2420/PRO4977	Homo sapiens (Human)	1278		GO:0004222				PF05986;PF07679;PF00014;PF08686;PF00090;	proteinaceous extracellular matrix [GO:0005578]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]; zinc ion binding [GO:0008270]
CHOYP_PGBM.2.3|m.44777	733	17	0	19	22	32	23	0.764	0.764	3.8446	3.8446	0	0	0.545089	CHOYP_PGBM.2.3|m.44777	O95428	PPN_HUMAN	23.4	329	202	14	356	653	915	1224	3.00E-12	74.3	1	O95428	PPN_HUMAN	reviewed	Papilin	PAPLN UNQ2420/PRO4977	Homo sapiens (Human)	1278		 GO:0004867				PF05986;PF07679;PF00014;PF08686;PF00090;	proteinaceous extracellular matrix [GO:0005578]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]; zinc ion binding [GO:0008270]
CHOYP_PGBM.2.3|m.44777	733	17	0	19	22	32	23	0.764	0.764	3.8446	3.8446	0	0	0.545089	CHOYP_PGBM.2.3|m.44777	O95428	PPN_HUMAN	23.4	329	202	14	356	653	915	1224	3.00E-12	74.3	1	O95428	PPN_HUMAN	reviewed	Papilin	PAPLN UNQ2420/PRO4977	Homo sapiens (Human)	1278		 GO:0005578				PF05986;PF07679;PF00014;PF08686;PF00090;	proteinaceous extracellular matrix [GO:0005578]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]; zinc ion binding [GO:0008270]
CHOYP_PGBM.2.3|m.44777	733	17	0	19	22	32	23	0.764	0.764	3.8446	3.8446	0	0	0.545089	CHOYP_PGBM.2.3|m.44777	O95428	PPN_HUMAN	23.4	329	202	14	356	653	915	1224	3.00E-12	74.3	1	O95428	PPN_HUMAN	reviewed	Papilin	PAPLN UNQ2420/PRO4977	Homo sapiens (Human)	1278		 GO:0008270				PF05986;PF07679;PF00014;PF08686;PF00090;	proteinaceous extracellular matrix [GO:0005578]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase inhibitor activity [GO:0004867]; zinc ion binding [GO:0008270]
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	GO:0000775				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0000793				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0003677				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0003723				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0005524				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0005634				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0005730				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0005737				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0006259				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0007088				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0007126				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0008022				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0008283				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0014070				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0016020				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0016604				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0030212				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0031100				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0034605				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:0051983				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_LOC100371881.1.2|m.3634	1686	1	0	2	4	13	10	1.981	1.981	3.8148	3.8148	0	0	0.545177	CHOYP_LOC100371881.1.2|m.3634	P46013	KI67_HUMAN	50.54	93	46	0	5	97	6	98	1.00E-27	126	1	P46013	KI67_HUMAN	reviewed	Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67)	MKI67	Homo sapiens (Human)	3256	animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]	 GO:1902275				PF00498;PF08065;PF15276;	"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ATP binding [GO:0005524]; DNA binding [GO:0003677]; protein C-terminus binding [GO:0008022]; RNA binding [GO:0003723]; animal organ regeneration [GO:0031100]; cell proliferation [GO:0008283]; cellular response to heat [GO:0034605]; DNA metabolic process [GO:0006259]; hyaluronan metabolic process [GO:0030212]; meiotic nuclear division [GO:0007126]; regulation of chromatin organization [GO:1902275]; regulation of chromosome segregation [GO:0051983]; regulation of mitotic nuclear division [GO:0007088]; response to organic cyclic compound [GO:0014070]"
CHOYP_contig_048721|m.57810	282	0	0	0	3	5	22	2.406	2.406	3.8048	3.8048	0	0	0.545207																												
CHOYP_BRAFLDRAFT_270672.1.1|m.25768	403	0	0	2	7	13	7	2.112	2.112	3.7531	3.7531	0	0	0.545359	CHOYP_BRAFLDRAFT_270672.1.1|m.25768	Q9Y617	SERC_HUMAN	63.19	364	134	0	34	397	6	369	2.00E-172	494	1	Q9Y617	SERC_HUMAN	reviewed	Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT)	PSAT1 PSA	Homo sapiens (Human)	370	L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]	GO:0004648	PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from 3-phospho-D-glycerate: step 2/3.; PATHWAY: Cofactor biosynthesis; pyridoxine 5'-phosphate biosynthesis; pyridoxine 5'-phosphate from D-erythrose 4-phosphate: step 3/5.		cd00611;	PF00266;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]
CHOYP_BRAFLDRAFT_270672.1.1|m.25768	403	0	0	2	7	13	7	2.112	2.112	3.7531	3.7531	0	0	0.545359	CHOYP_BRAFLDRAFT_270672.1.1|m.25768	Q9Y617	SERC_HUMAN	63.19	364	134	0	34	397	6	369	2.00E-172	494	1	Q9Y617	SERC_HUMAN	reviewed	Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT)	PSAT1 PSA	Homo sapiens (Human)	370	L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]	 GO:0005737	PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from 3-phospho-D-glycerate: step 2/3.; PATHWAY: Cofactor biosynthesis; pyridoxine 5'-phosphate biosynthesis; pyridoxine 5'-phosphate from D-erythrose 4-phosphate: step 3/5.		cd00611;	PF00266;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]
CHOYP_BRAFLDRAFT_270672.1.1|m.25768	403	0	0	2	7	13	7	2.112	2.112	3.7531	3.7531	0	0	0.545359	CHOYP_BRAFLDRAFT_270672.1.1|m.25768	Q9Y617	SERC_HUMAN	63.19	364	134	0	34	397	6	369	2.00E-172	494	1	Q9Y617	SERC_HUMAN	reviewed	Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT)	PSAT1 PSA	Homo sapiens (Human)	370	L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]	 GO:0005829	PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from 3-phospho-D-glycerate: step 2/3.; PATHWAY: Cofactor biosynthesis; pyridoxine 5'-phosphate biosynthesis; pyridoxine 5'-phosphate from D-erythrose 4-phosphate: step 3/5.		cd00611;	PF00266;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]
CHOYP_BRAFLDRAFT_270672.1.1|m.25768	403	0	0	2	7	13	7	2.112	2.112	3.7531	3.7531	0	0	0.545359	CHOYP_BRAFLDRAFT_270672.1.1|m.25768	Q9Y617	SERC_HUMAN	63.19	364	134	0	34	397	6	369	2.00E-172	494	1	Q9Y617	SERC_HUMAN	reviewed	Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT)	PSAT1 PSA	Homo sapiens (Human)	370	L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]	 GO:0006564	PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from 3-phospho-D-glycerate: step 2/3.; PATHWAY: Cofactor biosynthesis; pyridoxine 5'-phosphate biosynthesis; pyridoxine 5'-phosphate from D-erythrose 4-phosphate: step 3/5.		cd00611;	PF00266;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]
CHOYP_BRAFLDRAFT_270672.1.1|m.25768	403	0	0	2	7	13	7	2.112	2.112	3.7531	3.7531	0	0	0.545359	CHOYP_BRAFLDRAFT_270672.1.1|m.25768	Q9Y617	SERC_HUMAN	63.19	364	134	0	34	397	6	369	2.00E-172	494	1	Q9Y617	SERC_HUMAN	reviewed	Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT)	PSAT1 PSA	Homo sapiens (Human)	370	L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]	 GO:0008615	PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from 3-phospho-D-glycerate: step 2/3.; PATHWAY: Cofactor biosynthesis; pyridoxine 5'-phosphate biosynthesis; pyridoxine 5'-phosphate from D-erythrose 4-phosphate: step 3/5.		cd00611;	PF00266;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]
CHOYP_BRAFLDRAFT_270672.1.1|m.25768	403	0	0	2	7	13	7	2.112	2.112	3.7531	3.7531	0	0	0.545359	CHOYP_BRAFLDRAFT_270672.1.1|m.25768	Q9Y617	SERC_HUMAN	63.19	364	134	0	34	397	6	369	2.00E-172	494	1	Q9Y617	SERC_HUMAN	reviewed	Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT)	PSAT1 PSA	Homo sapiens (Human)	370	L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]	 GO:0070062	PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from 3-phospho-D-glycerate: step 2/3.; PATHWAY: Cofactor biosynthesis; pyridoxine 5'-phosphate biosynthesis; pyridoxine 5'-phosphate from D-erythrose 4-phosphate: step 3/5.		cd00611;	PF00266;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO:0004648]; L-serine biosynthetic process [GO:0006564]; pyridoxine biosynthetic process [GO:0008615]
CHOYP_BRAFLDRAFT_58194.1.1|m.27050	495	10	18	23	24	37	33	0.645	0.645	3.7217	3.7217	0	0	0.545452	CHOYP_BRAFLDRAFT_58194.1.1|m.27050	Q9Y600	CSAD_HUMAN	54.01	474	216	2	23	494	20	493	0	560	1	Q9Y600	CSAD_HUMAN	reviewed	Cysteine sulfinic acid decarboxylase (EC 4.1.1.29) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase)	CSAD CSD	Homo sapiens (Human)	493	carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]	GO:0004782	PATHWAY: Organosulfur biosynthesis; taurine biosynthesis; hypotaurine from L-cysteine: step 2/2.			PF00282;	pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]
CHOYP_BRAFLDRAFT_58194.1.1|m.27050	495	10	18	23	24	37	33	0.645	0.645	3.7217	3.7217	0	0	0.545452	CHOYP_BRAFLDRAFT_58194.1.1|m.27050	Q9Y600	CSAD_HUMAN	54.01	474	216	2	23	494	20	493	0	560	1	Q9Y600	CSAD_HUMAN	reviewed	Cysteine sulfinic acid decarboxylase (EC 4.1.1.29) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase)	CSAD CSD	Homo sapiens (Human)	493	carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]	 GO:0019752	PATHWAY: Organosulfur biosynthesis; taurine biosynthesis; hypotaurine from L-cysteine: step 2/2.			PF00282;	pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]
CHOYP_BRAFLDRAFT_58194.1.1|m.27050	495	10	18	23	24	37	33	0.645	0.645	3.7217	3.7217	0	0	0.545452	CHOYP_BRAFLDRAFT_58194.1.1|m.27050	Q9Y600	CSAD_HUMAN	54.01	474	216	2	23	494	20	493	0	560	1	Q9Y600	CSAD_HUMAN	reviewed	Cysteine sulfinic acid decarboxylase (EC 4.1.1.29) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase)	CSAD CSD	Homo sapiens (Human)	493	carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]	 GO:0030170	PATHWAY: Organosulfur biosynthesis; taurine biosynthesis; hypotaurine from L-cysteine: step 2/2.			PF00282;	pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]
CHOYP_BRAFLDRAFT_58194.1.1|m.27050	495	10	18	23	24	37	33	0.645	0.645	3.7217	3.7217	0	0	0.545452	CHOYP_BRAFLDRAFT_58194.1.1|m.27050	Q9Y600	CSAD_HUMAN	54.01	474	216	2	23	494	20	493	0	560	1	Q9Y600	CSAD_HUMAN	reviewed	Cysteine sulfinic acid decarboxylase (EC 4.1.1.29) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase)	CSAD CSD	Homo sapiens (Human)	493	carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]	 GO:0042412	PATHWAY: Organosulfur biosynthesis; taurine biosynthesis; hypotaurine from L-cysteine: step 2/2.			PF00282;	pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]
CHOYP_CATA.2.3|m.18454	393	18	10	20	25	28	35	0.641	0.641	3.7091	3.7091	0	0	0.545489																												
CHOYP_TVAG_106580.1.1|m.44429	1604	18	3	25	28	34	26	0.699	0.699	3.6406	3.6406	0	0	0.545692	CHOYP_TVAG_106580.1.1|m.44429	H2A0M0	NRP_PINMG	28.83	222	140	9	1381	1594	468	679	3.00E-14	81.6	1	H2A0M0	NRP_PINMG	reviewed	Asparagine-rich protein (Prism uncharacterized shell protein 1) (PUSP1)		Pinctada margaritifera (Black-lipped pearl oyster)	686		GO:0005576					extracellular region [GO:0005576]
CHOYP_contig_016567|m.19514	128	3	0	1	10	10	8	1.806	1.806	3.6111	3.6111	0	0	0.545781																												
CHOYP_contig_014958|m.17266	379	2	0	2	7	8	10	1.701	1.701	3.5702	3.5702	0	0	0.545906																												
CHOYP_LOC100708991.1.5|m.740	422	6	5	5	15	12	13	0.983	0.983	3.5695	3.5695	0	0	0.545908	CHOYP_LOC100708991.1.5|m.740	Q8C6K9	CO6A6_MOUSE	29.1	409	254	11	17	420	609	986	4.00E-41	162	1	Q8C6K9	CO6A6_MOUSE	reviewed	Collagen alpha-6(VI) chain	Col6a6	Mus musculus (Mouse)	2265	cell adhesion [GO:0007155]	GO:0005576				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_LOC100708991.1.5|m.740	422	6	5	5	15	12	13	0.983	0.983	3.5695	3.5695	0	0	0.545908	CHOYP_LOC100708991.1.5|m.740	Q8C6K9	CO6A6_MOUSE	29.1	409	254	11	17	420	609	986	4.00E-41	162	1	Q8C6K9	CO6A6_MOUSE	reviewed	Collagen alpha-6(VI) chain	Col6a6	Mus musculus (Mouse)	2265	cell adhesion [GO:0007155]	 GO:0005578				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_LOC100708991.1.5|m.740	422	6	5	5	15	12	13	0.983	0.983	3.5695	3.5695	0	0	0.545908	CHOYP_LOC100708991.1.5|m.740	Q8C6K9	CO6A6_MOUSE	29.1	409	254	11	17	420	609	986	4.00E-41	162	1	Q8C6K9	CO6A6_MOUSE	reviewed	Collagen alpha-6(VI) chain	Col6a6	Mus musculus (Mouse)	2265	cell adhesion [GO:0007155]	 GO:0005581				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_LOC100708991.1.5|m.740	422	6	5	5	15	12	13	0.983	0.983	3.5695	3.5695	0	0	0.545908	CHOYP_LOC100708991.1.5|m.740	Q8C6K9	CO6A6_MOUSE	29.1	409	254	11	17	420	609	986	4.00E-41	162	1	Q8C6K9	CO6A6_MOUSE	reviewed	Collagen alpha-6(VI) chain	Col6a6	Mus musculus (Mouse)	2265	cell adhesion [GO:0007155]	 GO:0007155				PF01391;PF00092;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; cell adhesion [GO:0007155]
CHOYP_CNE_1C34780.3.3|m.30615	174	7	4	8	16	17	15	0.95	0.95	3.4735	3.4735	0	0	0.546209																												
CHOYP_contig_017941|m.21005	2244	24	2	12	24	23	23	0.653	0.653	3.436	3.436	0	0	0.54633	CHOYP_contig_017941|m.21005	B3EWY9	MLP_ACRMI	27.89	1065	614	41	136	1134	387	1363	2.00E-90	331	1	B3EWY9	MLP_ACRMI	reviewed	Mucin-like protein (Fragment)		Acropora millepora (Staghorn coral)	1594	cell-matrix adhesion [GO:0007160]	GO:0005509				PF12662;PF06119;PF00090;PF00094;	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
CHOYP_contig_017941|m.21005	2244	24	2	12	24	23	23	0.653	0.653	3.436	3.436	0	0	0.54633	CHOYP_contig_017941|m.21005	B3EWY9	MLP_ACRMI	27.89	1065	614	41	136	1134	387	1363	2.00E-90	331	1	B3EWY9	MLP_ACRMI	reviewed	Mucin-like protein (Fragment)		Acropora millepora (Staghorn coral)	1594	cell-matrix adhesion [GO:0007160]	 GO:0007160				PF12662;PF06119;PF00090;PF00094;	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
CHOYP_contig_017941|m.21005	2244	24	2	12	24	23	23	0.653	0.653	3.436	3.436	0	0	0.54633	CHOYP_contig_017941|m.21005	B3EWY9	MLP_ACRMI	27.89	1065	614	41	136	1134	387	1363	2.00E-90	331	1	B3EWY9	MLP_ACRMI	reviewed	Mucin-like protein (Fragment)		Acropora millepora (Staghorn coral)	1594	cell-matrix adhesion [GO:0007160]	 GO:0016021				PF12662;PF06119;PF00090;PF00094;	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
CHOYP_YMS5.1.1|m.5494	1156	0	1	4	11	8	5	1.429	1.429	3.3683	3.3683	0	0	0.546555	CHOYP_YMS5.1.1|m.5494	P34501	YMS5_CAEEL	28.53	964	553	32	158	1019	311	1240	2.00E-94	335	1	P34501	YMS5_CAEEL	reviewed	Uncharacterized protein K03H1.5	K03H1.5	Caenorhabditis elegans	1385	cell-matrix adhesion [GO:0007160]	GO:0007160			cd00033;	PF03782;PF06119;PF00084;PF00094;	cell-matrix adhesion [GO:0007160]
CHOYP_BRAFLDRAFT_126943.1.3|m.6839	225	9	5	7	15	17	16	0.877	0.877	3.3188	3.3188	0	0	0.546726	CHOYP_BRAFLDRAFT_126943.1.3|m.6839	A8MGS9	Y1076_ALKOO	25.64	195	121	9	31	215	3	183	0.0000002	53.5	1	A8MGS9	Y1076_ALKOO	reviewed	Uncharacterized methyltransferase Clos_1076 (EC 2.1.1.-)	Clos_1076	Alkaliphilus oremlandii (strain OhILAs) (Clostridium oremlandii (strain OhILAs))	216		GO:0008168					methyltransferase activity [GO:0008168]
CHOYP_RS9.9.13|m.44486	363	28	0	28	32	35	31	0.565	0.565	3.2145	3.2145	0	0	0.547108	CHOYP_RS9.9.13|m.44486	P86954	ELDP2_PINMA	41.92	365	197	9	1	362	5	357	4.00E-83	263	1	P86954	ELDP2_PINMA	reviewed	EGF-like domain-containing protein 2		Pinctada maxima (Silver-lipped pearl oyster) (White-lipped pearl oyster)	357		GO:0005576					extracellular region [GO:0005576]
CHOYP_contig_002279|m.2484	556	5	5	15	13	17	23	0.804	0.804	3.1807	3.1807	0	0	0.547239	CHOYP_contig_002279|m.2484	Q5RA22	5NTC_PONAB	56.02	523	211	5	34	538	27	548	0	616	1	Q5RA22	5NTC_PONAB	reviewed	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II)	NT5C2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	561	nucleotide metabolic process [GO:0009117]	GO:0000166				PF05761;	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117]
CHOYP_contig_002279|m.2484	556	5	5	15	13	17	23	0.804	0.804	3.1807	3.1807	0	0	0.547239	CHOYP_contig_002279|m.2484	Q5RA22	5NTC_PONAB	56.02	523	211	5	34	538	27	548	0	616	1	Q5RA22	5NTC_PONAB	reviewed	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II)	NT5C2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	561	nucleotide metabolic process [GO:0009117]	 GO:0005737				PF05761;	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117]
CHOYP_contig_002279|m.2484	556	5	5	15	13	17	23	0.804	0.804	3.1807	3.1807	0	0	0.547239	CHOYP_contig_002279|m.2484	Q5RA22	5NTC_PONAB	56.02	523	211	5	34	538	27	548	0	616	1	Q5RA22	5NTC_PONAB	reviewed	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II)	NT5C2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	561	nucleotide metabolic process [GO:0009117]	 GO:0008253				PF05761;	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117]
CHOYP_contig_002279|m.2484	556	5	5	15	13	17	23	0.804	0.804	3.1807	3.1807	0	0	0.547239	CHOYP_contig_002279|m.2484	Q5RA22	5NTC_PONAB	56.02	523	211	5	34	538	27	548	0	616	1	Q5RA22	5NTC_PONAB	reviewed	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II)	NT5C2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	561	nucleotide metabolic process [GO:0009117]	 GO:0009117				PF05761;	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117]
CHOYP_contig_002279|m.2484	556	5	5	15	13	17	23	0.804	0.804	3.1807	3.1807	0	0	0.547239	CHOYP_contig_002279|m.2484	Q5RA22	5NTC_PONAB	56.02	523	211	5	34	538	27	548	0	616	1	Q5RA22	5NTC_PONAB	reviewed	Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II)	NT5C2	Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)	561	nucleotide metabolic process [GO:0009117]	 GO:0046872				PF05761;	cytoplasm [GO:0005737]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]; nucleotide metabolic process [GO:0009117]
CHOYP_contig_018956|m.22217	169	0	0	0	8	7	6	2.05	2.05	3.1623	3.1623	0	0	0.547311																												
CHOYP_TYRO1.6.6|m.44318	701	10	0	5	13	11	15	0.97	0.97	3.1467	3.1467	0	0	0.547374	CHOYP_TYRO1.6.6|m.44318	Q04604	TYRO_PELNI	28.63	248	113	10	167	363	205	439	4.00E-13	75.9	1	Q04604	TYRO_PELNI	reviewed	Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)	TYR TYRS	Pelophylax nigromaculatus (Black-spotted frog) (Rana nigromaculata)	532	melanin biosynthetic process from tyrosine [GO:0006583]	GO:0004503				PF00264;	integral component of membrane [GO:0016021]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; copper ion binding [GO:0005507]; L-DOPA monooxygenase activity [GO:0036263]; monophenol monooxygenase activity [GO:0004503]; melanin biosynthetic process from tyrosine [GO:0006583]
CHOYP_TYRO1.6.6|m.44318	701	10	0	5	13	11	15	0.97	0.97	3.1467	3.1467	0	0	0.547374	CHOYP_TYRO1.6.6|m.44318	Q04604	TYRO_PELNI	28.63	248	113	10	167	363	205	439	4.00E-13	75.9	1	Q04604	TYRO_PELNI	reviewed	Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)	TYR TYRS	Pelophylax nigromaculatus (Black-spotted frog) (Rana nigromaculata)	532	melanin biosynthetic process from tyrosine [GO:0006583]	 GO:0005507				PF00264;	integral component of membrane [GO:0016021]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; copper ion binding [GO:0005507]; L-DOPA monooxygenase activity [GO:0036263]; monophenol monooxygenase activity [GO:0004503]; melanin biosynthetic process from tyrosine [GO:0006583]
CHOYP_TYRO1.6.6|m.44318	701	10	0	5	13	11	15	0.97	0.97	3.1467	3.1467	0	0	0.547374	CHOYP_TYRO1.6.6|m.44318	Q04604	TYRO_PELNI	28.63	248	113	10	167	363	205	439	4.00E-13	75.9	1	Q04604	TYRO_PELNI	reviewed	Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)	TYR TYRS	Pelophylax nigromaculatus (Black-spotted frog) (Rana nigromaculata)	532	melanin biosynthetic process from tyrosine [GO:0006583]	 GO:0006583				PF00264;	integral component of membrane [GO:0016021]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; copper ion binding [GO:0005507]; L-DOPA monooxygenase activity [GO:0036263]; monophenol monooxygenase activity [GO:0004503]; melanin biosynthetic process from tyrosine [GO:0006583]
CHOYP_TYRO1.6.6|m.44318	701	10	0	5	13	11	15	0.97	0.97	3.1467	3.1467	0	0	0.547374	CHOYP_TYRO1.6.6|m.44318	Q04604	TYRO_PELNI	28.63	248	113	10	167	363	205	439	4.00E-13	75.9	1	Q04604	TYRO_PELNI	reviewed	Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)	TYR TYRS	Pelophylax nigromaculatus (Black-spotted frog) (Rana nigromaculata)	532	melanin biosynthetic process from tyrosine [GO:0006583]	 GO:0016021				PF00264;	integral component of membrane [GO:0016021]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; copper ion binding [GO:0005507]; L-DOPA monooxygenase activity [GO:0036263]; monophenol monooxygenase activity [GO:0004503]; melanin biosynthetic process from tyrosine [GO:0006583]
CHOYP_TYRO1.6.6|m.44318	701	10	0	5	13	11	15	0.97	0.97	3.1467	3.1467	0	0	0.547374	CHOYP_TYRO1.6.6|m.44318	Q04604	TYRO_PELNI	28.63	248	113	10	167	363	205	439	4.00E-13	75.9	1	Q04604	TYRO_PELNI	reviewed	Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)	TYR TYRS	Pelophylax nigromaculatus (Black-spotted frog) (Rana nigromaculata)	532	melanin biosynthetic process from tyrosine [GO:0006583]	 GO:0033162				PF00264;	integral component of membrane [GO:0016021]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; copper ion binding [GO:0005507]; L-DOPA monooxygenase activity [GO:0036263]; monophenol monooxygenase activity [GO:0004503]; melanin biosynthetic process from tyrosine [GO:0006583]
CHOYP_TYRO1.6.6|m.44318	701	10	0	5	13	11	15	0.97	0.97	3.1467	3.1467	0	0	0.547374	CHOYP_TYRO1.6.6|m.44318	Q04604	TYRO_PELNI	28.63	248	113	10	167	363	205	439	4.00E-13	75.9	1	Q04604	TYRO_PELNI	reviewed	Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)	TYR TYRS	Pelophylax nigromaculatus (Black-spotted frog) (Rana nigromaculata)	532	melanin biosynthetic process from tyrosine [GO:0006583]	 GO:0036263				PF00264;	integral component of membrane [GO:0016021]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; copper ion binding [GO:0005507]; L-DOPA monooxygenase activity [GO:0036263]; monophenol monooxygenase activity [GO:0004503]; melanin biosynthetic process from tyrosine [GO:0006583]
CHOYP_TYRO1.6.6|m.44318	701	10	0	5	13	11	15	0.97	0.97	3.1467	3.1467	0	0	0.547374	CHOYP_TYRO1.6.6|m.44318	Q04604	TYRO_PELNI	28.63	248	113	10	167	363	205	439	4.00E-13	75.9	1	Q04604	TYRO_PELNI	reviewed	Tyrosinase (EC 1.14.18.1) (Monophenol monooxygenase)	TYR TYRS	Pelophylax nigromaculatus (Black-spotted frog) (Rana nigromaculata)	532	melanin biosynthetic process from tyrosine [GO:0006583]	 GO:0042470				PF00264;	integral component of membrane [GO:0016021]; melanosome [GO:0042470]; melanosome membrane [GO:0033162]; copper ion binding [GO:0005507]; L-DOPA monooxygenase activity [GO:0036263]; monophenol monooxygenase activity [GO:0004503]; melanin biosynthetic process from tyrosine [GO:0006583]
CHOYP_TYRO1.2.6|m.42960	760	1	0	5	11	7	9	1.386	1.386	3.144	3.144	0	0	0.547385	CHOYP_TYRO1.2.6|m.42960	P56826	HCYG_SEPOF	30	180	91	8	210	374	249	408	0.000000002	64.7	1	P56826	HCYG_SEPOF	reviewed	"Hemocyanin, units G and H (Fragments)"		Sepia officinalis (Common cuttlefish)	560		GO:0005344				PF14830;PF00264;	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen transporter activity [GO:0005344]
CHOYP_TYRO1.2.6|m.42960	760	1	0	5	11	7	9	1.386	1.386	3.144	3.144	0	0	0.547385	CHOYP_TYRO1.2.6|m.42960	P56826	HCYG_SEPOF	30	180	91	8	210	374	249	408	0.000000002	64.7	1	P56826	HCYG_SEPOF	reviewed	"Hemocyanin, units G and H (Fragments)"		Sepia officinalis (Common cuttlefish)	560		 GO:0016491				PF14830;PF00264;	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen transporter activity [GO:0005344]
CHOYP_TYRO1.2.6|m.42960	760	1	0	5	11	7	9	1.386	1.386	3.144	3.144	0	0	0.547385	CHOYP_TYRO1.2.6|m.42960	P56826	HCYG_SEPOF	30	180	91	8	210	374	249	408	0.000000002	64.7	1	P56826	HCYG_SEPOF	reviewed	"Hemocyanin, units G and H (Fragments)"		Sepia officinalis (Common cuttlefish)	560		 GO:0046872				PF14830;PF00264;	metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; oxygen transporter activity [GO:0005344]
CHOYP_KAL1.1.1|m.60996	1941	18	5	14	20	26	20	0.619	0.619	3.0953	3.0953	0	0	0.547588																												
CHOYP_SCP.8.12|m.57173	180	15	14	17	24	26	27	0.548	0.548	3.0719	3.0719	0	0	0.54769																												
CHOYP_RN213.4.13|m.27716	4568	2	0	2	2	15	5	1.579	1.579	3.0591	3.0591	0	0	0.547747	CHOYP_RN213.4.13|m.27716	A0A0R4IBK5	R213A_DANRE	35.86	3561	2031	85	1074	4554	1811	5198	0	2004	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	GO:0002040	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_RN213.4.13|m.27716	4568	2	0	2	2	15	5	1.579	1.579	3.0591	3.0591	0	0	0.547747	CHOYP_RN213.4.13|m.27716	A0A0R4IBK5	R213A_DANRE	35.86	3561	2031	85	1074	4554	1811	5198	0	2004	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	 GO:0004842	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_RN213.4.13|m.27716	4568	2	0	2	2	15	5	1.579	1.579	3.0591	3.0591	0	0	0.547747	CHOYP_RN213.4.13|m.27716	A0A0R4IBK5	R213A_DANRE	35.86	3561	2031	85	1074	4554	1811	5198	0	2004	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	 GO:0005829	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_RN213.4.13|m.27716	4568	2	0	2	2	15	5	1.579	1.579	3.0591	3.0591	0	0	0.547747	CHOYP_RN213.4.13|m.27716	A0A0R4IBK5	R213A_DANRE	35.86	3561	2031	85	1074	4554	1811	5198	0	2004	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	 GO:0008270	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_RN213.4.13|m.27716	4568	2	0	2	2	15	5	1.579	1.579	3.0591	3.0591	0	0	0.547747	CHOYP_RN213.4.13|m.27716	A0A0R4IBK5	R213A_DANRE	35.86	3561	2031	85	1074	4554	1811	5198	0	2004	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	 GO:0016887	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_contig_055984|m.66583	167	18	11	21	29	26	27	0.533	0.533	3.0402	3.0402	0	0	0.547832																												
CHOYP_contig_004594|m.5279	257	1	0	7	8	12	9	1.237	1.237	2.9998	2.9998	0	0	0.548025																												
CHOYP_contig_034410|m.39066	2222	9	0	10	16	13	15	0.823	0.823	2.9409	2.9409	0	0	0.548332																												
CHOYP_LOC101062323.1.1|m.15918	227	2	1	3	6	11	6	1.438	1.438	2.8893	2.8893	0	0	0.548635	CHOYP_LOC101062323.1.1|m.15918	P54106	ICLN_XENLA	39.41	236	117	4	14	223	3	238	2.00E-38	139	1	P54106	ICLN_XENLA	reviewed	Methylosome subunit pICln (Chloride conductance regulatory protein ICln) (I(Cln))	clns1a icln	Xenopus laevis (African clawed frog)	241	cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]	GO:0000387					cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]
CHOYP_LOC101062323.1.1|m.15918	227	2	1	3	6	11	6	1.438	1.438	2.8893	2.8893	0	0	0.548635	CHOYP_LOC101062323.1.1|m.15918	P54106	ICLN_XENLA	39.41	236	117	4	14	223	3	238	2.00E-38	139	1	P54106	ICLN_XENLA	reviewed	Methylosome subunit pICln (Chloride conductance regulatory protein ICln) (I(Cln))	clns1a icln	Xenopus laevis (African clawed frog)	241	cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]	 GO:0005634					cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]
CHOYP_LOC101062323.1.1|m.15918	227	2	1	3	6	11	6	1.438	1.438	2.8893	2.8893	0	0	0.548635	CHOYP_LOC101062323.1.1|m.15918	P54106	ICLN_XENLA	39.41	236	117	4	14	223	3	238	2.00E-38	139	1	P54106	ICLN_XENLA	reviewed	Methylosome subunit pICln (Chloride conductance regulatory protein ICln) (I(Cln))	clns1a icln	Xenopus laevis (African clawed frog)	241	cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]	 GO:0005829					cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]
CHOYP_LOC101062323.1.1|m.15918	227	2	1	3	6	11	6	1.438	1.438	2.8893	2.8893	0	0	0.548635	CHOYP_LOC101062323.1.1|m.15918	P54106	ICLN_XENLA	39.41	236	117	4	14	223	3	238	2.00E-38	139	1	P54106	ICLN_XENLA	reviewed	Methylosome subunit pICln (Chloride conductance regulatory protein ICln) (I(Cln))	clns1a icln	Xenopus laevis (African clawed frog)	241	cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]	 GO:0005856					cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]
CHOYP_LOC101062323.1.1|m.15918	227	2	1	3	6	11	6	1.438	1.438	2.8893	2.8893	0	0	0.548635	CHOYP_LOC101062323.1.1|m.15918	P54106	ICLN_XENLA	39.41	236	117	4	14	223	3	238	2.00E-38	139	1	P54106	ICLN_XENLA	reviewed	Methylosome subunit pICln (Chloride conductance regulatory protein ICln) (I(Cln))	clns1a icln	Xenopus laevis (African clawed frog)	241	cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]	 GO:0005886					cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]
CHOYP_LOC101062323.1.1|m.15918	227	2	1	3	6	11	6	1.438	1.438	2.8893	2.8893	0	0	0.548635	CHOYP_LOC101062323.1.1|m.15918	P54106	ICLN_XENLA	39.41	236	117	4	14	223	3	238	2.00E-38	139	1	P54106	ICLN_XENLA	reviewed	Methylosome subunit pICln (Chloride conductance regulatory protein ICln) (I(Cln))	clns1a icln	Xenopus laevis (African clawed frog)	241	cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]	 GO:0006821					cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]
CHOYP_LOC101062323.1.1|m.15918	227	2	1	3	6	11	6	1.438	1.438	2.8893	2.8893	0	0	0.548635	CHOYP_LOC101062323.1.1|m.15918	P54106	ICLN_XENLA	39.41	236	117	4	14	223	3	238	2.00E-38	139	1	P54106	ICLN_XENLA	reviewed	Methylosome subunit pICln (Chloride conductance regulatory protein ICln) (I(Cln))	clns1a icln	Xenopus laevis (African clawed frog)	241	cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]	 GO:0006884					cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]
CHOYP_LOC101062323.1.1|m.15918	227	2	1	3	6	11	6	1.438	1.438	2.8893	2.8893	0	0	0.548635	CHOYP_LOC101062323.1.1|m.15918	P54106	ICLN_XENLA	39.41	236	117	4	14	223	3	238	2.00E-38	139	1	P54106	ICLN_XENLA	reviewed	Methylosome subunit pICln (Chloride conductance regulatory protein ICln) (I(Cln))	clns1a icln	Xenopus laevis (African clawed frog)	241	cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]	 GO:0034709					cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]
CHOYP_LOC101062323.1.1|m.15918	227	2	1	3	6	11	6	1.438	1.438	2.8893	2.8893	0	0	0.548635	CHOYP_LOC101062323.1.1|m.15918	P54106	ICLN_XENLA	39.41	236	117	4	14	223	3	238	2.00E-38	139	1	P54106	ICLN_XENLA	reviewed	Methylosome subunit pICln (Chloride conductance regulatory protein ICln) (I(Cln))	clns1a icln	Xenopus laevis (African clawed frog)	241	cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]	 GO:0034715					cytoskeleton [GO:0005856]; cytosol [GO:0005829]; methylosome [GO:0034709]; nucleus [GO:0005634]; pICln-Sm protein complex [GO:0034715]; plasma membrane [GO:0005886]; cell volume homeostasis [GO:0006884]; chloride transport [GO:0006821]; spliceosomal snRNP assembly [GO:0000387]
CHOYP_contig_039330|m.44540	694	9	0	12	16	15	15	0.779	0.779	2.8588	2.8588	0	0	0.54883																												
CHOYP_contig_023811|m.27063	467	3	2	7	10	12	8	0.992	0.992	2.8451	2.8451	0	0	0.548923																												
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	GO:0003015				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0005886				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0005887				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0005918				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0005919				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0007163				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0007391				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0008039				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0008104				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0008366				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0016080				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0016081				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0019991				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0021682				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0035151				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0045202				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0045216				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0048786				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0060857				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0061343				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0072553				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_NRX4.1.1|m.8135	1189	13	5	11	19	16	18	0.653	0.653	2.8308	2.8308	0	0	0.549022	CHOYP_NRX4.1.1|m.8135	Q94887	NRX4_DROME	37.37	1215	685	27	1	1188	119	1284	0	768	1	Q94887	NRX4_DROME	reviewed	Neurexin-4 (Neurexin IV)	Nrx-IV Nrx CG6827	Drosophila melanogaster (Fruit fly)	1284	"axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"	 GO:0097105				PF00008;PF00754;PF02210;	"integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; pleated septate junction [GO:0005919]; presynaptic active zone [GO:0048786]; septate junction [GO:0005918]; synapse [GO:0045202]; axon ensheathment [GO:0008366]; cell adhesion involved in heart morphogenesis [GO:0061343]; cell-cell junction organization [GO:0045216]; dorsal closure [GO:0007391]; establishment of glial blood-brain barrier [GO:0060857]; establishment or maintenance of cell polarity [GO:0007163]; heart process [GO:0003015]; nerve maturation [GO:0021682]; presynaptic membrane assembly [GO:0097105]; protein localization [GO:0008104]; regulation of tube size, open tracheal system [GO:0035151]; septate junction assembly [GO:0019991]; synaptic target recognition [GO:0008039]; synaptic vesicle docking [GO:0016081]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]"
CHOYP_KCP.3.13|m.17018	307	2	2	2	6	7	8	1.323	1.323	2.8041	2.8041	0	0	0.549217																												
CHOYP_PM20D2.1.1|m.27186	397	0	0	5	8	7	8	1.291	1.291	2.8031	2.8031	0	0	0.549224	CHOYP_PM20D2.1.1|m.27186	A3KG59	P20D2_MOUSE	52.72	404	180	5	4	396	22	425	3.00E-127	380	1	A3KG59	P20D2_MOUSE	reviewed	Peptidase M20 domain-containing protein 2 (Aminoacylase-1-like protein 2)	Pm20d2 Acy1l2 Gm424	Mus musculus (Mouse)	431	proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]	GO:0005654				PF07687;PF01546;	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]
CHOYP_PM20D2.1.1|m.27186	397	0	0	5	8	7	8	1.291	1.291	2.8031	2.8031	0	0	0.549224	CHOYP_PM20D2.1.1|m.27186	A3KG59	P20D2_MOUSE	52.72	404	180	5	4	396	22	425	3.00E-127	380	1	A3KG59	P20D2_MOUSE	reviewed	Peptidase M20 domain-containing protein 2 (Aminoacylase-1-like protein 2)	Pm20d2 Acy1l2 Gm424	Mus musculus (Mouse)	431	proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]	 GO:0006508				PF07687;PF01546;	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]
CHOYP_PM20D2.1.1|m.27186	397	0	0	5	8	7	8	1.291	1.291	2.8031	2.8031	0	0	0.549224	CHOYP_PM20D2.1.1|m.27186	A3KG59	P20D2_MOUSE	52.72	404	180	5	4	396	22	425	3.00E-127	380	1	A3KG59	P20D2_MOUSE	reviewed	Peptidase M20 domain-containing protein 2 (Aminoacylase-1-like protein 2)	Pm20d2 Acy1l2 Gm424	Mus musculus (Mouse)	431	proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]	 GO:0016805				PF07687;PF01546;	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]
CHOYP_PM20D2.1.1|m.27186	397	0	0	5	8	7	8	1.291	1.291	2.8031	2.8031	0	0	0.549224	CHOYP_PM20D2.1.1|m.27186	A3KG59	P20D2_MOUSE	52.72	404	180	5	4	396	22	425	3.00E-127	380	1	A3KG59	P20D2_MOUSE	reviewed	Peptidase M20 domain-containing protein 2 (Aminoacylase-1-like protein 2)	Pm20d2 Acy1l2 Gm424	Mus musculus (Mouse)	431	proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]	 GO:0032268				PF07687;PF01546;	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]
CHOYP_PM20D2.1.1|m.27186	397	0	0	5	8	7	8	1.291	1.291	2.8031	2.8031	0	0	0.549224	CHOYP_PM20D2.1.1|m.27186	A3KG59	P20D2_MOUSE	52.72	404	180	5	4	396	22	425	3.00E-127	380	1	A3KG59	P20D2_MOUSE	reviewed	Peptidase M20 domain-containing protein 2 (Aminoacylase-1-like protein 2)	Pm20d2 Acy1l2 Gm424	Mus musculus (Mouse)	431	proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]	 GO:0070062				PF07687;PF01546;	extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; dipeptidase activity [GO:0016805]; proteolysis [GO:0006508]; regulation of cellular protein metabolic process [GO:0032268]
CHOYP_NEMVEDRAFT_V1G224038.5.5|m.50649	138	5	4	1	7	10	9	1.007	1.007	2.7968	2.7968	0	0	0.549272																												
CHOYP_LOC100371994.1.1|m.50098	310	6	5	10	12	13	17	0.739	0.739	2.7897	2.7897	0	0	0.549326	CHOYP_LOC100371994.1.1|m.50098	Q29RI9	MAT2B_BOVIN	48.48	297	149	4	13	307	29	323	1.00E-99	303	1	Q29RI9	MAT2B_BOVIN	reviewed	Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta)	MAT2B	Bos taurus (Bovine)	334	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	GO:0005634	PATHWAY: Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. {ECO:0000250|UniProtKB:Q9NZL9}.			PF04321;	extracellular exosome [GO:0070062]; methionine adenosyltransferase complex [GO:0048269]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]
CHOYP_LOC100371994.1.1|m.50098	310	6	5	10	12	13	17	0.739	0.739	2.7897	2.7897	0	0	0.549326	CHOYP_LOC100371994.1.1|m.50098	Q29RI9	MAT2B_BOVIN	48.48	297	149	4	13	307	29	323	1.00E-99	303	1	Q29RI9	MAT2B_BOVIN	reviewed	Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta)	MAT2B	Bos taurus (Bovine)	334	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	 GO:0005739	PATHWAY: Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. {ECO:0000250|UniProtKB:Q9NZL9}.			PF04321;	extracellular exosome [GO:0070062]; methionine adenosyltransferase complex [GO:0048269]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]
CHOYP_LOC100371994.1.1|m.50098	310	6	5	10	12	13	17	0.739	0.739	2.7897	2.7897	0	0	0.549326	CHOYP_LOC100371994.1.1|m.50098	Q29RI9	MAT2B_BOVIN	48.48	297	149	4	13	307	29	323	1.00E-99	303	1	Q29RI9	MAT2B_BOVIN	reviewed	Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta)	MAT2B	Bos taurus (Bovine)	334	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	 GO:0006556	PATHWAY: Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. {ECO:0000250|UniProtKB:Q9NZL9}.			PF04321;	extracellular exosome [GO:0070062]; methionine adenosyltransferase complex [GO:0048269]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]
CHOYP_LOC100371994.1.1|m.50098	310	6	5	10	12	13	17	0.739	0.739	2.7897	2.7897	0	0	0.549326	CHOYP_LOC100371994.1.1|m.50098	Q29RI9	MAT2B_BOVIN	48.48	297	149	4	13	307	29	323	1.00E-99	303	1	Q29RI9	MAT2B_BOVIN	reviewed	Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta)	MAT2B	Bos taurus (Bovine)	334	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	 GO:0006730	PATHWAY: Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. {ECO:0000250|UniProtKB:Q9NZL9}.			PF04321;	extracellular exosome [GO:0070062]; methionine adenosyltransferase complex [GO:0048269]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]
CHOYP_LOC100371994.1.1|m.50098	310	6	5	10	12	13	17	0.739	0.739	2.7897	2.7897	0	0	0.549326	CHOYP_LOC100371994.1.1|m.50098	Q29RI9	MAT2B_BOVIN	48.48	297	149	4	13	307	29	323	1.00E-99	303	1	Q29RI9	MAT2B_BOVIN	reviewed	Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta)	MAT2B	Bos taurus (Bovine)	334	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	 GO:0048269	PATHWAY: Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. {ECO:0000250|UniProtKB:Q9NZL9}.			PF04321;	extracellular exosome [GO:0070062]; methionine adenosyltransferase complex [GO:0048269]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]
CHOYP_LOC100371994.1.1|m.50098	310	6	5	10	12	13	17	0.739	0.739	2.7897	2.7897	0	0	0.549326	CHOYP_LOC100371994.1.1|m.50098	Q29RI9	MAT2B_BOVIN	48.48	297	149	4	13	307	29	323	1.00E-99	303	1	Q29RI9	MAT2B_BOVIN	reviewed	Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta)	MAT2B	Bos taurus (Bovine)	334	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	 GO:0048270	PATHWAY: Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. {ECO:0000250|UniProtKB:Q9NZL9}.			PF04321;	extracellular exosome [GO:0070062]; methionine adenosyltransferase complex [GO:0048269]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]
CHOYP_LOC100371994.1.1|m.50098	310	6	5	10	12	13	17	0.739	0.739	2.7897	2.7897	0	0	0.549326	CHOYP_LOC100371994.1.1|m.50098	Q29RI9	MAT2B_BOVIN	48.48	297	149	4	13	307	29	323	1.00E-99	303	1	Q29RI9	MAT2B_BOVIN	reviewed	Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta)	MAT2B	Bos taurus (Bovine)	334	one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]	 GO:0070062	PATHWAY: Amino-acid biosynthesis; S-adenosyl-L-methionine biosynthesis; S-adenosyl-L-methionine from L-methionine: step 1/1. {ECO:0000250|UniProtKB:Q9NZL9}.			PF04321;	extracellular exosome [GO:0070062]; methionine adenosyltransferase complex [GO:0048269]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; methionine adenosyltransferase regulator activity [GO:0048270]; one-carbon metabolic process [GO:0006730]; S-adenosylmethionine biosynthetic process [GO:0006556]
CHOYP_GLIPR1L1.1.1|m.41745	240	0	0	0	5	4	9	1.917	1.917	2.7767	2.7767	0	0	0.549428	CHOYP_GLIPR1L1.1.1|m.41745	Q7T141	PI15A_DANRE	38.55	179	88	6	36	195	72	247	5.00E-30	117	1	Q7T141	PI15A_DANRE	reviewed	Peptidase inhibitor 15-A	pi15a pi15 si:rp71-1m12.1	Danio rerio (Zebrafish) (Brachydanio rerio)	260		GO:0005576				PF00188;	extracellular region [GO:0005576]; peptidase inhibitor activity [GO:0030414]
CHOYP_GLIPR1L1.1.1|m.41745	240	0	0	0	5	4	9	1.917	1.917	2.7767	2.7767	0	0	0.549428	CHOYP_GLIPR1L1.1.1|m.41745	Q7T141	PI15A_DANRE	38.55	179	88	6	36	195	72	247	5.00E-30	117	1	Q7T141	PI15A_DANRE	reviewed	Peptidase inhibitor 15-A	pi15a pi15 si:rp71-1m12.1	Danio rerio (Zebrafish) (Brachydanio rerio)	260		 GO:0030414				PF00188;	extracellular region [GO:0005576]; peptidase inhibitor activity [GO:0030414]
CHOYP_contig_016375|m.19279	449	0	0	0	5	5	7	1.798	1.798	2.7732	2.7732	0	0	0.549455																												
CHOYP_BM8F.2.2|m.35731	128	3	0	1	5	8	4	1.273	1.273	2.756	2.756	0	0	0.549595																												
CHOYP_AMY.3.3|m.64271	526	4	5	15	15	15	16	0.684	0.684	2.7459	2.7459	0	0	0.549679	CHOYP_AMY.3.3|m.64271	P91778	AMY_PECMA	70.54	516	140	4	4	519	5	508	0	726	1	P91778	AMY_PECMA	reviewed	"Alpha-amylase (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)"		Pecten maximus (King scallop) (Pilgrim's clam)	508	carbohydrate metabolic process [GO:0005975]	GO:0004556				PF00128;PF02806;	alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]
CHOYP_AMY.3.3|m.64271	526	4	5	15	15	15	16	0.684	0.684	2.7459	2.7459	0	0	0.549679	CHOYP_AMY.3.3|m.64271	P91778	AMY_PECMA	70.54	516	140	4	4	519	5	508	0	726	1	P91778	AMY_PECMA	reviewed	"Alpha-amylase (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)"		Pecten maximus (King scallop) (Pilgrim's clam)	508	carbohydrate metabolic process [GO:0005975]	 GO:0005975				PF00128;PF02806;	alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]
CHOYP_AMY.3.3|m.64271	526	4	5	15	15	15	16	0.684	0.684	2.7459	2.7459	0	0	0.549679	CHOYP_AMY.3.3|m.64271	P91778	AMY_PECMA	70.54	516	140	4	4	519	5	508	0	726	1	P91778	AMY_PECMA	reviewed	"Alpha-amylase (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)"		Pecten maximus (King scallop) (Pilgrim's clam)	508	carbohydrate metabolic process [GO:0005975]	 GO:0046872				PF00128;PF02806;	alpha-amylase activity [GO:0004556]; metal ion binding [GO:0046872]; carbohydrate metabolic process [GO:0005975]
CHOYP_contig_016405|m.19312	162	0	0	1	7	5	4	1.843	1.843	2.7374	2.7374	0	0	0.549751																												
CHOYP_contig_015692|m.18358	141	3	0	4	6	9	9	1.154	1.154	2.7326	2.7326	0	0	0.549792																												
CHOYP_GIGA2.1.1|m.44916	391	12	0	21	17	22	19	0.585	0.585	2.7002	2.7002	0	0	0.550079	CHOYP_GIGA2.1.1|m.44916	P86785	GIGA2_CRAGI	98.77	324	4	0	30	353	1	324	0	668	1	P86785	GIGA2_CRAGI	reviewed	Gigasin-2		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	340							
CHOYP_contig_053787|m.64362	625	0	0	2	3	4	12	1.661	1.661	2.6895	2.6895	0	0	0.550177																												
CHOYP_LOC100199379.2.2|m.63866	1227	5	0	8	9	11	10	0.812	0.812	2.6708	2.6708	0	0	0.550352																												
CHOYP_CSAD.1.1|m.40056	528	18	14	12	23	26	21	0.505	0.505	2.6654	2.6654	0	0	0.550404	CHOYP_CSAD.1.1|m.40056	Q9Y600	CSAD_HUMAN	50.77	455	218	4	75	527	43	493	7.00E-175	509	1	Q9Y600	CSAD_HUMAN	reviewed	Cysteine sulfinic acid decarboxylase (EC 4.1.1.29) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase)	CSAD CSD	Homo sapiens (Human)	493	carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]	GO:0004782	PATHWAY: Organosulfur biosynthesis; taurine biosynthesis; hypotaurine from L-cysteine: step 2/2.			PF00282;	pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]
CHOYP_CSAD.1.1|m.40056	528	18	14	12	23	26	21	0.505	0.505	2.6654	2.6654	0	0	0.550404	CHOYP_CSAD.1.1|m.40056	Q9Y600	CSAD_HUMAN	50.77	455	218	4	75	527	43	493	7.00E-175	509	1	Q9Y600	CSAD_HUMAN	reviewed	Cysteine sulfinic acid decarboxylase (EC 4.1.1.29) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase)	CSAD CSD	Homo sapiens (Human)	493	carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]	 GO:0019752	PATHWAY: Organosulfur biosynthesis; taurine biosynthesis; hypotaurine from L-cysteine: step 2/2.			PF00282;	pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]
CHOYP_CSAD.1.1|m.40056	528	18	14	12	23	26	21	0.505	0.505	2.6654	2.6654	0	0	0.550404	CHOYP_CSAD.1.1|m.40056	Q9Y600	CSAD_HUMAN	50.77	455	218	4	75	527	43	493	7.00E-175	509	1	Q9Y600	CSAD_HUMAN	reviewed	Cysteine sulfinic acid decarboxylase (EC 4.1.1.29) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase)	CSAD CSD	Homo sapiens (Human)	493	carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]	 GO:0030170	PATHWAY: Organosulfur biosynthesis; taurine biosynthesis; hypotaurine from L-cysteine: step 2/2.			PF00282;	pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]
CHOYP_CSAD.1.1|m.40056	528	18	14	12	23	26	21	0.505	0.505	2.6654	2.6654	0	0	0.550404	CHOYP_CSAD.1.1|m.40056	Q9Y600	CSAD_HUMAN	50.77	455	218	4	75	527	43	493	7.00E-175	509	1	Q9Y600	CSAD_HUMAN	reviewed	Cysteine sulfinic acid decarboxylase (EC 4.1.1.29) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase)	CSAD CSD	Homo sapiens (Human)	493	carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]	 GO:0042412	PATHWAY: Organosulfur biosynthesis; taurine biosynthesis; hypotaurine from L-cysteine: step 2/2.			PF00282;	pyridoxal phosphate binding [GO:0030170]; sulfinoalanine decarboxylase activity [GO:0004782]; carboxylic acid metabolic process [GO:0019752]; taurine biosynthetic process [GO:0042412]
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	GO:0001726				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0005543				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0005737				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0005886				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0007163				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0010592				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0015629				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0016020				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0030011				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0030027				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0030335				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0031234				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0031252				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0032403				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0044319				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0044354				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0045111				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0051639				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0061339				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:0090091				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:1900029				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:1902745				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_LR16A.1.3|m.9037	1363	10	10	19	16	24	24	0.547	0.547	2.6618	2.6618	0	0	0.550438	CHOYP_LR16A.1.3|m.9037	Q6F5E8	CARL2_HUMAN	31.26	675	397	10	1	625	248	905	5.00E-96	342	1	Q6F5E8	CARL2_HUMAN	reviewed	"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)"	CARMIL2 LRRC16C RLTPR	Homo sapiens (Human)	1435	"actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"	 GO:2000813				PF16000;PF13516;	"actin cytoskeleton [GO:0015629]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; intermediate filament cytoskeleton [GO:0045111]; lamellipodium [GO:0030027]; macropinosome [GO:0044354]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; phospholipid binding [GO:0005543]; protein complex binding [GO:0032403]; actin filament network formation [GO:0051639]; establishment or maintenance of cell polarity [GO:0007163]; establishment or maintenance of monopolar cell polarity [GO:0061339]; maintenance of cell polarity [GO:0030011]; negative regulation of barbed-end actin filament capping [GO:2000813]; positive regulation of cell migration [GO:0030335]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of lamellipodium organization [GO:1902745]; positive regulation of ruffle assembly [GO:1900029]; wound healing, spreading of cells [GO:0044319]"
CHOYP_ISCW_ISCW022925.1.2|m.61535	552	12	9	18	17	27	20	0.54	0.54	2.6462	2.6462	0	0	0.55059	CHOYP_ISCW_ISCW022925.1.2|m.61535	Q863I2	OXSR1_PIG	58.99	534	194	6	22	543	9	529	0	629	1	Q863I2	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	GO:0000287				PF12202;PF00069;	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; signal transducer, downstream of receptor, with serine/threonine kinase activity [GO:0004702]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]"
CHOYP_ISCW_ISCW022925.1.2|m.61535	552	12	9	18	17	27	20	0.54	0.54	2.6462	2.6462	0	0	0.55059	CHOYP_ISCW_ISCW022925.1.2|m.61535	Q863I2	OXSR1_PIG	58.99	534	194	6	22	543	9	529	0	629	1	Q863I2	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	 GO:0004674				PF12202;PF00069;	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; signal transducer, downstream of receptor, with serine/threonine kinase activity [GO:0004702]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]"
CHOYP_ISCW_ISCW022925.1.2|m.61535	552	12	9	18	17	27	20	0.54	0.54	2.6462	2.6462	0	0	0.55059	CHOYP_ISCW_ISCW022925.1.2|m.61535	Q863I2	OXSR1_PIG	58.99	534	194	6	22	543	9	529	0	629	1	Q863I2	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	 GO:0004702				PF12202;PF00069;	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; signal transducer, downstream of receptor, with serine/threonine kinase activity [GO:0004702]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]"
CHOYP_ISCW_ISCW022925.1.2|m.61535	552	12	9	18	17	27	20	0.54	0.54	2.6462	2.6462	0	0	0.55059	CHOYP_ISCW_ISCW022925.1.2|m.61535	Q863I2	OXSR1_PIG	58.99	534	194	6	22	543	9	529	0	629	1	Q863I2	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	 GO:0005524				PF12202;PF00069;	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; signal transducer, downstream of receptor, with serine/threonine kinase activity [GO:0004702]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]"
CHOYP_ISCW_ISCW022925.1.2|m.61535	552	12	9	18	17	27	20	0.54	0.54	2.6462	2.6462	0	0	0.55059	CHOYP_ISCW_ISCW022925.1.2|m.61535	Q863I2	OXSR1_PIG	58.99	534	194	6	22	543	9	529	0	629	1	Q863I2	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	 GO:0005737				PF12202;PF00069;	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; signal transducer, downstream of receptor, with serine/threonine kinase activity [GO:0004702]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]"
CHOYP_ISCW_ISCW022925.1.2|m.61535	552	12	9	18	17	27	20	0.54	0.54	2.6462	2.6462	0	0	0.55059	CHOYP_ISCW_ISCW022925.1.2|m.61535	Q863I2	OXSR1_PIG	58.99	534	194	6	22	543	9	529	0	629	1	Q863I2	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	 GO:0006468				PF12202;PF00069;	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; signal transducer, downstream of receptor, with serine/threonine kinase activity [GO:0004702]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]"
CHOYP_ISCW_ISCW022925.1.2|m.61535	552	12	9	18	17	27	20	0.54	0.54	2.6462	2.6462	0	0	0.55059	CHOYP_ISCW_ISCW022925.1.2|m.61535	Q863I2	OXSR1_PIG	58.99	534	194	6	22	543	9	529	0	629	1	Q863I2	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	 GO:0035556				PF12202;PF00069;	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; signal transducer, downstream of receptor, with serine/threonine kinase activity [GO:0004702]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]"
CHOYP_PAR14.15.17|m.60687	990	6	6	7	10	14	13	0.716	0.716	2.6379	2.6379	0	0	0.550672																												
CHOYP_LOC100373170.1.1|m.10994	271	2	2	2	6	6	7	1.23	1.23	2.6226	2.6226	0	0	0.550825	CHOYP_LOC100373170.1.1|m.10994	O57590	SURF4_TAKRU	73.78	267	70	0	4	270	3	269	6.00E-138	396	1	O57590	SURF4_TAKRU	reviewed	Surfeit locus protein 4	surf4	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	269		GO:0005789				PF02077;	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]
CHOYP_LOC100373170.1.1|m.10994	271	2	2	2	6	6	7	1.23	1.23	2.6226	2.6226	0	0	0.550825	CHOYP_LOC100373170.1.1|m.10994	O57590	SURF4_TAKRU	73.78	267	70	0	4	270	3	269	6.00E-138	396	1	O57590	SURF4_TAKRU	reviewed	Surfeit locus protein 4	surf4	Takifugu rubripes (Japanese pufferfish) (Fugu rubripes)	269		 GO:0016021				PF02077;	endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]
CHOYP_MUC5A.1.2|m.43407	264	0	0	8	4	8	14	0.987	0.987	2.6168	2.6168	0	0	0.550884																												
CHOYP_ELDP2.1.2|m.39081	558	21	3	22	27	25	23	0.525	0.525	2.6128	2.6128	0	0	0.550925	CHOYP_ELDP2.1.2|m.39081	B3A0R6	ELDP1_LOTGI	23.8	521	311	23	3	503	6	460	3.00E-24	110	1	B3A0R6	ELDP1_LOTGI	reviewed	EGF-like domain-containing protein 1 (Uncharacterized shell protein 17) (LUSP-17)		Lottia gigantea (Giant owl limpet)	513		GO:0005576					extracellular region [GO:0005576]
CHOYP_LOC100371248.1.2|m.10238	371	3	2	5	7	11	6	0.949	0.949	2.582	2.582	0	0	0.551246	CHOYP_LOC100371248.1.2|m.10238	Q49775	METH_MYCLE	24.23	326	194	11	61	363	59	354	4.00E-13	74.7	1	Q49775	METH_MYCLE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH ML1307 B2126_C1_157 MLCB2533.04	Mycobacterium leprae (strain TN)	1206	pteridine-containing compound metabolic process [GO:0042558]	GO:0005622	PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1.		cd02069;	PF02310;PF02607;PF02965;PF00809;PF02574;	intracellular [GO:0005622]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; S-adenosylmethionine-homocysteine S-methyltransferase activity [GO:0008898]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558]
CHOYP_LOC100371248.1.2|m.10238	371	3	2	5	7	11	6	0.949	0.949	2.582	2.582	0	0	0.551246	CHOYP_LOC100371248.1.2|m.10238	Q49775	METH_MYCLE	24.23	326	194	11	61	363	59	354	4.00E-13	74.7	1	Q49775	METH_MYCLE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH ML1307 B2126_C1_157 MLCB2533.04	Mycobacterium leprae (strain TN)	1206	pteridine-containing compound metabolic process [GO:0042558]	 GO:0008270	PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1.		cd02069;	PF02310;PF02607;PF02965;PF00809;PF02574;	intracellular [GO:0005622]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; S-adenosylmethionine-homocysteine S-methyltransferase activity [GO:0008898]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558]
CHOYP_LOC100371248.1.2|m.10238	371	3	2	5	7	11	6	0.949	0.949	2.582	2.582	0	0	0.551246	CHOYP_LOC100371248.1.2|m.10238	Q49775	METH_MYCLE	24.23	326	194	11	61	363	59	354	4.00E-13	74.7	1	Q49775	METH_MYCLE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH ML1307 B2126_C1_157 MLCB2533.04	Mycobacterium leprae (strain TN)	1206	pteridine-containing compound metabolic process [GO:0042558]	 GO:0008705	PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1.		cd02069;	PF02310;PF02607;PF02965;PF00809;PF02574;	intracellular [GO:0005622]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; S-adenosylmethionine-homocysteine S-methyltransferase activity [GO:0008898]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558]
CHOYP_LOC100371248.1.2|m.10238	371	3	2	5	7	11	6	0.949	0.949	2.582	2.582	0	0	0.551246	CHOYP_LOC100371248.1.2|m.10238	Q49775	METH_MYCLE	24.23	326	194	11	61	363	59	354	4.00E-13	74.7	1	Q49775	METH_MYCLE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH ML1307 B2126_C1_157 MLCB2533.04	Mycobacterium leprae (strain TN)	1206	pteridine-containing compound metabolic process [GO:0042558]	 GO:0008898	PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1.		cd02069;	PF02310;PF02607;PF02965;PF00809;PF02574;	intracellular [GO:0005622]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; S-adenosylmethionine-homocysteine S-methyltransferase activity [GO:0008898]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558]
CHOYP_LOC100371248.1.2|m.10238	371	3	2	5	7	11	6	0.949	0.949	2.582	2.582	0	0	0.551246	CHOYP_LOC100371248.1.2|m.10238	Q49775	METH_MYCLE	24.23	326	194	11	61	363	59	354	4.00E-13	74.7	1	Q49775	METH_MYCLE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH ML1307 B2126_C1_157 MLCB2533.04	Mycobacterium leprae (strain TN)	1206	pteridine-containing compound metabolic process [GO:0042558]	 GO:0031419	PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1.		cd02069;	PF02310;PF02607;PF02965;PF00809;PF02574;	intracellular [GO:0005622]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; S-adenosylmethionine-homocysteine S-methyltransferase activity [GO:0008898]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558]
CHOYP_LOC100371248.1.2|m.10238	371	3	2	5	7	11	6	0.949	0.949	2.582	2.582	0	0	0.551246	CHOYP_LOC100371248.1.2|m.10238	Q49775	METH_MYCLE	24.23	326	194	11	61	363	59	354	4.00E-13	74.7	1	Q49775	METH_MYCLE	reviewed	"Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Methionine synthase, vitamin-B12 dependent) (MS)"	metH ML1307 B2126_C1_157 MLCB2533.04	Mycobacterium leprae (strain TN)	1206	pteridine-containing compound metabolic process [GO:0042558]	 GO:0042558	PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via de novo pathway; L-methionine from L-homocysteine (MetH route): step 1/1.		cd02069;	PF02310;PF02607;PF02965;PF00809;PF02574;	intracellular [GO:0005622]; cobalamin binding [GO:0031419]; methionine synthase activity [GO:0008705]; S-adenosylmethionine-homocysteine S-methyltransferase activity [GO:0008898]; zinc ion binding [GO:0008270]; pteridine-containing compound metabolic process [GO:0042558]
CHOYP_contig_027593|m.31285	1430	5	2	13	14	12	14	0.728	0.728	2.5471	2.5471	0	0	0.551623	CHOYP_contig_027593|m.31285	O42350	CO1A2_LITCT	43.76	1291	637	20	175	1417	106	1355	4.00E-147	490	1	O42350	CO1A2_LITCT	reviewed	Collagen alpha-2(I) chain (Alpha-2 type I collagen)	COL1A2	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	1355		GO:0005201				PF01410;PF01391;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]
CHOYP_contig_027593|m.31285	1430	5	2	13	14	12	14	0.728	0.728	2.5471	2.5471	0	0	0.551623	CHOYP_contig_027593|m.31285	O42350	CO1A2_LITCT	43.76	1291	637	20	175	1417	106	1355	4.00E-147	490	1	O42350	CO1A2_LITCT	reviewed	Collagen alpha-2(I) chain (Alpha-2 type I collagen)	COL1A2	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	1355		 GO:0005578				PF01410;PF01391;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]
CHOYP_contig_027593|m.31285	1430	5	2	13	14	12	14	0.728	0.728	2.5471	2.5471	0	0	0.551623	CHOYP_contig_027593|m.31285	O42350	CO1A2_LITCT	43.76	1291	637	20	175	1417	106	1355	4.00E-147	490	1	O42350	CO1A2_LITCT	reviewed	Collagen alpha-2(I) chain (Alpha-2 type I collagen)	COL1A2	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	1355		 GO:0005581				PF01410;PF01391;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]
CHOYP_contig_027593|m.31285	1430	5	2	13	14	12	14	0.728	0.728	2.5471	2.5471	0	0	0.551623	CHOYP_contig_027593|m.31285	O42350	CO1A2_LITCT	43.76	1291	637	20	175	1417	106	1355	4.00E-147	490	1	O42350	CO1A2_LITCT	reviewed	Collagen alpha-2(I) chain (Alpha-2 type I collagen)	COL1A2	Lithobates catesbeiana (American bullfrog) (Rana catesbeiana)	1355		 GO:0046872				PF01410;PF01391;	collagen trimer [GO:0005581]; proteinaceous extracellular matrix [GO:0005578]; extracellular matrix structural constituent [GO:0005201]; metal ion binding [GO:0046872]
CHOYP_LOC100375427.1.1|m.6282	805	10	6	9	14	18	13	0.644	0.644	2.5384	2.5384	0	0	0.551719	CHOYP_LOC100375427.1.1|m.6282	Q9ULX7	CAH14_HUMAN	40.42	240	135	6	68	305	15	248	6.00E-48	177	1	Q9ULX7	CAH14_HUMAN	reviewed	Carbonic anhydrase 14 (EC 4.2.1.1) (Carbonate dehydratase XIV) (Carbonic anhydrase XIV) (CA-XIV)	CA14 UNQ690/PRO1335	Homo sapiens (Human)	337	bicarbonate transport [GO:0015701]	GO:0004089				PF00194;	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; metal ion binding [GO:0046872]; bicarbonate transport [GO:0015701]
CHOYP_LOC100375427.1.1|m.6282	805	10	6	9	14	18	13	0.644	0.644	2.5384	2.5384	0	0	0.551719	CHOYP_LOC100375427.1.1|m.6282	Q9ULX7	CAH14_HUMAN	40.42	240	135	6	68	305	15	248	6.00E-48	177	1	Q9ULX7	CAH14_HUMAN	reviewed	Carbonic anhydrase 14 (EC 4.2.1.1) (Carbonate dehydratase XIV) (Carbonic anhydrase XIV) (CA-XIV)	CA14 UNQ690/PRO1335	Homo sapiens (Human)	337	bicarbonate transport [GO:0015701]	 GO:0005886				PF00194;	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; metal ion binding [GO:0046872]; bicarbonate transport [GO:0015701]
CHOYP_LOC100375427.1.1|m.6282	805	10	6	9	14	18	13	0.644	0.644	2.5384	2.5384	0	0	0.551719	CHOYP_LOC100375427.1.1|m.6282	Q9ULX7	CAH14_HUMAN	40.42	240	135	6	68	305	15	248	6.00E-48	177	1	Q9ULX7	CAH14_HUMAN	reviewed	Carbonic anhydrase 14 (EC 4.2.1.1) (Carbonate dehydratase XIV) (Carbonic anhydrase XIV) (CA-XIV)	CA14 UNQ690/PRO1335	Homo sapiens (Human)	337	bicarbonate transport [GO:0015701]	 GO:0015701				PF00194;	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; metal ion binding [GO:0046872]; bicarbonate transport [GO:0015701]
CHOYP_LOC100375427.1.1|m.6282	805	10	6	9	14	18	13	0.644	0.644	2.5384	2.5384	0	0	0.551719	CHOYP_LOC100375427.1.1|m.6282	Q9ULX7	CAH14_HUMAN	40.42	240	135	6	68	305	15	248	6.00E-48	177	1	Q9ULX7	CAH14_HUMAN	reviewed	Carbonic anhydrase 14 (EC 4.2.1.1) (Carbonate dehydratase XIV) (Carbonic anhydrase XIV) (CA-XIV)	CA14 UNQ690/PRO1335	Homo sapiens (Human)	337	bicarbonate transport [GO:0015701]	 GO:0016021				PF00194;	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; metal ion binding [GO:0046872]; bicarbonate transport [GO:0015701]
CHOYP_LOC100375427.1.1|m.6282	805	10	6	9	14	18	13	0.644	0.644	2.5384	2.5384	0	0	0.551719	CHOYP_LOC100375427.1.1|m.6282	Q9ULX7	CAH14_HUMAN	40.42	240	135	6	68	305	15	248	6.00E-48	177	1	Q9ULX7	CAH14_HUMAN	reviewed	Carbonic anhydrase 14 (EC 4.2.1.1) (Carbonate dehydratase XIV) (Carbonic anhydrase XIV) (CA-XIV)	CA14 UNQ690/PRO1335	Homo sapiens (Human)	337	bicarbonate transport [GO:0015701]	 GO:0046872				PF00194;	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; carbonate dehydratase activity [GO:0004089]; metal ion binding [GO:0046872]; bicarbonate transport [GO:0015701]
CHOYP_BRAFLDRAFT_121480.1.1|m.48790	553	14	3	17	17	17	22	0.538	0.538	2.5333	2.5333	0	0	0.551776	CHOYP_BRAFLDRAFT_121480.1.1|m.48790	P86789	GIGA6_CRAGI	45.05	273	143	4	27	298	11	277	1.00E-75	248	1	P86789	GIGA6_CRAGI	reviewed	Gigasin-6		Crassostrea gigas (Pacific oyster) (Crassostrea angulata)	302		GO:0016021				PF00144;	integral component of membrane [GO:0016021]
CHOYP_BRAFLDRAFT_92365.3.3|m.51160	1494	8	0	5	8	11	11	0.799	0.799	2.4955	2.4955	0	0	0.552206	CHOYP_BRAFLDRAFT_92365.3.3|m.51160	B3EWY9	MLP_ACRMI	26.83	723	428	27	805	1468	387	1067	6.00E-47	189	1	B3EWY9	MLP_ACRMI	reviewed	Mucin-like protein (Fragment)		Acropora millepora (Staghorn coral)	1594	cell-matrix adhesion [GO:0007160]	GO:0005509				PF12662;PF06119;PF00090;PF00094;	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
CHOYP_BRAFLDRAFT_92365.3.3|m.51160	1494	8	0	5	8	11	11	0.799	0.799	2.4955	2.4955	0	0	0.552206	CHOYP_BRAFLDRAFT_92365.3.3|m.51160	B3EWY9	MLP_ACRMI	26.83	723	428	27	805	1468	387	1067	6.00E-47	189	1	B3EWY9	MLP_ACRMI	reviewed	Mucin-like protein (Fragment)		Acropora millepora (Staghorn coral)	1594	cell-matrix adhesion [GO:0007160]	 GO:0007160				PF12662;PF06119;PF00090;PF00094;	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
CHOYP_BRAFLDRAFT_92365.3.3|m.51160	1494	8	0	5	8	11	11	0.799	0.799	2.4955	2.4955	0	0	0.552206	CHOYP_BRAFLDRAFT_92365.3.3|m.51160	B3EWY9	MLP_ACRMI	26.83	723	428	27	805	1468	387	1067	6.00E-47	189	1	B3EWY9	MLP_ACRMI	reviewed	Mucin-like protein (Fragment)		Acropora millepora (Staghorn coral)	1594	cell-matrix adhesion [GO:0007160]	 GO:0016021				PF12662;PF06119;PF00090;PF00094;	integral component of membrane [GO:0016021]; calcium ion binding [GO:0005509]; cell-matrix adhesion [GO:0007160]
CHOYP_FABP7.2.2|m.29096	141	2	2	3	6	5	9	1.091	1.091	2.4875	2.4875	0	0	0.552299	CHOYP_FABP7.2.2|m.29096	P55054	FABP9_RAT	25.74	136	96	2	4	139	2	132	3.00E-12	63.9	1	P55054	FABP9_RAT	reviewed	Fatty acid-binding protein 9 (15 kDa perforatorial protein) (PERF 15) (Testis lipid-binding protein) (TLBP) (Testis-type fatty acid-binding protein) (T-FABP)	Fabp9 Perf15	Rattus norvegicus (Rat)	132	acrosome assembly [GO:0001675]	GO:0001669				PF00061;	acrosomal vesicle [GO:0001669]; lipid binding [GO:0008289]; transporter activity [GO:0005215]; acrosome assembly [GO:0001675]
CHOYP_FABP7.2.2|m.29096	141	2	2	3	6	5	9	1.091	1.091	2.4875	2.4875	0	0	0.552299	CHOYP_FABP7.2.2|m.29096	P55054	FABP9_RAT	25.74	136	96	2	4	139	2	132	3.00E-12	63.9	1	P55054	FABP9_RAT	reviewed	Fatty acid-binding protein 9 (15 kDa perforatorial protein) (PERF 15) (Testis lipid-binding protein) (TLBP) (Testis-type fatty acid-binding protein) (T-FABP)	Fabp9 Perf15	Rattus norvegicus (Rat)	132	acrosome assembly [GO:0001675]	 GO:0001675				PF00061;	acrosomal vesicle [GO:0001669]; lipid binding [GO:0008289]; transporter activity [GO:0005215]; acrosome assembly [GO:0001675]
CHOYP_FABP7.2.2|m.29096	141	2	2	3	6	5	9	1.091	1.091	2.4875	2.4875	0	0	0.552299	CHOYP_FABP7.2.2|m.29096	P55054	FABP9_RAT	25.74	136	96	2	4	139	2	132	3.00E-12	63.9	1	P55054	FABP9_RAT	reviewed	Fatty acid-binding protein 9 (15 kDa perforatorial protein) (PERF 15) (Testis lipid-binding protein) (TLBP) (Testis-type fatty acid-binding protein) (T-FABP)	Fabp9 Perf15	Rattus norvegicus (Rat)	132	acrosome assembly [GO:0001675]	 GO:0005215				PF00061;	acrosomal vesicle [GO:0001669]; lipid binding [GO:0008289]; transporter activity [GO:0005215]; acrosome assembly [GO:0001675]
CHOYP_FABP7.2.2|m.29096	141	2	2	3	6	5	9	1.091	1.091	2.4875	2.4875	0	0	0.552299	CHOYP_FABP7.2.2|m.29096	P55054	FABP9_RAT	25.74	136	96	2	4	139	2	132	3.00E-12	63.9	1	P55054	FABP9_RAT	reviewed	Fatty acid-binding protein 9 (15 kDa perforatorial protein) (PERF 15) (Testis lipid-binding protein) (TLBP) (Testis-type fatty acid-binding protein) (T-FABP)	Fabp9 Perf15	Rattus norvegicus (Rat)	132	acrosome assembly [GO:0001675]	 GO:0008289				PF00061;	acrosomal vesicle [GO:0001669]; lipid binding [GO:0008289]; transporter activity [GO:0005215]; acrosome assembly [GO:0001675]
CHOYP_HSC70.1.1|m.335	195	3	2	2	3	8	8	1.102	1.102	2.485	2.485	0	0	0.552328																												
CHOYP_Y0777.3.3|m.60141	1616	10	6	9	13	18	13	0.618	0.618	2.4776	2.4776	0	0	0.552415	CHOYP_Y0777.3.3|m.60141	Q90369	KALM_COTJA	37.86	103	53	3	1511	1602	65	167	3.00E-10	68.6	1	Q90369	KALM_COTJA	reviewed	Anosmin-1 (Kallmann syndrome protein homolog)	ANOS1 KAL KAL1	Coturnix coturnix japonica (Japanese quail) (Coturnix japonica)	674	cell adhesion [GO:0007155]	GO:0004867			cd00063;	PF00041;PF00095;	cell surface [GO:0009986]; extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_Y0777.3.3|m.60141	1616	10	6	9	13	18	13	0.618	0.618	2.4776	2.4776	0	0	0.552415	CHOYP_Y0777.3.3|m.60141	Q90369	KALM_COTJA	37.86	103	53	3	1511	1602	65	167	3.00E-10	68.6	1	Q90369	KALM_COTJA	reviewed	Anosmin-1 (Kallmann syndrome protein homolog)	ANOS1 KAL KAL1	Coturnix coturnix japonica (Japanese quail) (Coturnix japonica)	674	cell adhesion [GO:0007155]	 GO:0005576			cd00063;	PF00041;PF00095;	cell surface [GO:0009986]; extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_Y0777.3.3|m.60141	1616	10	6	9	13	18	13	0.618	0.618	2.4776	2.4776	0	0	0.552415	CHOYP_Y0777.3.3|m.60141	Q90369	KALM_COTJA	37.86	103	53	3	1511	1602	65	167	3.00E-10	68.6	1	Q90369	KALM_COTJA	reviewed	Anosmin-1 (Kallmann syndrome protein homolog)	ANOS1 KAL KAL1	Coturnix coturnix japonica (Japanese quail) (Coturnix japonica)	674	cell adhesion [GO:0007155]	 GO:0007155			cd00063;	PF00041;PF00095;	cell surface [GO:0009986]; extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_Y0777.3.3|m.60141	1616	10	6	9	13	18	13	0.618	0.618	2.4776	2.4776	0	0	0.552415	CHOYP_Y0777.3.3|m.60141	Q90369	KALM_COTJA	37.86	103	53	3	1511	1602	65	167	3.00E-10	68.6	1	Q90369	KALM_COTJA	reviewed	Anosmin-1 (Kallmann syndrome protein homolog)	ANOS1 KAL KAL1	Coturnix coturnix japonica (Japanese quail) (Coturnix japonica)	674	cell adhesion [GO:0007155]	 GO:0009986			cd00063;	PF00041;PF00095;	cell surface [GO:0009986]; extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_ISCW_ISCW023591.1.1|m.9921	470	2	1	3	5	5	9	1.25	1.25	2.4698	2.4698	0	0	0.552508	CHOYP_ISCW_ISCW023591.1.1|m.9921	P38942	CAT2_CLOK5	50.47	422	203	4	43	463	13	429	5.00E-136	405	1	P38942	CAT2_CLOK5	reviewed	4-hydroxybutyrate coenzyme A transferase (EC 2.8.3.-)	cat2 CKL_3018	Clostridium kluyveri (strain ATCC 8527 / DSM 555 / NCIMB 10680)	429	acetyl-CoA metabolic process [GO:0006084]	GO:0006084				PF13336;PF02550;	transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084]
CHOYP_ISCW_ISCW023591.1.1|m.9921	470	2	1	3	5	5	9	1.25	1.25	2.4698	2.4698	0	0	0.552508	CHOYP_ISCW_ISCW023591.1.1|m.9921	P38942	CAT2_CLOK5	50.47	422	203	4	43	463	13	429	5.00E-136	405	1	P38942	CAT2_CLOK5	reviewed	4-hydroxybutyrate coenzyme A transferase (EC 2.8.3.-)	cat2 CKL_3018	Clostridium kluyveri (strain ATCC 8527 / DSM 555 / NCIMB 10680)	429	acetyl-CoA metabolic process [GO:0006084]	 GO:0016740				PF13336;PF02550;	transferase activity [GO:0016740]; acetyl-CoA metabolic process [GO:0006084]
CHOYP_TRIADDRAFT_62546.1.2|m.5483	252	4	4	6	10	11	10	0.826	0.826	2.4606	2.4606	0	0	0.552618																												
CHOYP_BRAFLDRAFT_279625.1.1|m.51890	581	12	5	17	22	12	20	0.523	0.523	2.4589	2.4589	0	0	0.552638	CHOYP_BRAFLDRAFT_279625.1.1|m.51890	P41636	4CL_PINTA	41	539	292	13	52	576	8	534	1.00E-126	389	1	P41636	4CL_PINTA	reviewed	4-coumarate--CoA ligase (4CL) (EC 6.2.1.12) (4-coumaroyl-CoA synthase)	4CL	Pinus taeda (Loblolly pine)	537	phenylpropanoid metabolic process [GO:0009698]	GO:0005524	"PATHWAY: Phytoalexin biosynthesis; 3,4',5-trihydroxystilbene biosynthesis; 3,4',5-trihydroxystilbene from trans-4-coumarate: step 1/2."			PF00501;PF13193;	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]
CHOYP_BRAFLDRAFT_279625.1.1|m.51890	581	12	5	17	22	12	20	0.523	0.523	2.4589	2.4589	0	0	0.552638	CHOYP_BRAFLDRAFT_279625.1.1|m.51890	P41636	4CL_PINTA	41	539	292	13	52	576	8	534	1.00E-126	389	1	P41636	4CL_PINTA	reviewed	4-coumarate--CoA ligase (4CL) (EC 6.2.1.12) (4-coumaroyl-CoA synthase)	4CL	Pinus taeda (Loblolly pine)	537	phenylpropanoid metabolic process [GO:0009698]	 GO:0009698	"PATHWAY: Phytoalexin biosynthesis; 3,4',5-trihydroxystilbene biosynthesis; 3,4',5-trihydroxystilbene from trans-4-coumarate: step 1/2."			PF00501;PF13193;	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]
CHOYP_BRAFLDRAFT_279625.1.1|m.51890	581	12	5	17	22	12	20	0.523	0.523	2.4589	2.4589	0	0	0.552638	CHOYP_BRAFLDRAFT_279625.1.1|m.51890	P41636	4CL_PINTA	41	539	292	13	52	576	8	534	1.00E-126	389	1	P41636	4CL_PINTA	reviewed	4-coumarate--CoA ligase (4CL) (EC 6.2.1.12) (4-coumaroyl-CoA synthase)	4CL	Pinus taeda (Loblolly pine)	537	phenylpropanoid metabolic process [GO:0009698]	 GO:0016207	"PATHWAY: Phytoalexin biosynthesis; 3,4',5-trihydroxystilbene biosynthesis; 3,4',5-trihydroxystilbene from trans-4-coumarate: step 1/2."			PF00501;PF13193;	4-coumarate-CoA ligase activity [GO:0016207]; ATP binding [GO:0005524]; phenylpropanoid metabolic process [GO:0009698]
CHOYP_BRAFLDRAFT_117158.2.2|m.42430	605	4	2	7	11	9	8	0.825	0.825	2.4567	2.4567	0	0	0.552665	CHOYP_BRAFLDRAFT_117158.2.2|m.42430	Q5ADN9	PFA3_CANAL	30.97	310	171	8	248	523	28	328	7.00E-28	119	1	Q5ADN9	PFA3_CANAL	reviewed	Palmitoyltransferase PFA3 (EC 2.3.1.225) (Protein fatty acyltransferase 3)	PFA3 CaO19.14094 CaO19.6802	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	386		GO:0005774				PF01529;	integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]
CHOYP_BRAFLDRAFT_117158.2.2|m.42430	605	4	2	7	11	9	8	0.825	0.825	2.4567	2.4567	0	0	0.552665	CHOYP_BRAFLDRAFT_117158.2.2|m.42430	Q5ADN9	PFA3_CANAL	30.97	310	171	8	248	523	28	328	7.00E-28	119	1	Q5ADN9	PFA3_CANAL	reviewed	Palmitoyltransferase PFA3 (EC 2.3.1.225) (Protein fatty acyltransferase 3)	PFA3 CaO19.14094 CaO19.6802	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	386		 GO:0016021				PF01529;	integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]
CHOYP_BRAFLDRAFT_117158.2.2|m.42430	605	4	2	7	11	9	8	0.825	0.825	2.4567	2.4567	0	0	0.552665	CHOYP_BRAFLDRAFT_117158.2.2|m.42430	Q5ADN9	PFA3_CANAL	30.97	310	171	8	248	523	28	328	7.00E-28	119	1	Q5ADN9	PFA3_CANAL	reviewed	Palmitoyltransferase PFA3 (EC 2.3.1.225) (Protein fatty acyltransferase 3)	PFA3 CaO19.14094 CaO19.6802	Candida albicans (strain SC5314 / ATCC MYA-2876) (Yeast)	386		 GO:0019706				PF01529;	integral component of membrane [GO:0016021]; vacuolar membrane [GO:0005774]; protein-cysteine S-palmitoyltransferase activity [GO:0019706]
CHOYP_BRAFLDRAFT_125501.1.1|m.30916	283	2	2	5	9	9	4	0.969	0.969	2.454	2.454	0	0	0.552697																												
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	GO:0003723			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0005829			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0005886			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0005903			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0005925			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0008307			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0016528			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0030056			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0030506			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0031012			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0031581			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0042383			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0043034			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0045111			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0045296			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_LOC100903812.1.1|m.65786	885	8	6	5	11	12	14	0.734	0.734	2.4458	2.4458	0	0	0.552797	CHOYP_LOC100903812.1.1|m.65786	Q15149	PLEC_HUMAN	24.71	263	177	7	203	452	829	1083	2.00E-14	81.6	1	Q15149	PLEC_HUMAN	reviewed	Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1)	PLEC PLEC1	Homo sapiens (Human)	4684	hemidesmosome assembly [GO:0031581]	 GO:0070062			cd00014;	PF00307;PF00681;PF03501;	brush border [GO:0005903]; costamere [GO:0043034]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; hemidesmosome [GO:0030056]; intermediate filament cytoskeleton [GO:0045111]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; sarcoplasm [GO:0016528]; ankyrin binding [GO:0030506]; cadherin binding [GO:0045296]; RNA binding [GO:0003723]; structural constituent of muscle [GO:0008307]; hemidesmosome assembly [GO:0031581]
CHOYP_FABP6.2.2|m.59518	159	2	2	3	6	5	9	1.099	1.099	2.4389	2.4389	0	0	0.552881																												
CHOYP_LOC100030710.2.4|m.13432	4336	1	0	0	2	10	4	1.912	1.912	2.3989	2.3989	0	0	0.553384	CHOYP_LOC100030710.2.4|m.13432	A0A0R4IBK5	R213A_DANRE	35.86	3542	2013	84	832	4287	1807	5175	0	1998	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	GO:0002040	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_LOC100030710.2.4|m.13432	4336	1	0	0	2	10	4	1.912	1.912	2.3989	2.3989	0	0	0.553384	CHOYP_LOC100030710.2.4|m.13432	A0A0R4IBK5	R213A_DANRE	35.86	3542	2013	84	832	4287	1807	5175	0	1998	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	 GO:0004842	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_LOC100030710.2.4|m.13432	4336	1	0	0	2	10	4	1.912	1.912	2.3989	2.3989	0	0	0.553384	CHOYP_LOC100030710.2.4|m.13432	A0A0R4IBK5	R213A_DANRE	35.86	3542	2013	84	832	4287	1807	5175	0	1998	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	 GO:0005829	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_LOC100030710.2.4|m.13432	4336	1	0	0	2	10	4	1.912	1.912	2.3989	2.3989	0	0	0.553384	CHOYP_LOC100030710.2.4|m.13432	A0A0R4IBK5	R213A_DANRE	35.86	3542	2013	84	832	4287	1807	5175	0	1998	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	 GO:0008270	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_LOC100030710.2.4|m.13432	4336	1	0	0	2	10	4	1.912	1.912	2.3989	2.3989	0	0	0.553384	CHOYP_LOC100030710.2.4|m.13432	A0A0R4IBK5	R213A_DANRE	35.86	3542	2013	84	832	4287	1807	5175	0	1998	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	 GO:0016887	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_LOC100910862.2.2|m.45085	277	8	7	10	15	18	12	0.61	0.61	2.3932	2.3932	0	0	0.553457																												
CHOYP_SERB.1.1|m.7242	227	2	2	3	7	7	7	1.186	1.186	2.3899	2.3899	0	0	0.5535	CHOYP_SERB.1.1|m.7242	Q2KHU0	SERB_BOVIN	57.53	219	93	0	7	225	6	224	7.00E-93	278	1	Q2KHU0	SERB_BOVIN	reviewed	Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (L-3-phosphoserine phosphatase) (O-phosphoserine phosphohydrolase)	PSPH	Bos taurus (Bovine)	225	L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]	GO:0000287	PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from 3-phospho-D-glycerate: step 3/3.				calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphoserine phosphatase activity [GO:0004647]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]
CHOYP_SERB.1.1|m.7242	227	2	2	3	7	7	7	1.186	1.186	2.3899	2.3899	0	0	0.5535	CHOYP_SERB.1.1|m.7242	Q2KHU0	SERB_BOVIN	57.53	219	93	0	7	225	6	224	7.00E-93	278	1	Q2KHU0	SERB_BOVIN	reviewed	Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (L-3-phosphoserine phosphatase) (O-phosphoserine phosphohydrolase)	PSPH	Bos taurus (Bovine)	225	L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]	 GO:0004647	PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from 3-phospho-D-glycerate: step 3/3.				calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphoserine phosphatase activity [GO:0004647]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]
CHOYP_SERB.1.1|m.7242	227	2	2	3	7	7	7	1.186	1.186	2.3899	2.3899	0	0	0.5535	CHOYP_SERB.1.1|m.7242	Q2KHU0	SERB_BOVIN	57.53	219	93	0	7	225	6	224	7.00E-93	278	1	Q2KHU0	SERB_BOVIN	reviewed	Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (L-3-phosphoserine phosphatase) (O-phosphoserine phosphohydrolase)	PSPH	Bos taurus (Bovine)	225	L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]	 GO:0005509	PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from 3-phospho-D-glycerate: step 3/3.				calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphoserine phosphatase activity [GO:0004647]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]
CHOYP_SERB.1.1|m.7242	227	2	2	3	7	7	7	1.186	1.186	2.3899	2.3899	0	0	0.5535	CHOYP_SERB.1.1|m.7242	Q2KHU0	SERB_BOVIN	57.53	219	93	0	7	225	6	224	7.00E-93	278	1	Q2KHU0	SERB_BOVIN	reviewed	Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (L-3-phosphoserine phosphatase) (O-phosphoserine phosphohydrolase)	PSPH	Bos taurus (Bovine)	225	L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]	 GO:0006563	PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from 3-phospho-D-glycerate: step 3/3.				calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphoserine phosphatase activity [GO:0004647]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]
CHOYP_SERB.1.1|m.7242	227	2	2	3	7	7	7	1.186	1.186	2.3899	2.3899	0	0	0.5535	CHOYP_SERB.1.1|m.7242	Q2KHU0	SERB_BOVIN	57.53	219	93	0	7	225	6	224	7.00E-93	278	1	Q2KHU0	SERB_BOVIN	reviewed	Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (L-3-phosphoserine phosphatase) (O-phosphoserine phosphohydrolase)	PSPH	Bos taurus (Bovine)	225	L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]	 GO:0006564	PATHWAY: Amino-acid biosynthesis; L-serine biosynthesis; L-serine from 3-phospho-D-glycerate: step 3/3.				calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; phosphoserine phosphatase activity [GO:0004647]; L-serine biosynthetic process [GO:0006564]; L-serine metabolic process [GO:0006563]
CHOYP_HMCN1.33.44|m.58938	1249	4	6	4	7	12	11	0.789	0.789	2.386	2.386	0	0	0.553551	CHOYP_HMCN1.33.44|m.58938	P35329	CD22_MOUSE	23.78	555	344	17	226	771	212	696	3.00E-21	104	1	P35329	CD22_MOUSE	reviewed	B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22)	Cd22 Lyb-8 Siglec2	Mus musculus (Mouse)	862	cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]	GO:0005887				PF08205;PF13895;	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; coreceptor activity [GO:0015026]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]
CHOYP_HMCN1.33.44|m.58938	1249	4	6	4	7	12	11	0.789	0.789	2.386	2.386	0	0	0.553551	CHOYP_HMCN1.33.44|m.58938	P35329	CD22_MOUSE	23.78	555	344	17	226	771	212	696	3.00E-21	104	1	P35329	CD22_MOUSE	reviewed	B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22)	Cd22 Lyb-8 Siglec2	Mus musculus (Mouse)	862	cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]	 GO:0007155				PF08205;PF13895;	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; coreceptor activity [GO:0015026]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]
CHOYP_HMCN1.33.44|m.58938	1249	4	6	4	7	12	11	0.789	0.789	2.386	2.386	0	0	0.553551	CHOYP_HMCN1.33.44|m.58938	P35329	CD22_MOUSE	23.78	555	344	17	226	771	212	696	3.00E-21	104	1	P35329	CD22_MOUSE	reviewed	B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22)	Cd22 Lyb-8 Siglec2	Mus musculus (Mouse)	862	cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]	 GO:0007166				PF08205;PF13895;	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; coreceptor activity [GO:0015026]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]
CHOYP_HMCN1.33.44|m.58938	1249	4	6	4	7	12	11	0.789	0.789	2.386	2.386	0	0	0.553551	CHOYP_HMCN1.33.44|m.58938	P35329	CD22_MOUSE	23.78	555	344	17	226	771	212	696	3.00E-21	104	1	P35329	CD22_MOUSE	reviewed	B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22)	Cd22 Lyb-8 Siglec2	Mus musculus (Mouse)	862	cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]	 GO:0009897				PF08205;PF13895;	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; coreceptor activity [GO:0015026]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]
CHOYP_HMCN1.33.44|m.58938	1249	4	6	4	7	12	11	0.789	0.789	2.386	2.386	0	0	0.553551	CHOYP_HMCN1.33.44|m.58938	P35329	CD22_MOUSE	23.78	555	344	17	226	771	212	696	3.00E-21	104	1	P35329	CD22_MOUSE	reviewed	B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22)	Cd22 Lyb-8 Siglec2	Mus musculus (Mouse)	862	cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]	 GO:0015026				PF08205;PF13895;	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; coreceptor activity [GO:0015026]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]
CHOYP_HMCN1.33.44|m.58938	1249	4	6	4	7	12	11	0.789	0.789	2.386	2.386	0	0	0.553551	CHOYP_HMCN1.33.44|m.58938	P35329	CD22_MOUSE	23.78	555	344	17	226	771	212	696	3.00E-21	104	1	P35329	CD22_MOUSE	reviewed	B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22)	Cd22 Lyb-8 Siglec2	Mus musculus (Mouse)	862	cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]	 GO:0030246				PF08205;PF13895;	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; coreceptor activity [GO:0015026]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]
CHOYP_HMCN1.33.44|m.58938	1249	4	6	4	7	12	11	0.789	0.789	2.386	2.386	0	0	0.553551	CHOYP_HMCN1.33.44|m.58938	P35329	CD22_MOUSE	23.78	555	344	17	226	771	212	696	3.00E-21	104	1	P35329	CD22_MOUSE	reviewed	B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22)	Cd22 Lyb-8 Siglec2	Mus musculus (Mouse)	862	cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]	 GO:0070062				PF08205;PF13895;	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; carbohydrate binding [GO:0030246]; coreceptor activity [GO:0015026]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]
CHOYP_PAXB1.1.2|m.42816	1386	12	9	18	17	26	18	0.502	0.502	2.3688	2.3688	0	0	0.553778	CHOYP_PAXB1.1.2|m.42816	Q863I2	OXSR1_PIG	59.17	529	199	6	858	1377	9	529	0	629	1	Q863I2	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	GO:0000287				PF12202;PF00069;	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; signal transducer, downstream of receptor, with serine/threonine kinase activity [GO:0004702]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]"
CHOYP_PAXB1.1.2|m.42816	1386	12	9	18	17	26	18	0.502	0.502	2.3688	2.3688	0	0	0.553778	CHOYP_PAXB1.1.2|m.42816	Q863I2	OXSR1_PIG	59.17	529	199	6	858	1377	9	529	0	629	1	Q863I2	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	 GO:0004674				PF12202;PF00069;	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; signal transducer, downstream of receptor, with serine/threonine kinase activity [GO:0004702]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]"
CHOYP_PAXB1.1.2|m.42816	1386	12	9	18	17	26	18	0.502	0.502	2.3688	2.3688	0	0	0.553778	CHOYP_PAXB1.1.2|m.42816	Q863I2	OXSR1_PIG	59.17	529	199	6	858	1377	9	529	0	629	1	Q863I2	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	 GO:0004702				PF12202;PF00069;	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; signal transducer, downstream of receptor, with serine/threonine kinase activity [GO:0004702]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]"
CHOYP_PAXB1.1.2|m.42816	1386	12	9	18	17	26	18	0.502	0.502	2.3688	2.3688	0	0	0.553778	CHOYP_PAXB1.1.2|m.42816	Q863I2	OXSR1_PIG	59.17	529	199	6	858	1377	9	529	0	629	1	Q863I2	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	 GO:0005524				PF12202;PF00069;	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; signal transducer, downstream of receptor, with serine/threonine kinase activity [GO:0004702]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]"
CHOYP_PAXB1.1.2|m.42816	1386	12	9	18	17	26	18	0.502	0.502	2.3688	2.3688	0	0	0.553778	CHOYP_PAXB1.1.2|m.42816	Q863I2	OXSR1_PIG	59.17	529	199	6	858	1377	9	529	0	629	1	Q863I2	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	 GO:0005737				PF12202;PF00069;	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; signal transducer, downstream of receptor, with serine/threonine kinase activity [GO:0004702]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]"
CHOYP_PAXB1.1.2|m.42816	1386	12	9	18	17	26	18	0.502	0.502	2.3688	2.3688	0	0	0.553778	CHOYP_PAXB1.1.2|m.42816	Q863I2	OXSR1_PIG	59.17	529	199	6	858	1377	9	529	0	629	1	Q863I2	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	 GO:0006468				PF12202;PF00069;	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; signal transducer, downstream of receptor, with serine/threonine kinase activity [GO:0004702]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]"
CHOYP_PAXB1.1.2|m.42816	1386	12	9	18	17	26	18	0.502	0.502	2.3688	2.3688	0	0	0.553778	CHOYP_PAXB1.1.2|m.42816	Q863I2	OXSR1_PIG	59.17	529	199	6	858	1377	9	529	0	629	1	Q863I2	OXSR1_PIG	reviewed	Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein)	OXSR1 OSR1	Sus scrofa (Pig)	529	intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]	 GO:0035556				PF12202;PF00069;	"cytoplasm [GO:0005737]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine/threonine kinase activity [GO:0004674]; signal transducer, downstream of receptor, with serine/threonine kinase activity [GO:0004702]; intracellular signal transduction [GO:0035556]; protein phosphorylation [GO:0006468]"
CHOYP_RN213.7.13|m.45975	3659	0	1	1	1	9	3	1.499	1.499	2.3612	2.3612	0	0	0.553879	CHOYP_RN213.7.13|m.45975	A0A0R4IBK5	R213A_DANRE	46.53	1541	717	34	2150	3652	1811	3282	0	1314	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	GO:0002040	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_RN213.7.13|m.45975	3659	0	1	1	1	9	3	1.499	1.499	2.3612	2.3612	0	0	0.553879	CHOYP_RN213.7.13|m.45975	A0A0R4IBK5	R213A_DANRE	46.53	1541	717	34	2150	3652	1811	3282	0	1314	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	 GO:0004842	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_RN213.7.13|m.45975	3659	0	1	1	1	9	3	1.499	1.499	2.3612	2.3612	0	0	0.553879	CHOYP_RN213.7.13|m.45975	A0A0R4IBK5	R213A_DANRE	46.53	1541	717	34	2150	3652	1811	3282	0	1314	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	 GO:0005829	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_RN213.7.13|m.45975	3659	0	1	1	1	9	3	1.499	1.499	2.3612	2.3612	0	0	0.553879	CHOYP_RN213.7.13|m.45975	A0A0R4IBK5	R213A_DANRE	46.53	1541	717	34	2150	3652	1811	3282	0	1314	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	 GO:0008270	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_RN213.7.13|m.45975	3659	0	1	1	1	9	3	1.499	1.499	2.3612	2.3612	0	0	0.553879	CHOYP_RN213.7.13|m.45975	A0A0R4IBK5	R213A_DANRE	46.53	1541	717	34	2150	3652	1811	3282	0	1314	1	A0A0R4IBK5	R213A_DANRE	reviewed	E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha) (RING-type E3 ubiquitin transferase rnf213-alpha)	rnf213a	Danio rerio (Zebrafish) (Brachydanio rerio)	5209	sprouting angiogenesis [GO:0002040]	 GO:0016887	PATHWAY: Protein modification; protein ubiquitination. {ECO:0000250|UniProtKB:Q63HN8}.				cytosol [GO:0005829]; ATPase activity [GO:0016887]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270]; sprouting angiogenesis [GO:0002040]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	GO:0001501				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0001527				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0001656				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0005178				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0005179				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0005201				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0005509				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0005576				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0005578				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0005604				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0005615				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0005622				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0006006				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0007507				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0008201				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0009653				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0010737				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0031012				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0032403				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0033627				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0034199				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0035582				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0035583				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0042593				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0043010				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0045671				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0048048				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0048050				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0070062				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:0071560				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:1990314				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_LOC575161.4.5|m.42590	2226	12	0	7	12	12	13	0.664	0.664	2.3558	2.3558	0	0	0.553952	CHOYP_LOC575161.4.5|m.42590	Q61554	FBN1_MOUSE	31.96	1023	487	46	903	1804	474	1408	8.00E-81	302	1	Q61554	FBN1_MOUSE	reviewed	Fibrillin-1 [Cleaved into: Asprosin]	Fbn1 Fbn-1	Mus musculus (Mouse)	2873	activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]	 GO:2001205				PF12662;PF07645;PF00683;	basement membrane [GO:0005604]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular [GO:0005622]; microfibril [GO:0001527]; proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hormone activity [GO:0005179]; integrin binding [GO:0005178]; protein complex binding [GO:0032403]; activation of protein kinase A activity [GO:0034199]; anatomical structure morphogenesis [GO:0009653]; camera-type eye development [GO:0043010]; cell adhesion mediated by integrin [GO:0033627]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic eye morphogenesis [GO:0048048]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; heart development [GO:0007507]; metanephros development [GO:0001656]; negative regulation of osteoclast development [GO:2001205]; negative regulation of osteoclast differentiation [GO:0045671]; post-embryonic eye morphogenesis [GO:0048050]; protein kinase A signaling [GO:0010737]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of TGFbeta in extracellular matrix [GO:0035583]; skeletal system development [GO:0001501]
CHOYP_VOLCADRAFT_93060.1.2|m.3949	935	5	4	4	11	8	9	0.81	0.81	2.3462	2.3462	0	0	0.554082	CHOYP_VOLCADRAFT_93060.1.2|m.3949	O96790	DPGN_DIPMA	34.31	306	132	11	685	921	27	332	4.00E-31	130	1	O96790	DPGN_DIPMA	reviewed	Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment)		Dipetalogaster maximus (Blood-sucking bug)	351	negative regulation of coagulation [GO:0050819]	GO:0004867				PF00050;PF07648;	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]
CHOYP_VOLCADRAFT_93060.1.2|m.3949	935	5	4	4	11	8	9	0.81	0.81	2.3462	2.3462	0	0	0.554082	CHOYP_VOLCADRAFT_93060.1.2|m.3949	O96790	DPGN_DIPMA	34.31	306	132	11	685	921	27	332	4.00E-31	130	1	O96790	DPGN_DIPMA	reviewed	Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment)		Dipetalogaster maximus (Blood-sucking bug)	351	negative regulation of coagulation [GO:0050819]	 GO:0005576				PF00050;PF07648;	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]
CHOYP_VOLCADRAFT_93060.1.2|m.3949	935	5	4	4	11	8	9	0.81	0.81	2.3462	2.3462	0	0	0.554082	CHOYP_VOLCADRAFT_93060.1.2|m.3949	O96790	DPGN_DIPMA	34.31	306	132	11	685	921	27	332	4.00E-31	130	1	O96790	DPGN_DIPMA	reviewed	Serine protease inhibitor dipetalogastin (Dipetalin) (Fragment)		Dipetalogaster maximus (Blood-sucking bug)	351	negative regulation of coagulation [GO:0050819]	 GO:0050819				PF00050;PF07648;	extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; negative regulation of coagulation [GO:0050819]
CHOYP_BRAFLDRAFT_81609.1.1|m.94	451	6	7	18	11	16	24	0.531	0.531	2.3452	2.3452	0	0	0.554096	CHOYP_BRAFLDRAFT_81609.1.1|m.94	Q9Y6N5	SQRD_HUMAN	52.9	414	192	3	31	443	39	450	5.00E-163	474	1	Q9Y6N5	SQRD_HUMAN	reviewed	"Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.-)"	SQRDL CGI-44	Homo sapiens (Human)	450	"hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	GO:0005743				PF07992;	"mitochondrial inner membrane [GO:0005743]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"
CHOYP_BRAFLDRAFT_81609.1.1|m.94	451	6	7	18	11	16	24	0.531	0.531	2.3452	2.3452	0	0	0.554096	CHOYP_BRAFLDRAFT_81609.1.1|m.94	Q9Y6N5	SQRD_HUMAN	52.9	414	192	3	31	443	39	450	5.00E-163	474	1	Q9Y6N5	SQRD_HUMAN	reviewed	"Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.-)"	SQRDL CGI-44	Homo sapiens (Human)	450	"hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	 GO:0048038				PF07992;	"mitochondrial inner membrane [GO:0005743]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"
CHOYP_BRAFLDRAFT_81609.1.1|m.94	451	6	7	18	11	16	24	0.531	0.531	2.3452	2.3452	0	0	0.554096	CHOYP_BRAFLDRAFT_81609.1.1|m.94	Q9Y6N5	SQRD_HUMAN	52.9	414	192	3	31	443	39	450	5.00E-163	474	1	Q9Y6N5	SQRD_HUMAN	reviewed	"Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.-)"	SQRDL CGI-44	Homo sapiens (Human)	450	"hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	 GO:0070221				PF07992;	"mitochondrial inner membrane [GO:0005743]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"
CHOYP_BRAFLDRAFT_81609.1.1|m.94	451	6	7	18	11	16	24	0.531	0.531	2.3452	2.3452	0	0	0.554096	CHOYP_BRAFLDRAFT_81609.1.1|m.94	Q9Y6N5	SQRD_HUMAN	52.9	414	192	3	31	443	39	450	5.00E-163	474	1	Q9Y6N5	SQRD_HUMAN	reviewed	"Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.-)"	SQRDL CGI-44	Homo sapiens (Human)	450	"hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	 GO:0070224				PF07992;	"mitochondrial inner membrane [GO:0005743]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"
CHOYP_BRAFLDRAFT_81609.1.1|m.94	451	6	7	18	11	16	24	0.531	0.531	2.3452	2.3452	0	0	0.554096	CHOYP_BRAFLDRAFT_81609.1.1|m.94	Q9Y6N5	SQRD_HUMAN	52.9	414	192	3	31	443	39	450	5.00E-163	474	1	Q9Y6N5	SQRD_HUMAN	reviewed	"Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.-)"	SQRDL CGI-44	Homo sapiens (Human)	450	"hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"	 GO:0070813				PF07992;	"mitochondrial inner membrane [GO:0005743]; quinone binding [GO:0048038]; sulfide:quinone oxidoreductase activity [GO:0070224]; hydrogen sulfide metabolic process [GO:0070813]; sulfide oxidation, using sulfide:quinone oxidoreductase [GO:0070221]"
CHOYP_TRIADDRAFT_38448.1.1|m.27929	169	2	8	7	11	10	12	0.71	0.71	2.3385	2.3385	0	0	0.554188																												
CHOYP_NPC2.2.7|m.29742	151	4	3	5	8	10	8	0.828	0.828	2.3366	2.3366	0	0	0.554214	CHOYP_NPC2.2.7|m.29742	Q9Z0J0	NPC2_MOUSE	40.31	129	75	2	21	148	20	147	3.00E-28	107	1	Q9Z0J0	NPC2_MOUSE	reviewed	Epididymal secretory protein E1 (mE1) (Niemann Pick type C2 protein homolog)	Npc2	Mus musculus (Mouse)	149	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]	GO:0005615			cd00916;	PF02221;	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]
CHOYP_NPC2.2.7|m.29742	151	4	3	5	8	10	8	0.828	0.828	2.3366	2.3366	0	0	0.554214	CHOYP_NPC2.2.7|m.29742	Q9Z0J0	NPC2_MOUSE	40.31	129	75	2	21	148	20	147	3.00E-28	107	1	Q9Z0J0	NPC2_MOUSE	reviewed	Epididymal secretory protein E1 (mE1) (Niemann Pick type C2 protein homolog)	Npc2	Mus musculus (Mouse)	149	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]	 GO:0005764			cd00916;	PF02221;	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]
CHOYP_NPC2.2.7|m.29742	151	4	3	5	8	10	8	0.828	0.828	2.3366	2.3366	0	0	0.554214	CHOYP_NPC2.2.7|m.29742	Q9Z0J0	NPC2_MOUSE	40.31	129	75	2	21	148	20	147	3.00E-28	107	1	Q9Z0J0	NPC2_MOUSE	reviewed	Epididymal secretory protein E1 (mE1) (Niemann Pick type C2 protein homolog)	Npc2	Mus musculus (Mouse)	149	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]	 GO:0005783			cd00916;	PF02221;	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]
CHOYP_NPC2.2.7|m.29742	151	4	3	5	8	10	8	0.828	0.828	2.3366	2.3366	0	0	0.554214	CHOYP_NPC2.2.7|m.29742	Q9Z0J0	NPC2_MOUSE	40.31	129	75	2	21	148	20	147	3.00E-28	107	1	Q9Z0J0	NPC2_MOUSE	reviewed	Epididymal secretory protein E1 (mE1) (Niemann Pick type C2 protein homolog)	Npc2	Mus musculus (Mouse)	149	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]	 GO:0008203			cd00916;	PF02221;	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]
CHOYP_NPC2.2.7|m.29742	151	4	3	5	8	10	8	0.828	0.828	2.3366	2.3366	0	0	0.554214	CHOYP_NPC2.2.7|m.29742	Q9Z0J0	NPC2_MOUSE	40.31	129	75	2	21	148	20	147	3.00E-28	107	1	Q9Z0J0	NPC2_MOUSE	reviewed	Epididymal secretory protein E1 (mE1) (Niemann Pick type C2 protein homolog)	Npc2	Mus musculus (Mouse)	149	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]	 GO:0009615			cd00916;	PF02221;	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]
CHOYP_NPC2.2.7|m.29742	151	4	3	5	8	10	8	0.828	0.828	2.3366	2.3366	0	0	0.554214	CHOYP_NPC2.2.7|m.29742	Q9Z0J0	NPC2_MOUSE	40.31	129	75	2	21	148	20	147	3.00E-28	107	1	Q9Z0J0	NPC2_MOUSE	reviewed	Epididymal secretory protein E1 (mE1) (Niemann Pick type C2 protein homolog)	Npc2	Mus musculus (Mouse)	149	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]	 GO:0015485			cd00916;	PF02221;	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]
CHOYP_NPC2.2.7|m.29742	151	4	3	5	8	10	8	0.828	0.828	2.3366	2.3366	0	0	0.554214	CHOYP_NPC2.2.7|m.29742	Q9Z0J0	NPC2_MOUSE	40.31	129	75	2	21	148	20	147	3.00E-28	107	1	Q9Z0J0	NPC2_MOUSE	reviewed	Epididymal secretory protein E1 (mE1) (Niemann Pick type C2 protein homolog)	Npc2	Mus musculus (Mouse)	149	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]	 GO:0019899			cd00916;	PF02221;	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]
CHOYP_NPC2.2.7|m.29742	151	4	3	5	8	10	8	0.828	0.828	2.3366	2.3366	0	0	0.554214	CHOYP_NPC2.2.7|m.29742	Q9Z0J0	NPC2_MOUSE	40.31	129	75	2	21	148	20	147	3.00E-28	107	1	Q9Z0J0	NPC2_MOUSE	reviewed	Epididymal secretory protein E1 (mE1) (Niemann Pick type C2 protein homolog)	Npc2	Mus musculus (Mouse)	149	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]	 GO:0030301			cd00916;	PF02221;	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]
CHOYP_NPC2.2.7|m.29742	151	4	3	5	8	10	8	0.828	0.828	2.3366	2.3366	0	0	0.554214	CHOYP_NPC2.2.7|m.29742	Q9Z0J0	NPC2_MOUSE	40.31	129	75	2	21	148	20	147	3.00E-28	107	1	Q9Z0J0	NPC2_MOUSE	reviewed	Epididymal secretory protein E1 (mE1) (Niemann Pick type C2 protein homolog)	Npc2	Mus musculus (Mouse)	149	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]	 GO:0032366			cd00916;	PF02221;	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]
CHOYP_NPC2.2.7|m.29742	151	4	3	5	8	10	8	0.828	0.828	2.3366	2.3366	0	0	0.554214	CHOYP_NPC2.2.7|m.29742	Q9Z0J0	NPC2_MOUSE	40.31	129	75	2	21	148	20	147	3.00E-28	107	1	Q9Z0J0	NPC2_MOUSE	reviewed	Epididymal secretory protein E1 (mE1) (Niemann Pick type C2 protein homolog)	Npc2	Mus musculus (Mouse)	149	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]	 GO:0032367			cd00916;	PF02221;	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]
CHOYP_NPC2.2.7|m.29742	151	4	3	5	8	10	8	0.828	0.828	2.3366	2.3366	0	0	0.554214	CHOYP_NPC2.2.7|m.29742	Q9Z0J0	NPC2_MOUSE	40.31	129	75	2	21	148	20	147	3.00E-28	107	1	Q9Z0J0	NPC2_MOUSE	reviewed	Epididymal secretory protein E1 (mE1) (Niemann Pick type C2 protein homolog)	Npc2	Mus musculus (Mouse)	149	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]	 GO:0033344			cd00916;	PF02221;	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]
CHOYP_NPC2.2.7|m.29742	151	4	3	5	8	10	8	0.828	0.828	2.3366	2.3366	0	0	0.554214	CHOYP_NPC2.2.7|m.29742	Q9Z0J0	NPC2_MOUSE	40.31	129	75	2	21	148	20	147	3.00E-28	107	1	Q9Z0J0	NPC2_MOUSE	reviewed	Epididymal secretory protein E1 (mE1) (Niemann Pick type C2 protein homolog)	Npc2	Mus musculus (Mouse)	149	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]	 GO:0042632			cd00916;	PF02221;	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]
CHOYP_NPC2.2.7|m.29742	151	4	3	5	8	10	8	0.828	0.828	2.3366	2.3366	0	0	0.554214	CHOYP_NPC2.2.7|m.29742	Q9Z0J0	NPC2_MOUSE	40.31	129	75	2	21	148	20	147	3.00E-28	107	1	Q9Z0J0	NPC2_MOUSE	reviewed	Epididymal secretory protein E1 (mE1) (Niemann Pick type C2 protein homolog)	Npc2	Mus musculus (Mouse)	149	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]	 GO:0070062			cd00916;	PF02221;	endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosome [GO:0005764]; cholesterol binding [GO:0015485]; enzyme binding [GO:0019899]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; intracellular cholesterol transport [GO:0032367]; intracellular sterol transport [GO:0032366]; response to virus [GO:0009615]
CHOYP_BRAFLDRAFT_126555.2.6|m.5075	500	2	1	0	3	7	4	1.388	1.388	2.3097	2.3097	0	0	0.554593	CHOYP_BRAFLDRAFT_126555.2.6|m.5075	P54316	LIPR1_RAT	34.48	464	277	11	28	480	5	452	1.00E-89	288	1	P54316	LIPR1_RAT	reviewed	Inactive pancreatic lipase-related protein 1 (PL-RP1)	Pnliprp1 Plrp1	Rattus norvegicus (Rat)	473	lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]	GO:0004806			cd00707;	PF00151;PF01477;	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]
CHOYP_BRAFLDRAFT_126555.2.6|m.5075	500	2	1	0	3	7	4	1.388	1.388	2.3097	2.3097	0	0	0.554593	CHOYP_BRAFLDRAFT_126555.2.6|m.5075	P54316	LIPR1_RAT	34.48	464	277	11	28	480	5	452	1.00E-89	288	1	P54316	LIPR1_RAT	reviewed	Inactive pancreatic lipase-related protein 1 (PL-RP1)	Pnliprp1 Plrp1	Rattus norvegicus (Rat)	473	lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]	 GO:0005509			cd00707;	PF00151;PF01477;	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]
CHOYP_BRAFLDRAFT_126555.2.6|m.5075	500	2	1	0	3	7	4	1.388	1.388	2.3097	2.3097	0	0	0.554593	CHOYP_BRAFLDRAFT_126555.2.6|m.5075	P54316	LIPR1_RAT	34.48	464	277	11	28	480	5	452	1.00E-89	288	1	P54316	LIPR1_RAT	reviewed	Inactive pancreatic lipase-related protein 1 (PL-RP1)	Pnliprp1 Plrp1	Rattus norvegicus (Rat)	473	lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]	 GO:0005615			cd00707;	PF00151;PF01477;	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]
CHOYP_BRAFLDRAFT_126555.2.6|m.5075	500	2	1	0	3	7	4	1.388	1.388	2.3097	2.3097	0	0	0.554593	CHOYP_BRAFLDRAFT_126555.2.6|m.5075	P54316	LIPR1_RAT	34.48	464	277	11	28	480	5	452	1.00E-89	288	1	P54316	LIPR1_RAT	reviewed	Inactive pancreatic lipase-related protein 1 (PL-RP1)	Pnliprp1 Plrp1	Rattus norvegicus (Rat)	473	lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]	 GO:0006629			cd00707;	PF00151;PF01477;	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]
CHOYP_BRAFLDRAFT_126555.2.6|m.5075	500	2	1	0	3	7	4	1.388	1.388	2.3097	2.3097	0	0	0.554593	CHOYP_BRAFLDRAFT_126555.2.6|m.5075	P54316	LIPR1_RAT	34.48	464	277	11	28	480	5	452	1.00E-89	288	1	P54316	LIPR1_RAT	reviewed	Inactive pancreatic lipase-related protein 1 (PL-RP1)	Pnliprp1 Plrp1	Rattus norvegicus (Rat)	473	lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]	 GO:0016298			cd00707;	PF00151;PF01477;	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]
CHOYP_BRAFLDRAFT_126555.2.6|m.5075	500	2	1	0	3	7	4	1.388	1.388	2.3097	2.3097	0	0	0.554593	CHOYP_BRAFLDRAFT_126555.2.6|m.5075	P54316	LIPR1_RAT	34.48	464	277	11	28	480	5	452	1.00E-89	288	1	P54316	LIPR1_RAT	reviewed	Inactive pancreatic lipase-related protein 1 (PL-RP1)	Pnliprp1 Plrp1	Rattus norvegicus (Rat)	473	lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]	 GO:0031016			cd00707;	PF00151;PF01477;	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]
CHOYP_BRAFLDRAFT_126555.2.6|m.5075	500	2	1	0	3	7	4	1.388	1.388	2.3097	2.3097	0	0	0.554593	CHOYP_BRAFLDRAFT_126555.2.6|m.5075	P54316	LIPR1_RAT	34.48	464	277	11	28	480	5	452	1.00E-89	288	1	P54316	LIPR1_RAT	reviewed	Inactive pancreatic lipase-related protein 1 (PL-RP1)	Pnliprp1 Plrp1	Rattus norvegicus (Rat)	473	lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]	 GO:0043434			cd00707;	PF00151;PF01477;	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]
CHOYP_BRAFLDRAFT_126555.2.6|m.5075	500	2	1	0	3	7	4	1.388	1.388	2.3097	2.3097	0	0	0.554593	CHOYP_BRAFLDRAFT_126555.2.6|m.5075	P54316	LIPR1_RAT	34.48	464	277	11	28	480	5	452	1.00E-89	288	1	P54316	LIPR1_RAT	reviewed	Inactive pancreatic lipase-related protein 1 (PL-RP1)	Pnliprp1 Plrp1	Rattus norvegicus (Rat)	473	lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]	 GO:0051384			cd00707;	PF00151;PF01477;	extracellular space [GO:0005615]; calcium ion binding [GO:0005509]; lipase activity [GO:0016298]; triglyceride lipase activity [GO:0004806]; lipid metabolic process [GO:0006629]; pancreas development [GO:0031016]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]
CHOYP_contig_023814|m.27068	597	1	2	4	6	7	6	1.082	1.082	2.3065	2.3065	0	0	0.554639																												
CHOYP_ELDP2.2.2|m.40194	364	7	2	8	8	13	11	0.682	0.682	2.2998	2.2998	0	0	0.554736	CHOYP_ELDP2.2.2|m.40194	P86954	ELDP2_PINMA	37.05	359	214	6	7	363	9	357	3.00E-73	238	1	P86954	ELDP2_PINMA	reviewed	EGF-like domain-containing protein 2		Pinctada maxima (Silver-lipped pearl oyster) (White-lipped pearl oyster)	357		GO:0005576					extracellular region [GO:0005576]
CHOYP_CBLN3.1.2|m.29253	598	3	5	4	8	11	6	0.781	0.781	2.299	2.299	0	0	0.554747	CHOYP_CBLN3.1.2|m.29253	Q2KIX7	HP251_BOVIN	30.43	115	75	2	235	345	98	211	0.00000005	57	1	Q2KIX7	HP251_BOVIN	reviewed	Protein HP-25 homolog 1		Bos taurus (Bovine)	212		GO:0005576				PF00386;PF01391;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]
CHOYP_CBLN3.1.2|m.29253	598	3	5	4	8	11	6	0.781	0.781	2.299	2.299	0	0	0.554747	CHOYP_CBLN3.1.2|m.29253	Q2KIX7	HP251_BOVIN	30.43	115	75	2	235	345	98	211	0.00000005	57	1	Q2KIX7	HP251_BOVIN	reviewed	Protein HP-25 homolog 1		Bos taurus (Bovine)	212		 GO:0005581				PF00386;PF01391;	collagen trimer [GO:0005581]; extracellular region [GO:0005576]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	GO:0001725			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0005509			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0005634			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0005635			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0005737			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0005789			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0005882			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0005925			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0005938			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0007155			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0007409			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0008090			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0009898			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0014069			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0014704			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0015629			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0015630			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0016020			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0016021			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0030018			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0030056			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0030424			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0031410			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0031673			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0035371			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0042383			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0042803			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0045104			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0046907			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0048471			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0051010			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:0097038			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_LOC662585.2.2|m.7262	5439	9	12	15	17	18	22	0.509	0.509	2.2844	2.2844	0	0	0.554961	CHOYP_LOC662585.2.2|m.7262	Q91ZU6	DYST_MOUSE	32.38	3765	2378	39	1737	5432	3713	7378	0	1882	1	Q91ZU6	DYST_MOUSE	reviewed	Dystonin (Bullous pemphigoid antigen 1) (BPA) (Dystonia musculorum protein) (Hemidesmosomal plaque protein) (Microtubule actin cross-linking factor 2)	Dst Bpag1 Macf2	Mus musculus (Mouse)	7393	axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]	 GO:1904115			cd00014;cd00051;	PF00307;PF13499;PF02187;PF00681;PF00435;	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum membrane [GO:0005789]; focal adhesion [GO:0005925]; H zone [GO:0031673]; hemidesmosome [GO:0030056]; integral component of membrane [GO:0016021]; intercalated disc [GO:0014704]; intermediate filament [GO:0005882]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; microtubule plus-end [GO:0035371]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; sarcolemma [GO:0042383]; stress fiber [GO:0001725]; Z disc [GO:0030018]; calcium ion binding [GO:0005509]; microtubule plus-end binding [GO:0051010]; protein homodimerization activity [GO:0042803]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; intermediate filament cytoskeleton organization [GO:0045104]; intracellular transport [GO:0046907]; retrograde axonal transport [GO:0008090]
CHOYP_contig_010639|m.12333	187	0	0	5	3	7	8	0.976	0.976	2.274	2.274	0	0	0.555116																												
CHOYP_contig_004993|m.5721	139	2	1	3	4	3	10	1.113	1.113	2.2659	2.2659	0	0	0.555238																												
CHOYP_LOC100376308.1.1|m.60595	2604	8	0	7	8	12	12	0.709	0.709	2.2617	2.2617	0	0	0.555302	CHOYP_LOC100376308.1.1|m.60595	O88281	MEGF6_RAT	29.06	1163	498	59	219	1208	545	1553	4.00E-57	224	1	O88281	MEGF6_RAT	reviewed	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	Megf6 Egfl3	Rattus norvegicus (Rat)	1574		GO:0005509				PF12662;PF07645;PF12661;PF00053;	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
CHOYP_LOC100376308.1.1|m.60595	2604	8	0	7	8	12	12	0.709	0.709	2.2617	2.2617	0	0	0.555302	CHOYP_LOC100376308.1.1|m.60595	O88281	MEGF6_RAT	29.06	1163	498	59	219	1208	545	1553	4.00E-57	224	1	O88281	MEGF6_RAT	reviewed	Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3)	Megf6 Egfl3	Rattus norvegicus (Rat)	1574		 GO:0005576				PF12662;PF07645;PF12661;PF00053;	extracellular region [GO:0005576]; calcium ion binding [GO:0005509]
CHOYP_LOC101079138.1.4|m.4320	429	2	3	3	4	10	5	0.927	0.927	2.2446	2.2446	0	0	0.555565																												
CHOYP_KCP.9.13|m.43409	351	13	0	8	12	17	10	0.597	0.597	2.227	2.227	0	0	0.555842																												
CHOYP_LOC764722.1.3|m.16471	538	10	2	7	11	9	14	0.621	0.621	2.221	2.221	0	0	0.555938	CHOYP_LOC764722.1.3|m.16471	Q7YT83	TX31_CONTE	38.38	284	142	10	122	386	27	296	2.00E-48	175	1	Q7YT83	TX31_CONTE	reviewed	Cysteine-rich venom protein (CRVP) (EC 3.4.-.-) (Substrate-specific endoprotease Tex31)		Conus textile (Cloth-of-gold cone)	300		GO:0005576				PF00188;	extracellular region [GO:0005576]; peptidase activity [GO:0008233]
CHOYP_LOC764722.1.3|m.16471	538	10	2	7	11	9	14	0.621	0.621	2.221	2.221	0	0	0.555938	CHOYP_LOC764722.1.3|m.16471	Q7YT83	TX31_CONTE	38.38	284	142	10	122	386	27	296	2.00E-48	175	1	Q7YT83	TX31_CONTE	reviewed	Cysteine-rich venom protein (CRVP) (EC 3.4.-.-) (Substrate-specific endoprotease Tex31)		Conus textile (Cloth-of-gold cone)	300		 GO:0008233				PF00188;	extracellular region [GO:0005576]; peptidase activity [GO:0008233]
CHOYP_contig_025167|m.28650	417	1	0	3	4	8	3	1.174	1.174	2.2033	2.2033	0	0	0.556225																												
CHOYP_SRAP.16.18|m.58654	1816	2	0	0	4	5	6	1.43	1.43	2.196	2.196	0	0	0.556345	CHOYP_SRAP.16.18|m.58654	Q8K561	OTOAN_MOUSE	28.46	260	179	5	1535	1791	841	1096	6.00E-20	100	1	Q8K561	OTOAN_MOUSE	reviewed	Otoancorin	Otoa	Mus musculus (Mouse)	1137	cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]	GO:0005578					anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; proteinaceous extracellular matrix [GO:0005578]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]
CHOYP_SRAP.16.18|m.58654	1816	2	0	0	4	5	6	1.43	1.43	2.196	2.196	0	0	0.556345	CHOYP_SRAP.16.18|m.58654	Q8K561	OTOAN_MOUSE	28.46	260	179	5	1535	1791	841	1096	6.00E-20	100	1	Q8K561	OTOAN_MOUSE	reviewed	Otoancorin	Otoa	Mus musculus (Mouse)	1137	cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]	 GO:0007160					anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; proteinaceous extracellular matrix [GO:0005578]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]
CHOYP_SRAP.16.18|m.58654	1816	2	0	0	4	5	6	1.43	1.43	2.196	2.196	0	0	0.556345	CHOYP_SRAP.16.18|m.58654	Q8K561	OTOAN_MOUSE	28.46	260	179	5	1535	1791	841	1096	6.00E-20	100	1	Q8K561	OTOAN_MOUSE	reviewed	Otoancorin	Otoa	Mus musculus (Mouse)	1137	cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]	 GO:0007605					anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; proteinaceous extracellular matrix [GO:0005578]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]
CHOYP_SRAP.16.18|m.58654	1816	2	0	0	4	5	6	1.43	1.43	2.196	2.196	0	0	0.556345	CHOYP_SRAP.16.18|m.58654	Q8K561	OTOAN_MOUSE	28.46	260	179	5	1535	1791	841	1096	6.00E-20	100	1	Q8K561	OTOAN_MOUSE	reviewed	Otoancorin	Otoa	Mus musculus (Mouse)	1137	cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]	 GO:0009986					anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; proteinaceous extracellular matrix [GO:0005578]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]
CHOYP_SRAP.16.18|m.58654	1816	2	0	0	4	5	6	1.43	1.43	2.196	2.196	0	0	0.556345	CHOYP_SRAP.16.18|m.58654	Q8K561	OTOAN_MOUSE	28.46	260	179	5	1535	1791	841	1096	6.00E-20	100	1	Q8K561	OTOAN_MOUSE	reviewed	Otoancorin	Otoa	Mus musculus (Mouse)	1137	cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]	 GO:0016324					anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; proteinaceous extracellular matrix [GO:0005578]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]
CHOYP_SRAP.16.18|m.58654	1816	2	0	0	4	5	6	1.43	1.43	2.196	2.196	0	0	0.556345	CHOYP_SRAP.16.18|m.58654	Q8K561	OTOAN_MOUSE	28.46	260	179	5	1535	1791	841	1096	6.00E-20	100	1	Q8K561	OTOAN_MOUSE	reviewed	Otoancorin	Otoa	Mus musculus (Mouse)	1137	cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]	 GO:0019226					anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; proteinaceous extracellular matrix [GO:0005578]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]
CHOYP_SRAP.16.18|m.58654	1816	2	0	0	4	5	6	1.43	1.43	2.196	2.196	0	0	0.556345	CHOYP_SRAP.16.18|m.58654	Q8K561	OTOAN_MOUSE	28.46	260	179	5	1535	1791	841	1096	6.00E-20	100	1	Q8K561	OTOAN_MOUSE	reviewed	Otoancorin	Otoa	Mus musculus (Mouse)	1137	cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]	 GO:0031225					anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; proteinaceous extracellular matrix [GO:0005578]; cell-matrix adhesion [GO:0007160]; sensory perception of sound [GO:0007605]; transmission of nerve impulse [GO:0019226]
CHOYP_BRAFLDRAFT_89961.3.3|m.49198	180	1	3	1	2	5	8	1.109	1.109	2.1773	2.1773	0	0	0.556658																												
CHOYP_LOC100878391.1.1|m.28644	464	3	1	1	4	5	6	1.165	1.165	2.1691	2.1691	0	0	0.556798	CHOYP_LOC100878391.1.1|m.28644	O35094	TIM44_RAT	42.15	446	247	4	26	463	11	453	3.00E-119	363	1	O35094	TIM44_RAT	reviewed	Mitochondrial import inner membrane translocase subunit TIM44	Timm44 Mimt44 Tim44	Rattus norvegicus (Rat)	453	intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]	GO:0005524				PF04280;	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]
CHOYP_LOC100878391.1.1|m.28644	464	3	1	1	4	5	6	1.165	1.165	2.1691	2.1691	0	0	0.556798	CHOYP_LOC100878391.1.1|m.28644	O35094	TIM44_RAT	42.15	446	247	4	26	463	11	453	3.00E-119	363	1	O35094	TIM44_RAT	reviewed	Mitochondrial import inner membrane translocase subunit TIM44	Timm44 Mimt44 Tim44	Rattus norvegicus (Rat)	453	intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]	 GO:0005743				PF04280;	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]
CHOYP_LOC100878391.1.1|m.28644	464	3	1	1	4	5	6	1.165	1.165	2.1691	2.1691	0	0	0.556798	CHOYP_LOC100878391.1.1|m.28644	O35094	TIM44_RAT	42.15	446	247	4	26	463	11	453	3.00E-119	363	1	O35094	TIM44_RAT	reviewed	Mitochondrial import inner membrane translocase subunit TIM44	Timm44 Mimt44 Tim44	Rattus norvegicus (Rat)	453	intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]	 GO:0005759				PF04280;	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]
CHOYP_LOC100878391.1.1|m.28644	464	3	1	1	4	5	6	1.165	1.165	2.1691	2.1691	0	0	0.556798	CHOYP_LOC100878391.1.1|m.28644	O35094	TIM44_RAT	42.15	446	247	4	26	463	11	453	3.00E-119	363	1	O35094	TIM44_RAT	reviewed	Mitochondrial import inner membrane translocase subunit TIM44	Timm44 Mimt44 Tim44	Rattus norvegicus (Rat)	453	intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]	 GO:0006886				PF04280;	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]
CHOYP_LOC100878391.1.1|m.28644	464	3	1	1	4	5	6	1.165	1.165	2.1691	2.1691	0	0	0.556798	CHOYP_LOC100878391.1.1|m.28644	O35094	TIM44_RAT	42.15	446	247	4	26	463	11	453	3.00E-119	363	1	O35094	TIM44_RAT	reviewed	Mitochondrial import inner membrane translocase subunit TIM44	Timm44 Mimt44 Tim44	Rattus norvegicus (Rat)	453	intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]	 GO:0030150				PF04280;	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]
CHOYP_LOC100878391.1.1|m.28644	464	3	1	1	4	5	6	1.165	1.165	2.1691	2.1691	0	0	0.556798	CHOYP_LOC100878391.1.1|m.28644	O35094	TIM44_RAT	42.15	446	247	4	26	463	11	453	3.00E-119	363	1	O35094	TIM44_RAT	reviewed	Mitochondrial import inner membrane translocase subunit TIM44	Timm44 Mimt44 Tim44	Rattus norvegicus (Rat)	453	intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]	 GO:0051087				PF04280;	mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; ATP binding [GO:0005524]; chaperone binding [GO:0051087]; intracellular protein transport [GO:0006886]; protein import into mitochondrial matrix [GO:0030150]
CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	257	0	0	0	1	10	0	1.434	1.434	2.1585	2.1585	0	0	0.55698	CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	Q8MP06	SNO1_TYRJA	34.62	260	156	7	2	252	188	442	3.00E-32	127	1	Q8MP06	SNO1_TYRJA	reviewed	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	sno1	Tyria jacobaeae (Cinnabar moth)	456	alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]	GO:0004499				PF00743;	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	257	0	0	0	1	10	0	1.434	1.434	2.1585	2.1585	0	0	0.55698	CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	Q8MP06	SNO1_TYRJA	34.62	260	156	7	2	252	188	442	3.00E-32	127	1	Q8MP06	SNO1_TYRJA	reviewed	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	sno1	Tyria jacobaeae (Cinnabar moth)	456	alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]	 GO:0005576				PF00743;	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	257	0	0	0	1	10	0	1.434	1.434	2.1585	2.1585	0	0	0.55698	CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	Q8MP06	SNO1_TYRJA	34.62	260	156	7	2	252	188	442	3.00E-32	127	1	Q8MP06	SNO1_TYRJA	reviewed	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	sno1	Tyria jacobaeae (Cinnabar moth)	456	alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]	 GO:0009820				PF00743;	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	257	0	0	0	1	10	0	1.434	1.434	2.1585	2.1585	0	0	0.55698	CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	Q8MP06	SNO1_TYRJA	34.62	260	156	7	2	252	188	442	3.00E-32	127	1	Q8MP06	SNO1_TYRJA	reviewed	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	sno1	Tyria jacobaeae (Cinnabar moth)	456	alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]	 GO:0033784				PF00743;	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	257	0	0	0	1	10	0	1.434	1.434	2.1585	2.1585	0	0	0.55698	CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	Q8MP06	SNO1_TYRJA	34.62	260	156	7	2	252	188	442	3.00E-32	127	1	Q8MP06	SNO1_TYRJA	reviewed	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	sno1	Tyria jacobaeae (Cinnabar moth)	456	alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]	 GO:0050660				PF00743;	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	257	0	0	0	1	10	0	1.434	1.434	2.1585	2.1585	0	0	0.55698	CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	Q8MP06	SNO1_TYRJA	34.62	260	156	7	2	252	188	442	3.00E-32	127	1	Q8MP06	SNO1_TYRJA	reviewed	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	sno1	Tyria jacobaeae (Cinnabar moth)	456	alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]	 GO:0050661				PF00743;	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	257	0	0	0	1	10	0	1.434	1.434	2.1585	2.1585	0	0	0.55698	CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	Q8MP06	SNO1_TYRJA	34.62	260	156	7	2	252	188	442	3.00E-32	127	1	Q8MP06	SNO1_TYRJA	reviewed	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	sno1	Tyria jacobaeae (Cinnabar moth)	456	alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]	 GO:0051289				PF00743;	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	257	0	0	0	1	10	0	1.434	1.434	2.1585	2.1585	0	0	0.55698	CHOYP_NEMVEDRAFT_V1G235461.1.1|m.28341	Q8MP06	SNO1_TYRJA	34.62	260	156	7	2	252	188	442	3.00E-32	127	1	Q8MP06	SNO1_TYRJA	reviewed	Senecionine N-oxygenase (SNO) (EC 1.14.13.101)	sno1	Tyria jacobaeae (Cinnabar moth)	456	alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]	 GO:0055114				PF00743;	"extracellular region [GO:0005576]; flavin adenine dinucleotide binding [GO:0050660]; N,N-dimethylaniline monooxygenase activity [GO:0004499]; NADP binding [GO:0050661]; senecionine N-oxygenase activity [GO:0033784]; alkaloid metabolic process [GO:0009820]; oxidation-reduction process [GO:0055114]; protein homotetramerization [GO:0051289]"
CHOYP_LOC100863242.1.1|m.9849	749	5	8	10	13	14	12	0.568	0.568	2.1554	2.1554	0	0	0.557034	CHOYP_LOC100863242.1.1|m.9849	Q767L0	ABCF1_PIG	65.66	594	197	4	155	745	218	807	0	728	1	Q767L0	ABCF1_PIG	reviewed	ATP-binding cassette sub-family F member 1	ABCF1	Sus scrofa (Pig)	807	positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	GO:0005524				PF00005;PF12848;	cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]
CHOYP_LOC100863242.1.1|m.9849	749	5	8	10	13	14	12	0.568	0.568	2.1554	2.1554	0	0	0.557034	CHOYP_LOC100863242.1.1|m.9849	Q767L0	ABCF1_PIG	65.66	594	197	4	155	745	218	807	0	728	1	Q767L0	ABCF1_PIG	reviewed	ATP-binding cassette sub-family F member 1	ABCF1	Sus scrofa (Pig)	807	positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	 GO:0005635				PF00005;PF12848;	cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]
CHOYP_LOC100863242.1.1|m.9849	749	5	8	10	13	14	12	0.568	0.568	2.1554	2.1554	0	0	0.557034	CHOYP_LOC100863242.1.1|m.9849	Q767L0	ABCF1_PIG	65.66	594	197	4	155	745	218	807	0	728	1	Q767L0	ABCF1_PIG	reviewed	ATP-binding cassette sub-family F member 1	ABCF1	Sus scrofa (Pig)	807	positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	 GO:0005654				PF00005;PF12848;	cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]
CHOYP_LOC100863242.1.1|m.9849	749	5	8	10	13	14	12	0.568	0.568	2.1554	2.1554	0	0	0.557034	CHOYP_LOC100863242.1.1|m.9849	Q767L0	ABCF1_PIG	65.66	594	197	4	155	745	218	807	0	728	1	Q767L0	ABCF1_PIG	reviewed	ATP-binding cassette sub-family F member 1	ABCF1	Sus scrofa (Pig)	807	positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	 GO:0005737				PF00005;PF12848;	cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]
CHOYP_LOC100863242.1.1|m.9849	749	5	8	10	13	14	12	0.568	0.568	2.1554	2.1554	0	0	0.557034	CHOYP_LOC100863242.1.1|m.9849	Q767L0	ABCF1_PIG	65.66	594	197	4	155	745	218	807	0	728	1	Q767L0	ABCF1_PIG	reviewed	ATP-binding cassette sub-family F member 1	ABCF1	Sus scrofa (Pig)	807	positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	 GO:0006413				PF00005;PF12848;	cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]
CHOYP_LOC100863242.1.1|m.9849	749	5	8	10	13	14	12	0.568	0.568	2.1554	2.1554	0	0	0.557034	CHOYP_LOC100863242.1.1|m.9849	Q767L0	ABCF1_PIG	65.66	594	197	4	155	745	218	807	0	728	1	Q767L0	ABCF1_PIG	reviewed	ATP-binding cassette sub-family F member 1	ABCF1	Sus scrofa (Pig)	807	positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	 GO:0008494				PF00005;PF12848;	cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]
CHOYP_LOC100863242.1.1|m.9849	749	5	8	10	13	14	12	0.568	0.568	2.1554	2.1554	0	0	0.557034	CHOYP_LOC100863242.1.1|m.9849	Q767L0	ABCF1_PIG	65.66	594	197	4	155	745	218	807	0	728	1	Q767L0	ABCF1_PIG	reviewed	ATP-binding cassette sub-family F member 1	ABCF1	Sus scrofa (Pig)	807	positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	 GO:0016887				PF00005;PF12848;	cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]
CHOYP_LOC100863242.1.1|m.9849	749	5	8	10	13	14	12	0.568	0.568	2.1554	2.1554	0	0	0.557034	CHOYP_LOC100863242.1.1|m.9849	Q767L0	ABCF1_PIG	65.66	594	197	4	155	745	218	807	0	728	1	Q767L0	ABCF1_PIG	reviewed	ATP-binding cassette sub-family F member 1	ABCF1	Sus scrofa (Pig)	807	positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	 GO:0042788				PF00005;PF12848;	cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]
CHOYP_LOC100863242.1.1|m.9849	749	5	8	10	13	14	12	0.568	0.568	2.1554	2.1554	0	0	0.557034	CHOYP_LOC100863242.1.1|m.9849	Q767L0	ABCF1_PIG	65.66	594	197	4	155	745	218	807	0	728	1	Q767L0	ABCF1_PIG	reviewed	ATP-binding cassette sub-family F member 1	ABCF1	Sus scrofa (Pig)	807	positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	 GO:0043022				PF00005;PF12848;	cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]
CHOYP_LOC100863242.1.1|m.9849	749	5	8	10	13	14	12	0.568	0.568	2.1554	2.1554	0	0	0.557034	CHOYP_LOC100863242.1.1|m.9849	Q767L0	ABCF1_PIG	65.66	594	197	4	155	745	218	807	0	728	1	Q767L0	ABCF1_PIG	reviewed	ATP-binding cassette sub-family F member 1	ABCF1	Sus scrofa (Pig)	807	positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]	 GO:0045727				PF00005;PF12848;	cytoplasm [GO:0005737]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; polysomal ribosome [GO:0042788]; ATP binding [GO:0005524]; ATPase activity [GO:0016887]; ribosome binding [GO:0043022]; translation activator activity [GO:0008494]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]
CHOYP_LOC100692883.1.1|m.5437	238	1	0	1	6	3	4	1.608	1.608	2.1507	2.1507	0	0	0.557116	CHOYP_LOC100692883.1.1|m.5437	Q5IS41	NCAN_PANTR	30.92	152	68	4	35	186	1095	1209	2.00E-16	82.8	1	Q5IS41	NCAN_PANTR	reviewed	Neurocan core protein (Chondroitin sulfate proteoglycan 3)	NCAN CSPG3	Pan troglodytes (Chimpanzee)	1321	cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]	GO:0001501			cd00033;	PF00008;PF00059;PF00084;PF07686;PF00193;	proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
CHOYP_LOC100692883.1.1|m.5437	238	1	0	1	6	3	4	1.608	1.608	2.1507	2.1507	0	0	0.557116	CHOYP_LOC100692883.1.1|m.5437	Q5IS41	NCAN_PANTR	30.92	152	68	4	35	186	1095	1209	2.00E-16	82.8	1	Q5IS41	NCAN_PANTR	reviewed	Neurocan core protein (Chondroitin sulfate proteoglycan 3)	NCAN CSPG3	Pan troglodytes (Chimpanzee)	1321	cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]	 GO:0005201			cd00033;	PF00008;PF00059;PF00084;PF07686;PF00193;	proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
CHOYP_LOC100692883.1.1|m.5437	238	1	0	1	6	3	4	1.608	1.608	2.1507	2.1507	0	0	0.557116	CHOYP_LOC100692883.1.1|m.5437	Q5IS41	NCAN_PANTR	30.92	152	68	4	35	186	1095	1209	2.00E-16	82.8	1	Q5IS41	NCAN_PANTR	reviewed	Neurocan core protein (Chondroitin sulfate proteoglycan 3)	NCAN CSPG3	Pan troglodytes (Chimpanzee)	1321	cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]	 GO:0005509			cd00033;	PF00008;PF00059;PF00084;PF07686;PF00193;	proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
CHOYP_LOC100692883.1.1|m.5437	238	1	0	1	6	3	4	1.608	1.608	2.1507	2.1507	0	0	0.557116	CHOYP_LOC100692883.1.1|m.5437	Q5IS41	NCAN_PANTR	30.92	152	68	4	35	186	1095	1209	2.00E-16	82.8	1	Q5IS41	NCAN_PANTR	reviewed	Neurocan core protein (Chondroitin sulfate proteoglycan 3)	NCAN CSPG3	Pan troglodytes (Chimpanzee)	1321	cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]	 GO:0005540			cd00033;	PF00008;PF00059;PF00084;PF07686;PF00193;	proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
CHOYP_LOC100692883.1.1|m.5437	238	1	0	1	6	3	4	1.608	1.608	2.1507	2.1507	0	0	0.557116	CHOYP_LOC100692883.1.1|m.5437	Q5IS41	NCAN_PANTR	30.92	152	68	4	35	186	1095	1209	2.00E-16	82.8	1	Q5IS41	NCAN_PANTR	reviewed	Neurocan core protein (Chondroitin sulfate proteoglycan 3)	NCAN CSPG3	Pan troglodytes (Chimpanzee)	1321	cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]	 GO:0005578			cd00033;	PF00008;PF00059;PF00084;PF07686;PF00193;	proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
CHOYP_LOC100692883.1.1|m.5437	238	1	0	1	6	3	4	1.608	1.608	2.1507	2.1507	0	0	0.557116	CHOYP_LOC100692883.1.1|m.5437	Q5IS41	NCAN_PANTR	30.92	152	68	4	35	186	1095	1209	2.00E-16	82.8	1	Q5IS41	NCAN_PANTR	reviewed	Neurocan core protein (Chondroitin sulfate proteoglycan 3)	NCAN CSPG3	Pan troglodytes (Chimpanzee)	1321	cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]	 GO:0007155			cd00033;	PF00008;PF00059;PF00084;PF07686;PF00193;	proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
CHOYP_LOC100692883.1.1|m.5437	238	1	0	1	6	3	4	1.608	1.608	2.1507	2.1507	0	0	0.557116	CHOYP_LOC100692883.1.1|m.5437	Q5IS41	NCAN_PANTR	30.92	152	68	4	35	186	1095	1209	2.00E-16	82.8	1	Q5IS41	NCAN_PANTR	reviewed	Neurocan core protein (Chondroitin sulfate proteoglycan 3)	NCAN CSPG3	Pan troglodytes (Chimpanzee)	1321	cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]	 GO:0007417			cd00033;	PF00008;PF00059;PF00084;PF07686;PF00193;	proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
CHOYP_LOC100692883.1.1|m.5437	238	1	0	1	6	3	4	1.608	1.608	2.1507	2.1507	0	0	0.557116	CHOYP_LOC100692883.1.1|m.5437	Q5IS41	NCAN_PANTR	30.92	152	68	4	35	186	1095	1209	2.00E-16	82.8	1	Q5IS41	NCAN_PANTR	reviewed	Neurocan core protein (Chondroitin sulfate proteoglycan 3)	NCAN CSPG3	Pan troglodytes (Chimpanzee)	1321	cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]	 GO:0030246			cd00033;	PF00008;PF00059;PF00084;PF07686;PF00193;	proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; hyaluronic acid binding [GO:0005540]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]
CHOYP_LOC100175867.1.1|m.48982	429	0	0	0	1	3	7	1.396	1.396	2.1461	2.1461	0	0	0.557197	CHOYP_LOC100175867.1.1|m.48982	P05099	MATN1_CHICK	28.34	434	257	12	24	423	36	449	5.00E-42	159	1	P05099	MATN1_CHICK	reviewed	Cartilage matrix protein (Matrilin-1)	MATN1 CMP	Gallus gallus (Chicken)	493		GO:0005201				PF10393;PF00092;	proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]
CHOYP_LOC100175867.1.1|m.48982	429	0	0	0	1	3	7	1.396	1.396	2.1461	2.1461	0	0	0.557197	CHOYP_LOC100175867.1.1|m.48982	P05099	MATN1_CHICK	28.34	434	257	12	24	423	36	449	5.00E-42	159	1	P05099	MATN1_CHICK	reviewed	Cartilage matrix protein (Matrilin-1)	MATN1 CMP	Gallus gallus (Chicken)	493		 GO:0005509				PF10393;PF00092;	proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]
CHOYP_LOC100175867.1.1|m.48982	429	0	0	0	1	3	7	1.396	1.396	2.1461	2.1461	0	0	0.557197	CHOYP_LOC100175867.1.1|m.48982	P05099	MATN1_CHICK	28.34	434	257	12	24	423	36	449	5.00E-42	159	1	P05099	MATN1_CHICK	reviewed	Cartilage matrix protein (Matrilin-1)	MATN1 CMP	Gallus gallus (Chicken)	493		 GO:0005578				PF10393;PF00092;	proteinaceous extracellular matrix [GO:0005578]; calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]
CHOYP_LOC100372879.1.3|m.18886	544	0	0	0	3	5	3	1.404	1.404	2.1459	2.1459	0	0	0.5572	CHOYP_LOC100372879.1.3|m.18886	P18142	D2_DICDI	29.43	513	333	13	22	518	29	528	1.00E-58	209	1	P18142	D2_DICDI	reviewed	cAMP-regulated D2 protein	D2 DDB_G0283085	Dictyostelium discoideum (Slime mold)	535		GO:0033118				PF00135;	esterosome membrane [GO:0033118]; carboxylic ester hydrolase activity [GO:0052689]
CHOYP_LOC100372879.1.3|m.18886	544	0	0	0	3	5	3	1.404	1.404	2.1459	2.1459	0	0	0.5572	CHOYP_LOC100372879.1.3|m.18886	P18142	D2_DICDI	29.43	513	333	13	22	518	29	528	1.00E-58	209	1	P18142	D2_DICDI	reviewed	cAMP-regulated D2 protein	D2 DDB_G0283085	Dictyostelium discoideum (Slime mold)	535		 GO:0052689				PF00135;	esterosome membrane [GO:0033118]; carboxylic ester hydrolase activity [GO:0052689]
CHOYP_LOC662543.1.1|m.39811	911	7	4	9	7	15	14	0.595	0.595	2.1441	2.1441	0	0	0.557232	CHOYP_LOC662543.1.1|m.39811	Q14624	ITIH4_HUMAN	34.47	824	424	23	35	798	34	801	4.00E-120	394	1	Q14624	ITIH4_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4 IHRP ITIHL1 PK120 PRO1851	Homo sapiens (Human)	930	acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]	GO:0002576				PF06668;PF08487;PF00092;	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]
CHOYP_LOC662543.1.1|m.39811	911	7	4	9	7	15	14	0.595	0.595	2.1441	2.1441	0	0	0.557232	CHOYP_LOC662543.1.1|m.39811	Q14624	ITIH4_HUMAN	34.47	824	424	23	35	798	34	801	4.00E-120	394	1	Q14624	ITIH4_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4 IHRP ITIHL1 PK120 PRO1851	Homo sapiens (Human)	930	acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]	 GO:0004866				PF06668;PF08487;PF00092;	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]
CHOYP_LOC662543.1.1|m.39811	911	7	4	9	7	15	14	0.595	0.595	2.1441	2.1441	0	0	0.557232	CHOYP_LOC662543.1.1|m.39811	Q14624	ITIH4_HUMAN	34.47	824	424	23	35	798	34	801	4.00E-120	394	1	Q14624	ITIH4_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4 IHRP ITIHL1 PK120 PRO1851	Homo sapiens (Human)	930	acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]	 GO:0004867				PF06668;PF08487;PF00092;	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]
CHOYP_LOC662543.1.1|m.39811	911	7	4	9	7	15	14	0.595	0.595	2.1441	2.1441	0	0	0.557232	CHOYP_LOC662543.1.1|m.39811	Q14624	ITIH4_HUMAN	34.47	824	424	23	35	798	34	801	4.00E-120	394	1	Q14624	ITIH4_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4 IHRP ITIHL1 PK120 PRO1851	Homo sapiens (Human)	930	acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]	 GO:0005576				PF06668;PF08487;PF00092;	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]
CHOYP_LOC662543.1.1|m.39811	911	7	4	9	7	15	14	0.595	0.595	2.1441	2.1441	0	0	0.557232	CHOYP_LOC662543.1.1|m.39811	Q14624	ITIH4_HUMAN	34.47	824	424	23	35	798	34	801	4.00E-120	394	1	Q14624	ITIH4_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4 IHRP ITIHL1 PK120 PRO1851	Homo sapiens (Human)	930	acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]	 GO:0005886				PF06668;PF08487;PF00092;	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]
CHOYP_LOC662543.1.1|m.39811	911	7	4	9	7	15	14	0.595	0.595	2.1441	2.1441	0	0	0.557232	CHOYP_LOC662543.1.1|m.39811	Q14624	ITIH4_HUMAN	34.47	824	424	23	35	798	34	801	4.00E-120	394	1	Q14624	ITIH4_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4 IHRP ITIHL1 PK120 PRO1851	Homo sapiens (Human)	930	acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]	 GO:0006953				PF06668;PF08487;PF00092;	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]
CHOYP_LOC662543.1.1|m.39811	911	7	4	9	7	15	14	0.595	0.595	2.1441	2.1441	0	0	0.557232	CHOYP_LOC662543.1.1|m.39811	Q14624	ITIH4_HUMAN	34.47	824	424	23	35	798	34	801	4.00E-120	394	1	Q14624	ITIH4_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4 IHRP ITIHL1 PK120 PRO1851	Homo sapiens (Human)	930	acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]	 GO:0030212				PF06668;PF08487;PF00092;	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]
CHOYP_LOC662543.1.1|m.39811	911	7	4	9	7	15	14	0.595	0.595	2.1441	2.1441	0	0	0.557232	CHOYP_LOC662543.1.1|m.39811	Q14624	ITIH4_HUMAN	34.47	824	424	23	35	798	34	801	4.00E-120	394	1	Q14624	ITIH4_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4 IHRP ITIHL1 PK120 PRO1851	Homo sapiens (Human)	930	acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]	 GO:0031089				PF06668;PF08487;PF00092;	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]
CHOYP_LOC662543.1.1|m.39811	911	7	4	9	7	15	14	0.595	0.595	2.1441	2.1441	0	0	0.557232	CHOYP_LOC662543.1.1|m.39811	Q14624	ITIH4_HUMAN	34.47	824	424	23	35	798	34	801	4.00E-120	394	1	Q14624	ITIH4_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4 IHRP ITIHL1 PK120 PRO1851	Homo sapiens (Human)	930	acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]	 GO:0034097				PF06668;PF08487;PF00092;	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]
CHOYP_LOC662543.1.1|m.39811	911	7	4	9	7	15	14	0.595	0.595	2.1441	2.1441	0	0	0.557232	CHOYP_LOC662543.1.1|m.39811	Q14624	ITIH4_HUMAN	34.47	824	424	23	35	798	34	801	4.00E-120	394	1	Q14624	ITIH4_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4 IHRP ITIHL1 PK120 PRO1851	Homo sapiens (Human)	930	acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]	 GO:0070062				PF06668;PF08487;PF00092;	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]
CHOYP_LOC662543.1.1|m.39811	911	7	4	9	7	15	14	0.595	0.595	2.1441	2.1441	0	0	0.557232	CHOYP_LOC662543.1.1|m.39811	Q14624	ITIH4_HUMAN	34.47	824	424	23	35	798	34	801	4.00E-120	394	1	Q14624	ITIH4_HUMAN	reviewed	Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4]	ITIH4 IHRP ITIHL1 PK120 PRO1851	Homo sapiens (Human)	930	acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]	 GO:0072562				PF06668;PF08487;PF00092;	blood microparticle [GO:0072562]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; platelet dense granule lumen [GO:0031089]; endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; acute-phase response [GO:0006953]; hyaluronan metabolic process [GO:0030212]; platelet degranulation [GO:0002576]; response to cytokine [GO:0034097]
CHOYP_LOC100374280.1.1|m.17385	492	0	0	2	3	0	9	1.264	1.264	2.1355	2.1355	0	0	0.557384	CHOYP_LOC100374280.1.1|m.17385	Q10341	CYSA_SCHPO	59.54	304	119	2	97	400	68	367	8.00E-126	383	1	Q10341	CYSA_SCHPO	reviewed	Probable serine-O-acetyltransferase (EC 2.3.1.30)	cys2 SPBC106.17c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	504	cysteine biosynthetic process [GO:0019344]; sulfur compound metabolic process [GO:0006790]	GO:0005737	PATHWAY: Amino-acid biosynthesis; L-cysteine biosynthesis; L-cysteine from L-serine: step 1/2. {ECO:0000305|PubMed:17622533}.			PF00561;	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; serine O-acetyltransferase activity [GO:0009001]; cysteine biosynthetic process [GO:0019344]; sulfur compound metabolic process [GO:0006790]
CHOYP_LOC100374280.1.1|m.17385	492	0	0	2	3	0	9	1.264	1.264	2.1355	2.1355	0	0	0.557384	CHOYP_LOC100374280.1.1|m.17385	Q10341	CYSA_SCHPO	59.54	304	119	2	97	400	68	367	8.00E-126	383	1	Q10341	CYSA_SCHPO	reviewed	Probable serine-O-acetyltransferase (EC 2.3.1.30)	cys2 SPBC106.17c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	504	cysteine biosynthetic process [GO:0019344]; sulfur compound metabolic process [GO:0006790]	 GO:0005739	PATHWAY: Amino-acid biosynthesis; L-cysteine biosynthesis; L-cysteine from L-serine: step 1/2. {ECO:0000305|PubMed:17622533}.			PF00561;	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; serine O-acetyltransferase activity [GO:0009001]; cysteine biosynthetic process [GO:0019344]; sulfur compound metabolic process [GO:0006790]
CHOYP_LOC100374280.1.1|m.17385	492	0	0	2	3	0	9	1.264	1.264	2.1355	2.1355	0	0	0.557384	CHOYP_LOC100374280.1.1|m.17385	Q10341	CYSA_SCHPO	59.54	304	119	2	97	400	68	367	8.00E-126	383	1	Q10341	CYSA_SCHPO	reviewed	Probable serine-O-acetyltransferase (EC 2.3.1.30)	cys2 SPBC106.17c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	504	cysteine biosynthetic process [GO:0019344]; sulfur compound metabolic process [GO:0006790]	 GO:0006790	PATHWAY: Amino-acid biosynthesis; L-cysteine biosynthesis; L-cysteine from L-serine: step 1/2. {ECO:0000305|PubMed:17622533}.			PF00561;	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; serine O-acetyltransferase activity [GO:0009001]; cysteine biosynthetic process [GO:0019344]; sulfur compound metabolic process [GO:0006790]
CHOYP_LOC100374280.1.1|m.17385	492	0	0	2	3	0	9	1.264	1.264	2.1355	2.1355	0	0	0.557384	CHOYP_LOC100374280.1.1|m.17385	Q10341	CYSA_SCHPO	59.54	304	119	2	97	400	68	367	8.00E-126	383	1	Q10341	CYSA_SCHPO	reviewed	Probable serine-O-acetyltransferase (EC 2.3.1.30)	cys2 SPBC106.17c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	504	cysteine biosynthetic process [GO:0019344]; sulfur compound metabolic process [GO:0006790]	 GO:0009001	PATHWAY: Amino-acid biosynthesis; L-cysteine biosynthesis; L-cysteine from L-serine: step 1/2. {ECO:0000305|PubMed:17622533}.			PF00561;	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; serine O-acetyltransferase activity [GO:0009001]; cysteine biosynthetic process [GO:0019344]; sulfur compound metabolic process [GO:0006790]
CHOYP_LOC100374280.1.1|m.17385	492	0	0	2	3	0	9	1.264	1.264	2.1355	2.1355	0	0	0.557384	CHOYP_LOC100374280.1.1|m.17385	Q10341	CYSA_SCHPO	59.54	304	119	2	97	400	68	367	8.00E-126	383	1	Q10341	CYSA_SCHPO	reviewed	Probable serine-O-acetyltransferase (EC 2.3.1.30)	cys2 SPBC106.17c	Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast)	504	cysteine biosynthetic process [GO:0019344]; sulfur compound metabolic process [GO:0006790]	 GO:0019344	PATHWAY: Amino-acid biosynthesis; L-cysteine biosynthesis; L-cysteine from L-serine: step 1/2. {ECO:0000305|PubMed:17622533}.			PF00561;	cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; serine O-acetyltransferase activity [GO:0009001]; cysteine biosynthetic process [GO:0019344]; sulfur compound metabolic process [GO:0006790]
CHOYP_contig_018645|m.21889	254	0	0	4	3	8	5	1.062	1.062	2.1308	2.1308	0	0	0.557468																												
CHOYP_LOC579946.7.24|m.39737	1071	3	0	3	6	7	5	1.012	1.012	2.1269	2.1269	0	0	0.557538	CHOYP_LOC579946.7.24|m.39737	P22105	TENX_HUMAN	29.4	619	312	51	89	650	200	750	2.00E-31	138	1	P22105	TENX_HUMAN	reviewed	Tenascin-X (TN-X) (Hexabrachion-like protein)	TNXB HXBL TNX TNXB1 TNXB2 XB	Homo sapiens (Human)	4242	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]	GO:0005178			cd00063;cd00087;	PF07974;PF00147;PF00041;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
CHOYP_LOC579946.7.24|m.39737	1071	3	0	3	6	7	5	1.012	1.012	2.1269	2.1269	0	0	0.557538	CHOYP_LOC579946.7.24|m.39737	P22105	TENX_HUMAN	29.4	619	312	51	89	650	200	750	2.00E-31	138	1	P22105	TENX_HUMAN	reviewed	Tenascin-X (TN-X) (Hexabrachion-like protein)	TNXB HXBL TNX TNXB1 TNXB2 XB	Homo sapiens (Human)	4242	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]	 GO:0005578			cd00063;cd00087;	PF07974;PF00147;PF00041;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
CHOYP_LOC579946.7.24|m.39737	1071	3	0	3	6	7	5	1.012	1.012	2.1269	2.1269	0	0	0.557538	CHOYP_LOC579946.7.24|m.39737	P22105	TENX_HUMAN	29.4	619	312	51	89	650	200	750	2.00E-31	138	1	P22105	TENX_HUMAN	reviewed	Tenascin-X (TN-X) (Hexabrachion-like protein)	TNXB HXBL TNX TNXB1 TNXB2 XB	Homo sapiens (Human)	4242	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]	 GO:0005615			cd00063;cd00087;	PF07974;PF00147;PF00041;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
CHOYP_LOC579946.7.24|m.39737	1071	3	0	3	6	7	5	1.012	1.012	2.1269	2.1269	0	0	0.557538	CHOYP_LOC579946.7.24|m.39737	P22105	TENX_HUMAN	29.4	619	312	51	89	650	200	750	2.00E-31	138	1	P22105	TENX_HUMAN	reviewed	Tenascin-X (TN-X) (Hexabrachion-like protein)	TNXB HXBL TNX TNXB1 TNXB2 XB	Homo sapiens (Human)	4242	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]	 GO:0005622			cd00063;cd00087;	PF07974;PF00147;PF00041;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
CHOYP_LOC579946.7.24|m.39737	1071	3	0	3	6	7	5	1.012	1.012	2.1269	2.1269	0	0	0.557538	CHOYP_LOC579946.7.24|m.39737	P22105	TENX_HUMAN	29.4	619	312	51	89	650	200	750	2.00E-31	138	1	P22105	TENX_HUMAN	reviewed	Tenascin-X (TN-X) (Hexabrachion-like protein)	TNXB HXBL TNX TNXB1 TNXB2 XB	Homo sapiens (Human)	4242	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]	 GO:0007155			cd00063;cd00087;	PF07974;PF00147;PF00041;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
CHOYP_LOC579946.7.24|m.39737	1071	3	0	3	6	7	5	1.012	1.012	2.1269	2.1269	0	0	0.557538	CHOYP_LOC579946.7.24|m.39737	P22105	TENX_HUMAN	29.4	619	312	51	89	650	200	750	2.00E-31	138	1	P22105	TENX_HUMAN	reviewed	Tenascin-X (TN-X) (Hexabrachion-like protein)	TNXB HXBL TNX TNXB1 TNXB2 XB	Homo sapiens (Human)	4242	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]	 GO:0008201			cd00063;cd00087;	PF07974;PF00147;PF00041;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
CHOYP_LOC579946.7.24|m.39737	1071	3	0	3	6	7	5	1.012	1.012	2.1269	2.1269	0	0	0.557538	CHOYP_LOC579946.7.24|m.39737	P22105	TENX_HUMAN	29.4	619	312	51	89	650	200	750	2.00E-31	138	1	P22105	TENX_HUMAN	reviewed	Tenascin-X (TN-X) (Hexabrachion-like protein)	TNXB HXBL TNX TNXB1 TNXB2 XB	Homo sapiens (Human)	4242	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]	 GO:0030036			cd00063;cd00087;	PF07974;PF00147;PF00041;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
CHOYP_LOC579946.7.24|m.39737	1071	3	0	3	6	7	5	1.012	1.012	2.1269	2.1269	0	0	0.557538	CHOYP_LOC579946.7.24|m.39737	P22105	TENX_HUMAN	29.4	619	312	51	89	650	200	750	2.00E-31	138	1	P22105	TENX_HUMAN	reviewed	Tenascin-X (TN-X) (Hexabrachion-like protein)	TNXB HXBL TNX TNXB1 TNXB2 XB	Homo sapiens (Human)	4242	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]	 GO:0030199			cd00063;cd00087;	PF07974;PF00147;PF00041;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
CHOYP_LOC579946.7.24|m.39737	1071	3	0	3	6	7	5	1.012	1.012	2.1269	2.1269	0	0	0.557538	CHOYP_LOC579946.7.24|m.39737	P22105	TENX_HUMAN	29.4	619	312	51	89	650	200	750	2.00E-31	138	1	P22105	TENX_HUMAN	reviewed	Tenascin-X (TN-X) (Hexabrachion-like protein)	TNXB HXBL TNX TNXB1 TNXB2 XB	Homo sapiens (Human)	4242	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]	 GO:0032963			cd00063;cd00087;	PF07974;PF00147;PF00041;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
CHOYP_LOC579946.7.24|m.39737	1071	3	0	3	6	7	5	1.012	1.012	2.1269	2.1269	0	0	0.557538	CHOYP_LOC579946.7.24|m.39737	P22105	TENX_HUMAN	29.4	619	312	51	89	650	200	750	2.00E-31	138	1	P22105	TENX_HUMAN	reviewed	Tenascin-X (TN-X) (Hexabrachion-like protein)	TNXB HXBL TNX TNXB1 TNXB2 XB	Homo sapiens (Human)	4242	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]	 GO:0048251			cd00063;cd00087;	PF07974;PF00147;PF00041;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
CHOYP_LOC579946.7.24|m.39737	1071	3	0	3	6	7	5	1.012	1.012	2.1269	2.1269	0	0	0.557538	CHOYP_LOC579946.7.24|m.39737	P22105	TENX_HUMAN	29.4	619	312	51	89	650	200	750	2.00E-31	138	1	P22105	TENX_HUMAN	reviewed	Tenascin-X (TN-X) (Hexabrachion-like protein)	TNXB HXBL TNX TNXB1 TNXB2 XB	Homo sapiens (Human)	4242	actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]	 GO:0070062			cd00063;cd00087;	PF07974;PF00147;PF00041;	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; intracellular [GO:0005622]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; actin cytoskeleton organization [GO:0030036]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; elastic fiber assembly [GO:0048251]
CHOYP_LOC577931.3.3|m.35020	3394	4	5	4	6	7	13	0.746	0.746	2.1248	2.1248	0	0	0.557576	CHOYP_LOC577931.3.3|m.35020	P07589	FINC_BOVIN	26.15	348	196	15	1496	1831	1773	2071	7.00E-12	75.9	1	P07589	FINC_BOVIN	reviewed	Fibronectin (FN) [Cleaved into: Anastellin]	FN1	Bos taurus (Bovine)	2478	acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]	GO:0001525			cd00062;cd00063;	PF00039;PF00040;PF00041;	extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]
CHOYP_LOC577931.3.3|m.35020	3394	4	5	4	6	7	13	0.746	0.746	2.1248	2.1248	0	0	0.557576	CHOYP_LOC577931.3.3|m.35020	P07589	FINC_BOVIN	26.15	348	196	15	1496	1831	1773	2071	7.00E-12	75.9	1	P07589	FINC_BOVIN	reviewed	Fibronectin (FN) [Cleaved into: Anastellin]	FN1	Bos taurus (Bovine)	2478	acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]	 GO:0005576			cd00062;cd00063;	PF00039;PF00040;PF00041;	extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]
CHOYP_LOC577931.3.3|m.35020	3394	4	5	4	6	7	13	0.746	0.746	2.1248	2.1248	0	0	0.557576	CHOYP_LOC577931.3.3|m.35020	P07589	FINC_BOVIN	26.15	348	196	15	1496	1831	1773	2071	7.00E-12	75.9	1	P07589	FINC_BOVIN	reviewed	Fibronectin (FN) [Cleaved into: Anastellin]	FN1	Bos taurus (Bovine)	2478	acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]	 GO:0005578			cd00062;cd00063;	PF00039;PF00040;PF00041;	extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]
CHOYP_LOC577931.3.3|m.35020	3394	4	5	4	6	7	13	0.746	0.746	2.1248	2.1248	0	0	0.557576	CHOYP_LOC577931.3.3|m.35020	P07589	FINC_BOVIN	26.15	348	196	15	1496	1831	1773	2071	7.00E-12	75.9	1	P07589	FINC_BOVIN	reviewed	Fibronectin (FN) [Cleaved into: Anastellin]	FN1	Bos taurus (Bovine)	2478	acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]	 GO:0006953			cd00062;cd00063;	PF00039;PF00040;PF00041;	extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]
CHOYP_LOC577931.3.3|m.35020	3394	4	5	4	6	7	13	0.746	0.746	2.1248	2.1248	0	0	0.557576	CHOYP_LOC577931.3.3|m.35020	P07589	FINC_BOVIN	26.15	348	196	15	1496	1831	1773	2071	7.00E-12	75.9	1	P07589	FINC_BOVIN	reviewed	Fibronectin (FN) [Cleaved into: Anastellin]	FN1	Bos taurus (Bovine)	2478	acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]	 GO:0007155			cd00062;cd00063;	PF00039;PF00040;PF00041;	extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]
CHOYP_LOC577931.3.3|m.35020	3394	4	5	4	6	7	13	0.746	0.746	2.1248	2.1248	0	0	0.557576	CHOYP_LOC577931.3.3|m.35020	P07589	FINC_BOVIN	26.15	348	196	15	1496	1831	1773	2071	7.00E-12	75.9	1	P07589	FINC_BOVIN	reviewed	Fibronectin (FN) [Cleaved into: Anastellin]	FN1	Bos taurus (Bovine)	2478	acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]	 GO:0008201			cd00062;cd00063;	PF00039;PF00040;PF00041;	extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]
CHOYP_LOC577931.3.3|m.35020	3394	4	5	4	6	7	13	0.746	0.746	2.1248	2.1248	0	0	0.557576	CHOYP_LOC577931.3.3|m.35020	P07589	FINC_BOVIN	26.15	348	196	15	1496	1831	1773	2071	7.00E-12	75.9	1	P07589	FINC_BOVIN	reviewed	Fibronectin (FN) [Cleaved into: Anastellin]	FN1	Bos taurus (Bovine)	2478	acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]	 GO:0008360			cd00062;cd00063;	PF00039;PF00040;PF00041;	extracellular region [GO:0005576]; proteinaceous extracellular matrix [GO:0005578]; heparin binding [GO:0008201]; acute-phase response [GO:0006953]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; regulation of cell shape [GO:0008360]
CHOYP_contig_010226|m.11916	319	3	1	6	7	7	7	0.795	0.795	2.1118	2.1118	0	0	0.557812																												
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	GO:0001822				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0003824				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0004957				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0005615				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0005654				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0005829				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0006693				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0007179				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0007565				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0007567				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0016323				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0016404				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0030728				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0032355				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0032496				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0043065				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0045471				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0045786				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0051287				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0070062				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0070403				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0070493				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:0097070				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_HPGD.1.3|m.50258	260	5	5	6	9	12	7	0.639	0.639	2.1109	2.1109	0	0	0.557828	CHOYP_HPGD.1.3|m.50258	Q8VCC1	PGDH_MOUSE	40.3	263	150	3	1	258	1	261	8.00E-59	194	1	Q8VCC1	PGDH_MOUSE	reviewed	15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1)	Hpgd Pgdh1	Mus musculus (Mouse)	269	ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]	 GO:1904707				PF00106;	basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; 15-hydroxyprostaglandin dehydrogenase (NAD+) activity [GO:0016404]; catalytic activity [GO:0003824]; NAD binding [GO:0051287]; NAD+ binding [GO:0070403]; prostaglandin E receptor activity [GO:0004957]; ductus arteriosus closure [GO:0097070]; female pregnancy [GO:0007565]; kidney development [GO:0001822]; negative regulation of cell cycle [GO:0045786]; ovulation [GO:0030728]; parturition [GO:0007567]; positive regulation of apoptotic process [GO:0043065]; positive regulation of vascular smooth muscle cell proliferation [GO:1904707]; prostaglandin metabolic process [GO:0006693]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; thrombin-activated receptor signaling pathway [GO:0070493]; transforming growth factor beta receptor signaling pathway [GO:0007179]
CHOYP_LOC100642881.1.1|m.14183	897	4	4	5	10	13	3	0.748	0.748	2.1095	2.1095	0	0	0.557854	CHOYP_LOC100642881.1.1|m.14183	Q8NCN5	PDPR_HUMAN	46.51	860	441	12	29	883	17	862	0	746	1	Q8NCN5	PDPR_HUMAN	reviewed	"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)"	PDPR KIAA1990	Homo sapiens (Human)	879	regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]	GO:0004741				PF01266;PF16350;PF01571;PF08669;	mitochondrial matrix [GO:0005759]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; oxidoreductase activity [GO:0016491]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]
CHOYP_LOC100642881.1.1|m.14183	897	4	4	5	10	13	3	0.748	0.748	2.1095	2.1095	0	0	0.557854	CHOYP_LOC100642881.1.1|m.14183	Q8NCN5	PDPR_HUMAN	46.51	860	441	12	29	883	17	862	0	746	1	Q8NCN5	PDPR_HUMAN	reviewed	"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)"	PDPR KIAA1990	Homo sapiens (Human)	879	regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]	 GO:0005759				PF01266;PF16350;PF01571;PF08669;	mitochondrial matrix [GO:0005759]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; oxidoreductase activity [GO:0016491]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]
CHOYP_LOC100642881.1.1|m.14183	897	4	4	5	10	13	3	0.748	0.748	2.1095	2.1095	0	0	0.557854	CHOYP_LOC100642881.1.1|m.14183	Q8NCN5	PDPR_HUMAN	46.51	860	441	12	29	883	17	862	0	746	1	Q8NCN5	PDPR_HUMAN	reviewed	"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)"	PDPR KIAA1990	Homo sapiens (Human)	879	regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]	 GO:0010510				PF01266;PF16350;PF01571;PF08669;	mitochondrial matrix [GO:0005759]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; oxidoreductase activity [GO:0016491]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]
CHOYP_LOC100642881.1.1|m.14183	897	4	4	5	10	13	3	0.748	0.748	2.1095	2.1095	0	0	0.557854	CHOYP_LOC100642881.1.1|m.14183	Q8NCN5	PDPR_HUMAN	46.51	860	441	12	29	883	17	862	0	746	1	Q8NCN5	PDPR_HUMAN	reviewed	"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)"	PDPR KIAA1990	Homo sapiens (Human)	879	regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]	 GO:0016491				PF01266;PF16350;PF01571;PF08669;	mitochondrial matrix [GO:0005759]; [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO:0004741]; oxidoreductase activity [GO:0016491]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]
CHOYP_AGAP_AGAP005057.1.1|m.62428	325	0	0	2	3	4	5	1.2	1.2	2.1046	2.1046	0	0	0.557944	CHOYP_AGAP_AGAP005057.1.1|m.62428	Q60ZR7	RIC3_CAEBR	28.93	121	59	5	22	137	49	147	0.0000001	56.2	1	Q60ZR7	RIC3_CAEBR	reviewed	Resistance to inhibitors of cholinesterase protein 3	ric-3 CBG17683	Caenorhabditis briggsae	385	"positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"	GO:0005789				PF15361;	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; acetylcholine receptor binding [GO:0033130]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"
CHOYP_AGAP_AGAP005057.1.1|m.62428	325	0	0	2	3	4	5	1.2	1.2	2.1046	2.1046	0	0	0.557944	CHOYP_AGAP_AGAP005057.1.1|m.62428	Q60ZR7	RIC3_CAEBR	28.93	121	59	5	22	137	49	147	0.0000001	56.2	1	Q60ZR7	RIC3_CAEBR	reviewed	Resistance to inhibitors of cholinesterase protein 3	ric-3 CBG17683	Caenorhabditis briggsae	385	"positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"	 GO:0007271				PF15361;	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; acetylcholine receptor binding [GO:0033130]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"
CHOYP_AGAP_AGAP005057.1.1|m.62428	325	0	0	2	3	4	5	1.2	1.2	2.1046	2.1046	0	0	0.557944	CHOYP_AGAP_AGAP005057.1.1|m.62428	Q60ZR7	RIC3_CAEBR	28.93	121	59	5	22	137	49	147	0.0000001	56.2	1	Q60ZR7	RIC3_CAEBR	reviewed	Resistance to inhibitors of cholinesterase protein 3	ric-3 CBG17683	Caenorhabditis briggsae	385	"positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"	 GO:0016021				PF15361;	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; acetylcholine receptor binding [GO:0033130]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"
CHOYP_AGAP_AGAP005057.1.1|m.62428	325	0	0	2	3	4	5	1.2	1.2	2.1046	2.1046	0	0	0.557944	CHOYP_AGAP_AGAP005057.1.1|m.62428	Q60ZR7	RIC3_CAEBR	28.93	121	59	5	22	137	49	147	0.0000001	56.2	1	Q60ZR7	RIC3_CAEBR	reviewed	Resistance to inhibitors of cholinesterase protein 3	ric-3 CBG17683	Caenorhabditis briggsae	385	"positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"	 GO:0032224				PF15361;	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; acetylcholine receptor binding [GO:0033130]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"
CHOYP_AGAP_AGAP005057.1.1|m.62428	325	0	0	2	3	4	5	1.2	1.2	2.1046	2.1046	0	0	0.557944	CHOYP_AGAP_AGAP005057.1.1|m.62428	Q60ZR7	RIC3_CAEBR	28.93	121	59	5	22	137	49	147	0.0000001	56.2	1	Q60ZR7	RIC3_CAEBR	reviewed	Resistance to inhibitors of cholinesterase protein 3	ric-3 CBG17683	Caenorhabditis briggsae	385	"positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"	 GO:0033130				PF15361;	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; acetylcholine receptor binding [GO:0033130]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"
CHOYP_AGAP_AGAP005057.1.1|m.62428	325	0	0	2	3	4	5	1.2	1.2	2.1046	2.1046	0	0	0.557944	CHOYP_AGAP_AGAP005057.1.1|m.62428	Q60ZR7	RIC3_CAEBR	28.93	121	59	5	22	137	49	147	0.0000001	56.2	1	Q60ZR7	RIC3_CAEBR	reviewed	Resistance to inhibitors of cholinesterase protein 3	ric-3 CBG17683	Caenorhabditis briggsae	385	"positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"	 GO:0034394				PF15361;	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; acetylcholine receptor binding [GO:0033130]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"
CHOYP_AGAP_AGAP005057.1.1|m.62428	325	0	0	2	3	4	5	1.2	1.2	2.1046	2.1046	0	0	0.557944	CHOYP_AGAP_AGAP005057.1.1|m.62428	Q60ZR7	RIC3_CAEBR	28.93	121	59	5	22	137	49	147	0.0000001	56.2	1	Q60ZR7	RIC3_CAEBR	reviewed	Resistance to inhibitors of cholinesterase protein 3	ric-3 CBG17683	Caenorhabditis briggsae	385	"positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"	 GO:0043005				PF15361;	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; acetylcholine receptor binding [GO:0033130]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"
CHOYP_AGAP_AGAP005057.1.1|m.62428	325	0	0	2	3	4	5	1.2	1.2	2.1046	2.1046	0	0	0.557944	CHOYP_AGAP_AGAP005057.1.1|m.62428	Q60ZR7	RIC3_CAEBR	28.93	121	59	5	22	137	49	147	0.0000001	56.2	1	Q60ZR7	RIC3_CAEBR	reviewed	Resistance to inhibitors of cholinesterase protein 3	ric-3 CBG17683	Caenorhabditis briggsae	385	"positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"	 GO:0043025				PF15361;	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; acetylcholine receptor binding [GO:0033130]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"
CHOYP_AGAP_AGAP005057.1.1|m.62428	325	0	0	2	3	4	5	1.2	1.2	2.1046	2.1046	0	0	0.557944	CHOYP_AGAP_AGAP005057.1.1|m.62428	Q60ZR7	RIC3_CAEBR	28.93	121	59	5	22	137	49	147	0.0000001	56.2	1	Q60ZR7	RIC3_CAEBR	reviewed	Resistance to inhibitors of cholinesterase protein 3	ric-3 CBG17683	Caenorhabditis briggsae	385	"positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"	 GO:0043231				PF15361;	"endoplasmic reticulum membrane [GO:0005789]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; acetylcholine receptor binding [GO:0033130]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; protein localization to cell surface [GO:0034394]; synaptic transmission, cholinergic [GO:0007271]"
CHOYP_LOC101069440.3.3|m.28439	361	0	0	0	4	4	3	1.493	1.493	2.1041	2.1041	0	0	0.557953	CHOYP_LOC101069440.3.3|m.28439	O27273	COMC_METTH	37.32	351	195	11	8	352	3	334	5.00E-55	189	1	O27273	COMC_METTH	reviewed	L-sulfolactate dehydrogenase (EC 1.1.1.337) ((R)-sulfolactate dehydrogenase) (L-2-hydroxycarboxylate dehydrogenase (NAD(+)))	comC MTH_1205	Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H) (Methanobacterium thermoautotrophicum)	341	coenzyme M biosynthetic process [GO:0019295]	GO:0005737	"PATHWAY: Cofactor biosynthesis; coenzyme M biosynthesis; sulfoacetaldehyde from phosphoenolpyruvate and sulfite: step 3/4.; PATHWAY: Cofactor biosynthesis; 5,6,7,8-tetrahydromethanopterin biosynthesis."			PF02615;	cytoplasm [GO:0005737]; L-2-hydroxycarboxylate dehydrogenase (NAD+) activity [GO:0102443]; coenzyme M biosynthetic process [GO:0019295]
CHOYP_LOC101069440.3.3|m.28439	361	0	0	0	4	4	3	1.493	1.493	2.1041	2.1041	0	0	0.557953	CHOYP_LOC101069440.3.3|m.28439	O27273	COMC_METTH	37.32	351	195	11	8	352	3	334	5.00E-55	189	1	O27273	COMC_METTH	reviewed	L-sulfolactate dehydrogenase (EC 1.1.1.337) ((R)-sulfolactate dehydrogenase) (L-2-hydroxycarboxylate dehydrogenase (NAD(+)))	comC MTH_1205	Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H) (Methanobacterium thermoautotrophicum)	341	coenzyme M biosynthetic process [GO:0019295]	 GO:0019295	"PATHWAY: Cofactor biosynthesis; coenzyme M biosynthesis; sulfoacetaldehyde from phosphoenolpyruvate and sulfite: step 3/4.; PATHWAY: Cofactor biosynthesis; 5,6,7,8-tetrahydromethanopterin biosynthesis."			PF02615;	cytoplasm [GO:0005737]; L-2-hydroxycarboxylate dehydrogenase (NAD+) activity [GO:0102443]; coenzyme M biosynthetic process [GO:0019295]
CHOYP_LOC101069440.3.3|m.28439	361	0	0	0	4	4	3	1.493	1.493	2.1041	2.1041	0	0	0.557953	CHOYP_LOC101069440.3.3|m.28439	O27273	COMC_METTH	37.32	351	195	11	8	352	3	334	5.00E-55	189	1	O27273	COMC_METTH	reviewed	L-sulfolactate dehydrogenase (EC 1.1.1.337) ((R)-sulfolactate dehydrogenase) (L-2-hydroxycarboxylate dehydrogenase (NAD(+)))	comC MTH_1205	Methanothermobacter thermautotrophicus (strain ATCC 29096 / DSM 1053 / JCM 10044 / NBRC 100330 / Delta H) (Methanobacterium thermoautotrophicum)	341	coenzyme M biosynthetic process [GO:0019295]	 GO:0102443	"PATHWAY: Cofactor biosynthesis; coenzyme M biosynthesis; sulfoacetaldehyde from phosphoenolpyruvate and sulfite: step 3/4.; PATHWAY: Cofactor biosynthesis; 5,6,7,8-tetrahydromethanopterin biosynthesis."			PF02615;	cytoplasm [GO:0005737]; L-2-hydroxycarboxylate dehydrogenase (NAD+) activity [GO:0102443]; coenzyme M biosynthetic process [GO:0019295]
CHOYP_CPIPJ_CPIJ007723.3.4|m.30316	389	3	1	3	6	8	4	0.98	0.98	2.0979	2.0979	0	0	0.558068	CHOYP_CPIPJ_CPIJ007723.3.4|m.30316	Q6GL69	MK67I_XENTR	45.11	184	96	2	4	187	3	181	5.00E-46	165	1	Q6GL69	MK67I_XENTR	reviewed	MKI67 FHA domain-interacting nucleolar phosphoprotein-like	nifk mki67ipl	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	276	negative regulation of phosphatase activity [GO:0010923]	GO:0000166				PF12196;PF00076;	nucleolus [GO:0005730]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; negative regulation of phosphatase activity [GO:0010923]
CHOYP_CPIPJ_CPIJ007723.3.4|m.30316	389	3	1	3	6	8	4	0.98	0.98	2.0979	2.0979	0	0	0.558068	CHOYP_CPIPJ_CPIJ007723.3.4|m.30316	Q6GL69	MK67I_XENTR	45.11	184	96	2	4	187	3	181	5.00E-46	165	1	Q6GL69	MK67I_XENTR	reviewed	MKI67 FHA domain-interacting nucleolar phosphoprotein-like	nifk mki67ipl	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	276	negative regulation of phosphatase activity [GO:0010923]	 GO:0003723				PF12196;PF00076;	nucleolus [GO:0005730]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; negative regulation of phosphatase activity [GO:0010923]
CHOYP_CPIPJ_CPIJ007723.3.4|m.30316	389	3	1	3	6	8	4	0.98	0.98	2.0979	2.0979	0	0	0.558068	CHOYP_CPIPJ_CPIJ007723.3.4|m.30316	Q6GL69	MK67I_XENTR	45.11	184	96	2	4	187	3	181	5.00E-46	165	1	Q6GL69	MK67I_XENTR	reviewed	MKI67 FHA domain-interacting nucleolar phosphoprotein-like	nifk mki67ipl	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	276	negative regulation of phosphatase activity [GO:0010923]	 GO:0005730				PF12196;PF00076;	nucleolus [GO:0005730]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; negative regulation of phosphatase activity [GO:0010923]
CHOYP_CPIPJ_CPIJ007723.3.4|m.30316	389	3	1	3	6	8	4	0.98	0.98	2.0979	2.0979	0	0	0.558068	CHOYP_CPIPJ_CPIJ007723.3.4|m.30316	Q6GL69	MK67I_XENTR	45.11	184	96	2	4	187	3	181	5.00E-46	165	1	Q6GL69	MK67I_XENTR	reviewed	MKI67 FHA domain-interacting nucleolar phosphoprotein-like	nifk mki67ipl	Xenopus tropicalis (Western clawed frog) (Silurana tropicalis)	276	negative regulation of phosphatase activity [GO:0010923]	 GO:0010923				PF12196;PF00076;	nucleolus [GO:0005730]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; negative regulation of phosphatase activity [GO:0010923]
CHOYP_BRAFLDRAFT_57552.1.1|m.8199	862	2	2	2	2	10	4	1.03	1.03	2.0935	2.0935	0	0	0.558149	CHOYP_BRAFLDRAFT_57552.1.1|m.8199	Q9R1C7	PR40A_MOUSE	46.24	837	327	10	120	861	145	953	0	607	1	Q9R1C7	PR40A_MOUSE	reviewed	Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)	Prpf40a Fbp11 Fnbp3	Mus musculus (Mouse)	953	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	GO:0000398				PF01846;PF00397;	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
CHOYP_BRAFLDRAFT_57552.1.1|m.8199	862	2	2	2	2	10	4	1.03	1.03	2.0935	2.0935	0	0	0.558149	CHOYP_BRAFLDRAFT_57552.1.1|m.8199	Q9R1C7	PR40A_MOUSE	46.24	837	327	10	120	861	145	953	0	607	1	Q9R1C7	PR40A_MOUSE	reviewed	Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)	Prpf40a Fbp11 Fnbp3	Mus musculus (Mouse)	953	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	 GO:0003723				PF01846;PF00397;	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
CHOYP_BRAFLDRAFT_57552.1.1|m.8199	862	2	2	2	2	10	4	1.03	1.03	2.0935	2.0935	0	0	0.558149	CHOYP_BRAFLDRAFT_57552.1.1|m.8199	Q9R1C7	PR40A_MOUSE	46.24	837	327	10	120	861	145	953	0	607	1	Q9R1C7	PR40A_MOUSE	reviewed	Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)	Prpf40a Fbp11 Fnbp3	Mus musculus (Mouse)	953	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	 GO:0005634				PF01846;PF00397;	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
CHOYP_BRAFLDRAFT_57552.1.1|m.8199	862	2	2	2	2	10	4	1.03	1.03	2.0935	2.0935	0	0	0.558149	CHOYP_BRAFLDRAFT_57552.1.1|m.8199	Q9R1C7	PR40A_MOUSE	46.24	837	327	10	120	861	145	953	0	607	1	Q9R1C7	PR40A_MOUSE	reviewed	Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)	Prpf40a Fbp11 Fnbp3	Mus musculus (Mouse)	953	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	 GO:0005685				PF01846;PF00397;	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
CHOYP_BRAFLDRAFT_57552.1.1|m.8199	862	2	2	2	2	10	4	1.03	1.03	2.0935	2.0935	0	0	0.558149	CHOYP_BRAFLDRAFT_57552.1.1|m.8199	Q9R1C7	PR40A_MOUSE	46.24	837	327	10	120	861	145	953	0	607	1	Q9R1C7	PR40A_MOUSE	reviewed	Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)	Prpf40a Fbp11 Fnbp3	Mus musculus (Mouse)	953	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	 GO:0005829				PF01846;PF00397;	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
CHOYP_BRAFLDRAFT_57552.1.1|m.8199	862	2	2	2	2	10	4	1.03	1.03	2.0935	2.0935	0	0	0.558149	CHOYP_BRAFLDRAFT_57552.1.1|m.8199	Q9R1C7	PR40A_MOUSE	46.24	837	327	10	120	861	145	953	0	607	1	Q9R1C7	PR40A_MOUSE	reviewed	Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)	Prpf40a Fbp11 Fnbp3	Mus musculus (Mouse)	953	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	 GO:0007010				PF01846;PF00397;	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
CHOYP_BRAFLDRAFT_57552.1.1|m.8199	862	2	2	2	2	10	4	1.03	1.03	2.0935	2.0935	0	0	0.558149	CHOYP_BRAFLDRAFT_57552.1.1|m.8199	Q9R1C7	PR40A_MOUSE	46.24	837	327	10	120	861	145	953	0	607	1	Q9R1C7	PR40A_MOUSE	reviewed	Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)	Prpf40a Fbp11 Fnbp3	Mus musculus (Mouse)	953	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	 GO:0008360				PF01846;PF00397;	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
CHOYP_BRAFLDRAFT_57552.1.1|m.8199	862	2	2	2	2	10	4	1.03	1.03	2.0935	2.0935	0	0	0.558149	CHOYP_BRAFLDRAFT_57552.1.1|m.8199	Q9R1C7	PR40A_MOUSE	46.24	837	327	10	120	861	145	953	0	607	1	Q9R1C7	PR40A_MOUSE	reviewed	Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)	Prpf40a Fbp11 Fnbp3	Mus musculus (Mouse)	953	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	 GO:0016020				PF01846;PF00397;	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
CHOYP_BRAFLDRAFT_57552.1.1|m.8199	862	2	2	2	2	10	4	1.03	1.03	2.0935	2.0935	0	0	0.558149	CHOYP_BRAFLDRAFT_57552.1.1|m.8199	Q9R1C7	PR40A_MOUSE	46.24	837	327	10	120	861	145	953	0	607	1	Q9R1C7	PR40A_MOUSE	reviewed	Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)	Prpf40a Fbp11 Fnbp3	Mus musculus (Mouse)	953	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	 GO:0016363				PF01846;PF00397;	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
CHOYP_BRAFLDRAFT_57552.1.1|m.8199	862	2	2	2	2	10	4	1.03	1.03	2.0935	2.0935	0	0	0.558149	CHOYP_BRAFLDRAFT_57552.1.1|m.8199	Q9R1C7	PR40A_MOUSE	46.24	837	327	10	120	861	145	953	0	607	1	Q9R1C7	PR40A_MOUSE	reviewed	Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)	Prpf40a Fbp11 Fnbp3	Mus musculus (Mouse)	953	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	 GO:0016477				PF01846;PF00397;	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
CHOYP_BRAFLDRAFT_57552.1.1|m.8199	862	2	2	2	2	10	4	1.03	1.03	2.0935	2.0935	0	0	0.558149	CHOYP_BRAFLDRAFT_57552.1.1|m.8199	Q9R1C7	PR40A_MOUSE	46.24	837	327	10	120	861	145	953	0	607	1	Q9R1C7	PR40A_MOUSE	reviewed	Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)	Prpf40a Fbp11 Fnbp3	Mus musculus (Mouse)	953	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	 GO:0016607				PF01846;PF00397;	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
CHOYP_BRAFLDRAFT_57552.1.1|m.8199	862	2	2	2	2	10	4	1.03	1.03	2.0935	2.0935	0	0	0.558149	CHOYP_BRAFLDRAFT_57552.1.1|m.8199	Q9R1C7	PR40A_MOUSE	46.24	837	327	10	120	861	145	953	0	607	1	Q9R1C7	PR40A_MOUSE	reviewed	Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)	Prpf40a Fbp11 Fnbp3	Mus musculus (Mouse)	953	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	 GO:0032465				PF01846;PF00397;	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
CHOYP_BRAFLDRAFT_57552.1.1|m.8199	862	2	2	2	2	10	4	1.03	1.03	2.0935	2.0935	0	0	0.558149	CHOYP_BRAFLDRAFT_57552.1.1|m.8199	Q9R1C7	PR40A_MOUSE	46.24	837	327	10	120	861	145	953	0	607	1	Q9R1C7	PR40A_MOUSE	reviewed	Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)	Prpf40a Fbp11 Fnbp3	Mus musculus (Mouse)	953	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	 GO:0070064				PF01846;PF00397;	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
CHOYP_BRAFLDRAFT_57552.1.1|m.8199	862	2	2	2	2	10	4	1.03	1.03	2.0935	2.0935	0	0	0.558149	CHOYP_BRAFLDRAFT_57552.1.1|m.8199	Q9R1C7	PR40A_MOUSE	46.24	837	327	10	120	861	145	953	0	607	1	Q9R1C7	PR40A_MOUSE	reviewed	Pre-mRNA-processing factor 40 homolog A (Formin-binding protein 11) (FBP-11) (Formin-binding protein 3)	Prpf40a Fbp11 Fnbp3	Mus musculus (Mouse)	953	"cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"	 GO:0071004				PF01846;PF00397;	"cytosol [GO:0005829]; membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004]; proline-rich region binding [GO:0070064]; RNA binding [GO:0003723]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]"
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	GO:0004872				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0005246				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0005886				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0005887				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0007158				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0007269				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0007411				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0007416				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0007612				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0030534				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0035176				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0043234				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0046872				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0050839				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0051965				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0071625				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0090129				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0097109				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC100720440.1.2|m.11473	1137	7	8	11	13	13	15	0.508	0.508	2.0933	2.0933	0	0	0.558153	CHOYP_LOC100720440.1.2|m.11473	Q9Y4C0	NRX3A_HUMAN	26.44	329	184	14	827	1135	251	541	4.00E-13	78.2	1	Q9Y4C0	NRX3A_HUMAN	reviewed	Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha)	NRXN3 C14orf60 KIAA0743	Homo sapiens (Human)	1643	adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]	 GO:0098793				PF00008;PF02210;PF01034;	integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; protein complex [GO:0043234]; calcium channel regulator activity [GO:0005246]; cell adhesion molecule binding [GO:0050839]; metal ion binding [GO:0046872]; neuroligin family protein binding [GO:0097109]; receptor activity [GO:0004872]; adult behavior [GO:0030534]; axon guidance [GO:0007411]; learning [GO:0007612]; neuron cell-cell adhesion [GO:0007158]; neurotransmitter secretion [GO:0007269]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synapse maturation [GO:0090129]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625]
CHOYP_LOC564392.1.1|m.29701	441	0	2	0	3	3	6	1.217	1.217	2.0885	2.0885	0	0	0.558243	CHOYP_LOC564392.1.1|m.29701	Q92485	ASM3B_HUMAN	36.8	413	246	6	24	425	21	429	4.00E-91	290	1	Q92485	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B	Homo sapiens (Human)	455	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]	GO:0004767				PF00149;	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
CHOYP_LOC564392.1.1|m.29701	441	0	2	0	3	3	6	1.217	1.217	2.0885	2.0885	0	0	0.558243	CHOYP_LOC564392.1.1|m.29701	Q92485	ASM3B_HUMAN	36.8	413	246	6	24	425	21	429	4.00E-91	290	1	Q92485	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B	Homo sapiens (Human)	455	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]	 GO:0005615				PF00149;	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
CHOYP_LOC564392.1.1|m.29701	441	0	2	0	3	3	6	1.217	1.217	2.0885	2.0885	0	0	0.558243	CHOYP_LOC564392.1.1|m.29701	Q92485	ASM3B_HUMAN	36.8	413	246	6	24	425	21	429	4.00E-91	290	1	Q92485	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B	Homo sapiens (Human)	455	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]	 GO:0005886				PF00149;	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
CHOYP_LOC564392.1.1|m.29701	441	0	2	0	3	3	6	1.217	1.217	2.0885	2.0885	0	0	0.558243	CHOYP_LOC564392.1.1|m.29701	Q92485	ASM3B_HUMAN	36.8	413	246	6	24	425	21	429	4.00E-91	290	1	Q92485	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B	Homo sapiens (Human)	455	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]	 GO:0006685				PF00149;	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
CHOYP_LOC564392.1.1|m.29701	441	0	2	0	3	3	6	1.217	1.217	2.0885	2.0885	0	0	0.558243	CHOYP_LOC564392.1.1|m.29701	Q92485	ASM3B_HUMAN	36.8	413	246	6	24	425	21	429	4.00E-91	290	1	Q92485	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B	Homo sapiens (Human)	455	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]	 GO:0006954				PF00149;	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
CHOYP_LOC564392.1.1|m.29701	441	0	2	0	3	3	6	1.217	1.217	2.0885	2.0885	0	0	0.558243	CHOYP_LOC564392.1.1|m.29701	Q92485	ASM3B_HUMAN	36.8	413	246	6	24	425	21	429	4.00E-91	290	1	Q92485	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B	Homo sapiens (Human)	455	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]	 GO:0008081				PF00149;	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
CHOYP_LOC564392.1.1|m.29701	441	0	2	0	3	3	6	1.217	1.217	2.0885	2.0885	0	0	0.558243	CHOYP_LOC564392.1.1|m.29701	Q92485	ASM3B_HUMAN	36.8	413	246	6	24	425	21	429	4.00E-91	290	1	Q92485	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B	Homo sapiens (Human)	455	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]	 GO:0016798				PF00149;	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
CHOYP_LOC564392.1.1|m.29701	441	0	2	0	3	3	6	1.217	1.217	2.0885	2.0885	0	0	0.558243	CHOYP_LOC564392.1.1|m.29701	Q92485	ASM3B_HUMAN	36.8	413	246	6	24	425	21	429	4.00E-91	290	1	Q92485	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B	Homo sapiens (Human)	455	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]	 GO:0031225				PF00149;	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
CHOYP_LOC564392.1.1|m.29701	441	0	2	0	3	3	6	1.217	1.217	2.0885	2.0885	0	0	0.558243	CHOYP_LOC564392.1.1|m.29701	Q92485	ASM3B_HUMAN	36.8	413	246	6	24	425	21	429	4.00E-91	290	1	Q92485	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B	Homo sapiens (Human)	455	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]	 GO:0034122				PF00149;	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
CHOYP_LOC564392.1.1|m.29701	441	0	2	0	3	3	6	1.217	1.217	2.0885	2.0885	0	0	0.558243	CHOYP_LOC564392.1.1|m.29701	Q92485	ASM3B_HUMAN	36.8	413	246	6	24	425	21	429	4.00E-91	290	1	Q92485	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B	Homo sapiens (Human)	455	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]	 GO:0045087				PF00149;	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
CHOYP_LOC564392.1.1|m.29701	441	0	2	0	3	3	6	1.217	1.217	2.0885	2.0885	0	0	0.558243	CHOYP_LOC564392.1.1|m.29701	Q92485	ASM3B_HUMAN	36.8	413	246	6	24	425	21	429	4.00E-91	290	1	Q92485	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B	Homo sapiens (Human)	455	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]	 GO:0046466				PF00149;	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
CHOYP_LOC564392.1.1|m.29701	441	0	2	0	3	3	6	1.217	1.217	2.0885	2.0885	0	0	0.558243	CHOYP_LOC564392.1.1|m.29701	Q92485	ASM3B_HUMAN	36.8	413	246	6	24	425	21	429	4.00E-91	290	1	Q92485	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B	Homo sapiens (Human)	455	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]	 GO:0046872				PF00149;	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
CHOYP_LOC564392.1.1|m.29701	441	0	2	0	3	3	6	1.217	1.217	2.0885	2.0885	0	0	0.558243	CHOYP_LOC564392.1.1|m.29701	Q92485	ASM3B_HUMAN	36.8	413	246	6	24	425	21	429	4.00E-91	290	1	Q92485	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B	Homo sapiens (Human)	455	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]	 GO:0050728				PF00149;	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
CHOYP_LOC564392.1.1|m.29701	441	0	2	0	3	3	6	1.217	1.217	2.0885	2.0885	0	0	0.558243	CHOYP_LOC564392.1.1|m.29701	Q92485	ASM3B_HUMAN	36.8	413	246	6	24	425	21	429	4.00E-91	290	1	Q92485	ASM3B_HUMAN	reviewed	Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-)	SMPDL3B ASML3B	Homo sapiens (Human)	455	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]	 GO:0070062				PF00149;	"anchored component of membrane [GO:0031225]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; hydrolase activity, acting on glycosyl bonds [GO:0016798]; metal ion binding [GO:0046872]; phosphoric diester hydrolase activity [GO:0008081]; sphingomyelin phosphodiesterase activity [GO:0004767]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; membrane lipid catabolic process [GO:0046466]; negative regulation of inflammatory response [GO:0050728]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; sphingomyelin catabolic process [GO:0006685]"
CHOYP_BRAFLDRAFT_226345.1.1|m.55555	674	9	3	7	11	11	12	0.626	0.626	2.0802	2.0802	0	0	0.558399	CHOYP_BRAFLDRAFT_226345.1.1|m.55555	Q9BXB4	OSB11_HUMAN	48.99	690	312	11	3	666	63	738	0	644	1	Q9BXB4	OSB11_HUMAN	reviewed	Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11)	OSBPL11 ORP11 OSBP12	Homo sapiens (Human)	747	fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]	GO:0005654				PF01237;PF00169;	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]
CHOYP_BRAFLDRAFT_226345.1.1|m.55555	674	9	3	7	11	11	12	0.626	0.626	2.0802	2.0802	0	0	0.558399	CHOYP_BRAFLDRAFT_226345.1.1|m.55555	Q9BXB4	OSB11_HUMAN	48.99	690	312	11	3	666	63	738	0	644	1	Q9BXB4	OSB11_HUMAN	reviewed	Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11)	OSBPL11 ORP11 OSBP12	Homo sapiens (Human)	747	fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]	 GO:0005794				PF01237;PF00169;	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]
CHOYP_BRAFLDRAFT_226345.1.1|m.55555	674	9	3	7	11	11	12	0.626	0.626	2.0802	2.0802	0	0	0.558399	CHOYP_BRAFLDRAFT_226345.1.1|m.55555	Q9BXB4	OSB11_HUMAN	48.99	690	312	11	3	666	63	738	0	644	1	Q9BXB4	OSB11_HUMAN	reviewed	Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11)	OSBPL11 ORP11 OSBP12	Homo sapiens (Human)	747	fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]	 GO:0006869				PF01237;PF00169;	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]
CHOYP_BRAFLDRAFT_226345.1.1|m.55555	674	9	3	7	11	11	12	0.626	0.626	2.0802	2.0802	0	0	0.558399	CHOYP_BRAFLDRAFT_226345.1.1|m.55555	Q9BXB4	OSB11_HUMAN	48.99	690	312	11	3	666	63	738	0	644	1	Q9BXB4	OSB11_HUMAN	reviewed	Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11)	OSBPL11 ORP11 OSBP12	Homo sapiens (Human)	747	fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]	 GO:0008289				PF01237;PF00169;	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]
CHOYP_BRAFLDRAFT_226345.1.1|m.55555	674	9	3	7	11	11	12	0.626	0.626	2.0802	2.0802	0	0	0.558399	CHOYP_BRAFLDRAFT_226345.1.1|m.55555	Q9BXB4	OSB11_HUMAN	48.99	690	312	11	3	666	63	738	0	644	1	Q9BXB4	OSB11_HUMAN	reviewed	Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11)	OSBPL11 ORP11 OSBP12	Homo sapiens (Human)	747	fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]	 GO:0010890				PF01237;PF00169;	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]
CHOYP_BRAFLDRAFT_226345.1.1|m.55555	674	9	3	7	11	11	12	0.626	0.626	2.0802	2.0802	0	0	0.558399	CHOYP_BRAFLDRAFT_226345.1.1|m.55555	Q9BXB4	OSB11_HUMAN	48.99	690	312	11	3	666	63	738	0	644	1	Q9BXB4	OSB11_HUMAN	reviewed	Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11)	OSBPL11 ORP11 OSBP12	Homo sapiens (Human)	747	fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]	 GO:0031902				PF01237;PF00169;	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]
CHOYP_BRAFLDRAFT_226345.1.1|m.55555	674	9	3	7	11	11	12	0.626	0.626	2.0802	2.0802	0	0	0.558399	CHOYP_BRAFLDRAFT_226345.1.1|m.55555	Q9BXB4	OSB11_HUMAN	48.99	690	312	11	3	666	63	738	0	644	1	Q9BXB4	OSB11_HUMAN	reviewed	Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11)	OSBPL11 ORP11 OSBP12	Homo sapiens (Human)	747	fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]	 GO:0045444				PF01237;PF00169;	Golgi apparatus [GO:0005794]; late endosome membrane [GO:0031902]; nucleoplasm [GO:0005654]; lipid binding [GO:0008289]; fat cell differentiation [GO:0045444]; lipid transport [GO:0006869]; positive regulation of sequestering of triglyceride [GO:0010890]
CHOYP_LOC100377864.1.1|m.33298	417	1	0	1	5	4	2	1.435	1.435	2.0784	2.0784	0	0	0.558433																												
CHOYP_contig_028345|m.32285	1106	2	0	0	5	4	3	1.264	1.264	2.0778	2.0778	0	0	0.558445																												
CHOYP_AAEL_AAEL008069.1.2|m.58164	583	6	7	11	8	15	17	0.553	0.553	2.0709	2.0709	0	0	0.558576	CHOYP_AAEL_AAEL008069.1.2|m.58164	P0C6B8	SVEP1_RAT	29.22	551	288	19	28	543	932	1415	3.00E-38	156	1	P0C6B8	SVEP1_RAT	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	Svep1	Rattus norvegicus (Rat)	3564	cell adhesion [GO:0007155]	GO:0005509			cd00033;cd00152;	PF00008;PF07645;PF07699;PF02494;PF00354;PF00084;PF00092;	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]
CHOYP_AAEL_AAEL008069.1.2|m.58164	583	6	7	11	8	15	17	0.553	0.553	2.0709	2.0709	0	0	0.558576	CHOYP_AAEL_AAEL008069.1.2|m.58164	P0C6B8	SVEP1_RAT	29.22	551	288	19	28	543	932	1415	3.00E-38	156	1	P0C6B8	SVEP1_RAT	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	Svep1	Rattus norvegicus (Rat)	3564	cell adhesion [GO:0007155]	 GO:0005576			cd00033;cd00152;	PF00008;PF07645;PF07699;PF02494;PF00354;PF00084;PF00092;	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]
CHOYP_AAEL_AAEL008069.1.2|m.58164	583	6	7	11	8	15	17	0.553	0.553	2.0709	2.0709	0	0	0.558576	CHOYP_AAEL_AAEL008069.1.2|m.58164	P0C6B8	SVEP1_RAT	29.22	551	288	19	28	543	932	1415	3.00E-38	156	1	P0C6B8	SVEP1_RAT	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	Svep1	Rattus norvegicus (Rat)	3564	cell adhesion [GO:0007155]	 GO:0005737			cd00033;cd00152;	PF00008;PF07645;PF07699;PF02494;PF00354;PF00084;PF00092;	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]
CHOYP_AAEL_AAEL008069.1.2|m.58164	583	6	7	11	8	15	17	0.553	0.553	2.0709	2.0709	0	0	0.558576	CHOYP_AAEL_AAEL008069.1.2|m.58164	P0C6B8	SVEP1_RAT	29.22	551	288	19	28	543	932	1415	3.00E-38	156	1	P0C6B8	SVEP1_RAT	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	Svep1	Rattus norvegicus (Rat)	3564	cell adhesion [GO:0007155]	 GO:0007155			cd00033;cd00152;	PF00008;PF07645;PF07699;PF02494;PF00354;PF00084;PF00092;	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]
CHOYP_AAEL_AAEL008069.1.2|m.58164	583	6	7	11	8	15	17	0.553	0.553	2.0709	2.0709	0	0	0.558576	CHOYP_AAEL_AAEL008069.1.2|m.58164	P0C6B8	SVEP1_RAT	29.22	551	288	19	28	543	932	1415	3.00E-38	156	1	P0C6B8	SVEP1_RAT	reviewed	"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1"	Svep1	Rattus norvegicus (Rat)	3564	cell adhesion [GO:0007155]	 GO:0016020			cd00033;cd00152;	PF00008;PF07645;PF07699;PF02494;PF00354;PF00084;PF00092;	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; membrane [GO:0016020]; calcium ion binding [GO:0005509]; cell adhesion [GO:0007155]
CHOYP_ECD.1.1|m.61798	550	2	1	5	6	5	6	0.799	0.799	2.0654	2.0654	0	0	0.558681	CHOYP_ECD.1.1|m.61798	O95905	ECD_HUMAN	39.39	495	277	8	11	495	160	641	1.00E-110	350	1	O95905	ECD_HUMAN	reviewed	Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)	ECD	Homo sapiens (Human)	644	cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	GO:0003713				PF07093;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]
CHOYP_ECD.1.1|m.61798	550	2	1	5	6	5	6	0.799	0.799	2.0654	2.0654	0	0	0.558681	CHOYP_ECD.1.1|m.61798	O95905	ECD_HUMAN	39.39	495	277	8	11	495	160	641	1.00E-110	350	1	O95905	ECD_HUMAN	reviewed	Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)	ECD	Homo sapiens (Human)	644	cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	 GO:0005634				PF07093;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]
CHOYP_ECD.1.1|m.61798	550	2	1	5	6	5	6	0.799	0.799	2.0654	2.0654	0	0	0.558681	CHOYP_ECD.1.1|m.61798	O95905	ECD_HUMAN	39.39	495	277	8	11	495	160	641	1.00E-110	350	1	O95905	ECD_HUMAN	reviewed	Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)	ECD	Homo sapiens (Human)	644	cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	 GO:0005654				PF07093;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]
CHOYP_ECD.1.1|m.61798	550	2	1	5	6	5	6	0.799	0.799	2.0654	2.0654	0	0	0.558681	CHOYP_ECD.1.1|m.61798	O95905	ECD_HUMAN	39.39	495	277	8	11	495	160	641	1.00E-110	350	1	O95905	ECD_HUMAN	reviewed	Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)	ECD	Homo sapiens (Human)	644	cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	 GO:0005737				PF07093;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]
CHOYP_ECD.1.1|m.61798	550	2	1	5	6	5	6	0.799	0.799	2.0654	2.0654	0	0	0.558681	CHOYP_ECD.1.1|m.61798	O95905	ECD_HUMAN	39.39	495	277	8	11	495	160	641	1.00E-110	350	1	O95905	ECD_HUMAN	reviewed	Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)	ECD	Homo sapiens (Human)	644	cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	 GO:0005829				PF07093;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]
CHOYP_ECD.1.1|m.61798	550	2	1	5	6	5	6	0.799	0.799	2.0654	2.0654	0	0	0.558681	CHOYP_ECD.1.1|m.61798	O95905	ECD_HUMAN	39.39	495	277	8	11	495	160	641	1.00E-110	350	1	O95905	ECD_HUMAN	reviewed	Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)	ECD	Homo sapiens (Human)	644	cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	 GO:0006110				PF07093;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]
CHOYP_ECD.1.1|m.61798	550	2	1	5	6	5	6	0.799	0.799	2.0654	2.0654	0	0	0.558681	CHOYP_ECD.1.1|m.61798	O95905	ECD_HUMAN	39.39	495	277	8	11	495	160	641	1.00E-110	350	1	O95905	ECD_HUMAN	reviewed	Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)	ECD	Homo sapiens (Human)	644	cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	 GO:0006366				PF07093;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]
CHOYP_ECD.1.1|m.61798	550	2	1	5	6	5	6	0.799	0.799	2.0654	2.0654	0	0	0.558681	CHOYP_ECD.1.1|m.61798	O95905	ECD_HUMAN	39.39	495	277	8	11	495	160	641	1.00E-110	350	1	O95905	ECD_HUMAN	reviewed	Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)	ECD	Homo sapiens (Human)	644	cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	 GO:0006397				PF07093;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]
CHOYP_ECD.1.1|m.61798	550	2	1	5	6	5	6	0.799	0.799	2.0654	2.0654	0	0	0.558681	CHOYP_ECD.1.1|m.61798	O95905	ECD_HUMAN	39.39	495	277	8	11	495	160	641	1.00E-110	350	1	O95905	ECD_HUMAN	reviewed	Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)	ECD	Homo sapiens (Human)	644	cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	 GO:0008283				PF07093;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]
CHOYP_ECD.1.1|m.61798	550	2	1	5	6	5	6	0.799	0.799	2.0654	2.0654	0	0	0.558681	CHOYP_ECD.1.1|m.61798	O95905	ECD_HUMAN	39.39	495	277	8	11	495	160	641	1.00E-110	350	1	O95905	ECD_HUMAN	reviewed	Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)	ECD	Homo sapiens (Human)	644	cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	 GO:0008380				PF07093;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]
CHOYP_ECD.1.1|m.61798	550	2	1	5	6	5	6	0.799	0.799	2.0654	2.0654	0	0	0.558681	CHOYP_ECD.1.1|m.61798	O95905	ECD_HUMAN	39.39	495	277	8	11	495	160	641	1.00E-110	350	1	O95905	ECD_HUMAN	reviewed	Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)	ECD	Homo sapiens (Human)	644	cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	 GO:0035035				PF07093;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]
CHOYP_ECD.1.1|m.61798	550	2	1	5	6	5	6	0.799	0.799	2.0654	2.0654	0	0	0.558681	CHOYP_ECD.1.1|m.61798	O95905	ECD_HUMAN	39.39	495	277	8	11	495	160	641	1.00E-110	350	1	O95905	ECD_HUMAN	reviewed	Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)	ECD	Homo sapiens (Human)	644	cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	 GO:0045944				PF07093;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]
CHOYP_ECD.1.1|m.61798	550	2	1	5	6	5	6	0.799	0.799	2.0654	2.0654	0	0	0.558681	CHOYP_ECD.1.1|m.61798	O95905	ECD_HUMAN	39.39	495	277	8	11	495	160	641	1.00E-110	350	1	O95905	ECD_HUMAN	reviewed	Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1)	ECD	Homo sapiens (Human)	644	cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]	 GO:2000045				PF07093;	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; histone acetyltransferase binding [GO:0035035]; transcription coactivator activity [GO:0003713]; cell proliferation [GO:0008283]; mRNA processing [GO:0006397]; positive regulation of transcription from RNA polymerase II promoter [GO:0045944]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glycolytic process [GO:0006110]; RNA splicing [GO:0008380]; transcription from RNA polymerase II promoter [GO:0006366]
CHOYP_DCDC2.3.7|m.36589	714	3	1	4	4	9	5	0.878	0.878	2.0563	2.0563	0	0	0.558857	CHOYP_DCDC2.3.7|m.36589	A2VCK2	DCD2B_HUMAN	24.79	351	228	9	20	369	11	326	6.00E-18	89.4	1	A2VCK2	DCD2B_HUMAN	reviewed	Doublecortin domain-containing protein 2B	DCDC2B	Homo sapiens (Human)	349	intracellular signal transduction [GO:0035556]	GO:0005622			cd01617;	PF03607;	intracellular [GO:0005622]; intracellular signal transduction [GO:0035556]
CHOYP_DCDC2.3.7|m.36589	714	3	1	4	4	9	5	0.878	0.878	2.0563	2.0563	0	0	0.558857	CHOYP_DCDC2.3.7|m.36589	A2VCK2	DCD2B_HUMAN	24.79	351	228	9	20	369	11	326	6.00E-18	89.4	1	A2VCK2	DCD2B_HUMAN	reviewed	Doublecortin domain-containing protein 2B	DCDC2B	Homo sapiens (Human)	349	intracellular signal transduction [GO:0035556]	 GO:0035556			cd01617;	PF03607;	intracellular [GO:0005622]; intracellular signal transduction [GO:0035556]
CHOYP_C1QL4L.6.7|m.26358	361	0	2	1	4	5	3	1.228	1.228	2.048	2.048	0	0	0.559019																												
CHOYP_BRAFLDRAFT_60200.1.3|m.22202	219	7	7	8	11	13	13	0.559	0.559	2.0283	2.0283	0	0	0.559408	CHOYP_BRAFLDRAFT_60200.1.3|m.22202	Q8NC51	PAIRB_HUMAN	33.92	227	113	6	5	198	9	231	1.00E-11	66.6	1	Q8NC51	PAIRB_HUMAN	reviewed	Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1)	SERBP1 PAIRBP1 CGI-55	Homo sapiens (Human)	408	regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]	GO:0003723				PF04774;PF16174;	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]
CHOYP_BRAFLDRAFT_60200.1.3|m.22202	219	7	7	8	11	13	13	0.559	0.559	2.0283	2.0283	0	0	0.559408	CHOYP_BRAFLDRAFT_60200.1.3|m.22202	Q8NC51	PAIRB_HUMAN	33.92	227	113	6	5	198	9	231	1.00E-11	66.6	1	Q8NC51	PAIRB_HUMAN	reviewed	Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1)	SERBP1 PAIRBP1 CGI-55	Homo sapiens (Human)	408	regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]	 GO:0003730				PF04774;PF16174;	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]
CHOYP_BRAFLDRAFT_60200.1.3|m.22202	219	7	7	8	11	13	13	0.559	0.559	2.0283	2.0283	0	0	0.559408	CHOYP_BRAFLDRAFT_60200.1.3|m.22202	Q8NC51	PAIRB_HUMAN	33.92	227	113	6	5	198	9	231	1.00E-11	66.6	1	Q8NC51	PAIRB_HUMAN	reviewed	Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1)	SERBP1 PAIRBP1 CGI-55	Homo sapiens (Human)	408	regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]	 GO:0005634				PF04774;PF16174;	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]
CHOYP_BRAFLDRAFT_60200.1.3|m.22202	219	7	7	8	11	13	13	0.559	0.559	2.0283	2.0283	0	0	0.559408	CHOYP_BRAFLDRAFT_60200.1.3|m.22202	Q8NC51	PAIRB_HUMAN	33.92	227	113	6	5	198	9	231	1.00E-11	66.6	1	Q8NC51	PAIRB_HUMAN	reviewed	Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1)	SERBP1 PAIRBP1 CGI-55	Homo sapiens (Human)	408	regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]	 GO:0005829				PF04774;PF16174;	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]
CHOYP_BRAFLDRAFT_60200.1.3|m.22202	219	7	7	8	11	13	13	0.559	0.559	2.0283	2.0283	0	0	0.559408	CHOYP_BRAFLDRAFT_60200.1.3|m.22202	Q8NC51	PAIRB_HUMAN	33.92	227	113	6	5	198	9	231	1.00E-11	66.6	1	Q8NC51	PAIRB_HUMAN	reviewed	Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1)	SERBP1 PAIRBP1 CGI-55	Homo sapiens (Human)	408	regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]	 GO:0005886				PF04774;PF16174;	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]
CHOYP_BRAFLDRAFT_60200.1.3|m.22202	219	7	7	8	11	13	13	0.559	0.559	2.0283	2.0283	0	0	0.559408	CHOYP_BRAFLDRAFT_60200.1.3|m.22202	Q8NC51	PAIRB_HUMAN	33.92	227	113	6	5	198	9	231	1.00E-11	66.6	1	Q8NC51	PAIRB_HUMAN	reviewed	Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1)	SERBP1 PAIRBP1 CGI-55	Homo sapiens (Human)	408	regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]	 GO:0016020				PF04774;PF16174;	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]
CHOYP_BRAFLDRAFT_60200.1.3|m.22202	219	7	7	8	11	13	13	0.559	0.559	2.0283	2.0283	0	0	0.559408	CHOYP_BRAFLDRAFT_60200.1.3|m.22202	Q8NC51	PAIRB_HUMAN	33.92	227	113	6	5	198	9	231	1.00E-11	66.6	1	Q8NC51	PAIRB_HUMAN	reviewed	Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1)	SERBP1 PAIRBP1 CGI-55	Homo sapiens (Human)	408	regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]	 GO:0042981				PF04774;PF16174;	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]
CHOYP_BRAFLDRAFT_60200.1.3|m.22202	219	7	7	8	11	13	13	0.559	0.559	2.0283	2.0283	0	0	0.559408	CHOYP_BRAFLDRAFT_60200.1.3|m.22202	Q8NC51	PAIRB_HUMAN	33.92	227	113	6	5	198	9	231	1.00E-11	66.6	1	Q8NC51	PAIRB_HUMAN	reviewed	Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1)	SERBP1 PAIRBP1 CGI-55	Homo sapiens (Human)	408	regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]	 GO:0043488				PF04774;PF16174;	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]
CHOYP_BRAFLDRAFT_60200.1.3|m.22202	219	7	7	8	11	13	13	0.559	0.559	2.0283	2.0283	0	0	0.559408	CHOYP_BRAFLDRAFT_60200.1.3|m.22202	Q8NC51	PAIRB_HUMAN	33.92	227	113	6	5	198	9	231	1.00E-11	66.6	1	Q8NC51	PAIRB_HUMAN	reviewed	Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1)	SERBP1 PAIRBP1 CGI-55	Homo sapiens (Human)	408	regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]	 GO:0045296				PF04774;PF16174;	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]
CHOYP_BRAFLDRAFT_60200.1.3|m.22202	219	7	7	8	11	13	13	0.559	0.559	2.0283	2.0283	0	0	0.559408	CHOYP_BRAFLDRAFT_60200.1.3|m.22202	Q8NC51	PAIRB_HUMAN	33.92	227	113	6	5	198	9	231	1.00E-11	66.6	1	Q8NC51	PAIRB_HUMAN	reviewed	Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1)	SERBP1 PAIRBP1 CGI-55	Homo sapiens (Human)	408	regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]	 GO:0048471				PF04774;PF16174;	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]
CHOYP_BRAFLDRAFT_60200.1.3|m.22202	219	7	7	8	11	13	13	0.559	0.559	2.0283	2.0283	0	0	0.559408	CHOYP_BRAFLDRAFT_60200.1.3|m.22202	Q8NC51	PAIRB_HUMAN	33.92	227	113	6	5	198	9	231	1.00E-11	66.6	1	Q8NC51	PAIRB_HUMAN	reviewed	Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1)	SERBP1 PAIRBP1 CGI-55	Homo sapiens (Human)	408	regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]	 GO:0070062				PF04774;PF16174;	cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; cadherin binding [GO:0045296]; mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]
CHOYP_contig_024742|m.28122	463	4	1	5	9	8	3	0.766	0.766	2.017	2.017	0	0	0.559635																												
CHOYP_LOC100535716.2.3|m.39162	470	13	2	7	11	13	13	0.545	0.545	2.0095	2.0095	0	0	0.559787	CHOYP_LOC100535716.2.3|m.39162	P33005	KALM_CHICK	50.94	53	24	1	163	213	115	167	7.00E-10	65.1	1	P33005	KALM_CHICK	reviewed	Anosmin-1 (Kallmann syndrome protein homolog)	ANOS1 KAL KAL1	Gallus gallus (Chicken)	675	cell adhesion [GO:0007155]	GO:0004867			cd00063;	PF00041;PF00095;	cell surface [GO:0009986]; extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC100535716.2.3|m.39162	470	13	2	7	11	13	13	0.545	0.545	2.0095	2.0095	0	0	0.559787	CHOYP_LOC100535716.2.3|m.39162	P33005	KALM_CHICK	50.94	53	24	1	163	213	115	167	7.00E-10	65.1	1	P33005	KALM_CHICK	reviewed	Anosmin-1 (Kallmann syndrome protein homolog)	ANOS1 KAL KAL1	Gallus gallus (Chicken)	675	cell adhesion [GO:0007155]	 GO:0005576			cd00063;	PF00041;PF00095;	cell surface [GO:0009986]; extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC100535716.2.3|m.39162	470	13	2	7	11	13	13	0.545	0.545	2.0095	2.0095	0	0	0.559787	CHOYP_LOC100535716.2.3|m.39162	P33005	KALM_CHICK	50.94	53	24	1	163	213	115	167	7.00E-10	65.1	1	P33005	KALM_CHICK	reviewed	Anosmin-1 (Kallmann syndrome protein homolog)	ANOS1 KAL KAL1	Gallus gallus (Chicken)	675	cell adhesion [GO:0007155]	 GO:0007155			cd00063;	PF00041;PF00095;	cell surface [GO:0009986]; extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
CHOYP_LOC100535716.2.3|m.39162	470	13	2	7	11	13	13	0.545	0.545	2.0095	2.0095	0	0	0.559787	CHOYP_LOC100535716.2.3|m.39162	P33005	KALM_CHICK	50.94	53	24	1	163	213	115	167	7.00E-10	65.1	1	P33005	KALM_CHICK	reviewed	Anosmin-1 (Kallmann syndrome protein homolog)	ANOS1 KAL KAL1	Gallus gallus (Chicken)	675	cell adhesion [GO:0007155]	 GO:0009986			cd00063;	PF00041;PF00095;	cell surface [GO:0009986]; extracellular region [GO:0005576]; serine-type endopeptidase inhibitor activity [GO:0004867]; cell adhesion [GO:0007155]
